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ABSTRACT
INTRODUCTION
Diabetes is a worldwide epidemic, causing a high disease and economic burden. Type 2 diabetes, 
the most common form of diabetes, is associated with overweight and obesity and an unfavourable 
lifestyle, including unhealthy diet and physical inactivity. Over the last two decades, many large-
scale experimental trials have shown that type 2 diabetes can be delayed or prevented by lifestyle 
modification in high-risk subjects. This evidence has been translated and implemented in 
interventions in real-world settings, however, no (cost)effective diabetes prevention programme 
in Dutch primary health care was available at the start of the current project in 2008. Therefore the 
SLIMMER study (SLIM iMplementation Experience Region Noord- en Oost-Gelderland) was started 
in which the SLIM intervention, revealing a 47% diabetes risk reduction, was translated to Dutch 
primary health care. The aim of this thesis was to implement the SLIMMER intervention in Dutch 
primary health care and to evaluate its (cost)effectiveness and implementation.
METHODS
In 2010-2011, the SLIMMER intervention was tested for its feasibility and desired impact in a one-
year pilot study (n = 31) with process evaluation, including quantitative and qualitative methods. 
From 2011 to 2014, the SLIMMER intervention was implemented on a larger scale in Dutch public 
health and primary health care. A randomised controlled trial was conducted (n = 316), including 
subjects aged 40 to 70 years with impaired fasting glucose or high risk of diabetes. The 10-month 
SLIMMER intervention involved a dietary and physical activity programme, including case 
management and a maintenance programme. The control group received usual health care. A 
logic model of change was composed to link intervention activities with intervention outcomes in 
a logical order. Primary outcome was fasting insulin. Measurements were performed at baseline 
and after 12 and 18 months and covered quality of life, clinical and metabolic risk factors (e.g. 
glucose tolerance, serum lipids, body fatness, and blood pressure), and eating and physical activity 
behaviour. Furthermore, a process evaluation including quantitative and qualitative methods 
was conducted. Data on process indicators (recruitment, reach, dose received, acceptability, 
implementation integrity, and applicability) were collected in semi-structured interviews with 
health care professional (n = 45) and intervention participant questionnaires (n = 155). Moreover, 
cost-effectiveness analyses were performed from both a societal and a health care perspective. 
Participants completed questionnaires to assess health care utilisation, participant out-of-pocket 
costs, and productivity losses. 
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RESULTS
The pilot study showed that participants lost on average 3.5 kg (p = 0.005) of their body weight. 
Both participants and health care professionals were satisfied with the intervention, which was 
implemented as planned and appeared to be suitable for application in practice. Refinements were 
identified and made prior to further implementation. The randomised controlled trial showed that 
after 12 and 18 months, the intervention group significantly improved weight (β=-2.7 kg (95% CI: 
-3.7;-1.7) and β=-2.5 kg (95% CI: -3.6;-1.4), respectively), and fasting insulin (β=-12.1 pmol/l (95% 
CI: -19.6;-4.6) and β=-8.0 pmol/l (95% CI: -14.7;-0.53), respectively) compared with the control 
group. Intervention subjects improved weight and glucose tolerance, independent of manner of 
recruitment (laboratory glucose test or Diabetes Risk Test). Furthermore, intake of total and saturated 
fat decreased and fibre intake increased in the intervention group compared with the control group, 
both at 12 and 18 months (p < 0.05). The DHD-index score – indicating adherence to the Dutch 
dietary guidelines – was significantly higher in the intervention group than in the control group, 
both at 12 and at 18 months (p < 0.05). Vigorous activities and physical fitness improved both at 12 
and at 18 months. Finally, beneficial changes in several domains of quality of life were found both 
at 12 and at 18 months, although not all domains reached statistical significance. From the process 
evaluation it was revealed that it was possible to recruit the intended high-risk population, and the 
SLIMMER intervention was very well received by both participants and health care professionals. The 
intervention programme was to a large extent implemented as planned and was applicable in Dutch 
primary health care. Higher dose received and participant acceptability were related to improved 
health outcomes and dietary behaviour, but not to physical activity behaviour. The cost-effectiveness 
analysis showed that, from a societal perspective, the incremental costs of the SLIMMER lifestyle 
intervention were €547 and that the incremental effect was 0.02 QALY, resulting in an incremental 
cost-effectiveness ratio (ICER) of 28,094/QALY. When cost-effectiveness was calculated from a health 
care perspective, the ICER decreased to 13,605/QALY, with a moderate probability of being cost-
effective (56% at a willingness to pay (WTP) of €20,000/QALY and 81% at a WTP of €80,000/QALY.
CONCLUSION
In conclusion, this study showed that a thorough preparation of translation and implementation 
has led to a cost-effective intervention to prevent type 2 diabetes which is feasible to implement 
in Dutch primary health care. In fact, our clinical effects were larger than those in most other 
real-world intervention programmes, and most effects sustained at 18 months. Furthermore, 
we showed that a higher intervention dose and participant acceptability were associated with 
improved health outcomes and dietary behaviour. Further research is needed on effects and 
costs over longer follow-up, effective intervention components, and consequences of suggested 
adaptations of the programme on intervention effectiveness. The results of this study provide 
valuable insights that can contribute to structural embedding and funding of effective diabetes 
prevention programmes in Dutch primary health care. 
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DIABETES MELLITUS
Diabetes mellitus is a chronic non-communicable metabolic disorder of glucose 
homeostasis that occurs when the pancreas is no longer able to produce insulin 
(β-cell dysfunction), or when the body is resistant to insulin (insulin resistance) [1, 2]. 
The body needs insulin to absorb glucose from the blood into the cells of the body to 
produce energy. Insulin deficiency and insulin resistance will lead to increased levels of 
glucose in the blood. There are three main types of diabetes. Type 1 diabetes is caused 
by an autoimmune reaction in which the β-cells in the pancreas do not produce insulin 
anymore. Type 2 diabetes is characterised by insulin resistance and relative insulin 
deficiency. The third type, gestational diabetes, consists of high blood glucose levels 
during pregnancy [1].
The history of diabetes mellitus dates back to ancient times when symptoms and 
remedies for treatment of excessive urination were described for the first time [3]. The 
physician Aretaeus (130-200 AC) was the first to use the term diabetes, derived from the 
Greek word for siphon, which means ‘the flow of liquids through tubes’. Later, the Greek 
word mellitus, meaning ‘the smell, colour, and flavour of honey’, was added to the name, 
to reflect the sweet taste and smell of patients’ urine [3]. At that time, diabetes mellitus 
was a rare disease. Nowadays, diabetes is expanded to a worldwide epidemic with 382 
million people affected in 2013 [1]. It is estimated that this number will increase to 592 
million by 2035. In the Netherlands, 834.100 people were diagnosed with diabetes in 
2011. Furthermore, it is estimated that about 25% of people with diabetes have not been 
diagnosed yet and thus are unaware of their disease [4]. 
Type 2 diabetes is the most common form of diabetes, accounting for 90% of all 
diabetes cases [4]. Genetic factors and environmental aspects together are important 
determinants of the development of diabetes [2]. Type 2 diabetes usually occurs in adults 
but nowadays is increasingly seen in children and adolescents [1]. Type 2 diabetes may 
remain undiagnosed for many years, leading to severe complications like retinopathy, 
nephropathy, neuropathy, and cardiovascular diseases [5]. It was estimated that 5.1 
million people aged between 20 and 79 years died from diabetes in 2013, accounting 
for 8.4% of global all-cause mortality among people in this age group [1]. In addition to 
this disease burden, diabetes causes a large economic burden. Diabetes costs at least 
USD 548 billion in health expenditure in 2013, accounting for 10.8% of total health care 
expenditure worldwide [1]. In the Netherlands, diabetes health care costs amounted 1.7 
billion Euros in 2011, which is 1.9% of total health care expenditure [4].  
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DIAGNOSIS OF TYPE 2 DIABETES AND PREDIABETES
According to the World Health Organization (WHO), diabetes is defi ned as fasting 
plasma glucose ≥7.0 mmol/l (126 mg/dl) or 2-hour plasma glucose ≥11.1 mmol/l (200 
mg/dl) (see Table 1.1) [6]. In 2011, WHO concluded that HbA1c can also be used as a 
diagnostic test for diabetes in which an HbA1c of 6.5% is recommended as the cut-off 
point [7]. As the onset of type 2 diabetes is gradual, most individuals progress through 
a state of prediabetes (intermediate hyperglycaemia), a high-risk state for diabetes 
development and adverse outcomes. Prediabetes is typically defi ned as blood glucose 
concentrations higher than normal, but lower than diabetes thresholds. According to 
WHO, individuals at risk have one or both prediabetic conditions: impaired fasting 
glucose (IFG), defi ned as fasting plasma glucose (FPG) concentration of 6.1 to 6.9 
mmol/l (110 to 125 mg/dl) and, if measured, a 2-hour plasma glucose of <7.8 mmol/l (140 
mg/dl); and impaired glucose tolerance (IGT), defi ned as an FPG concentration of <7.0 
mmol/l (126 mg/dl) and a 2-hour plasma glucose concentration of ≥7.8 and <11.1 mmol/l 
(140 and 200 mg/dl), measured during a 75 g oral glucose tolerance test [6]. In 2013, 
316 million people worldwide, or 6.9% of adults, were estimated to have IGT and this 
number is expected to increase to 471 million, or 8% of the adult population, by 2035 [1]. 
In 2010, approximately 8% of the Dutch population aged 30-70 years had prediabetes 
(IFG or IGT) [8]. Around 5-10% of people with prediabetes become diabetic every year 
and up to 70% of individuals with prediabetes will eventually develop diabetes [9]. 
Table 1.1. Diagnostic criteria for diabetes and intermediate hyperglycaemia (according to the World Health 
Organization) [6, 7].
Type 2 diabetes
Fasting glucose (mmol/l)a OR ≥7.0 mmol/l (126 mg/dl)
2-hour glucose (mmol/l)a,b ≥11.1 mmol/l (200 mg/dl)
HbA1c ≥6.5%
Impaired Fasting Glucose (IFG)
Fasting glucose (mmol/l)a ANDc 6.1 to 6.9 mmol/l (110 to 125 mg/dl)
2-hour glucose (mmol/l)a,b <7.8 mmol/l (140 mg/dl)
Impaired Glucose Tolerance (IGT)
Fasting glucose (mmol/l)a AND <7.0 mmol/l (126 mg/dl)
2-hour glucose (mmol/l)a,b ≥7.8 and <11.1 mmol/l (140 and 200 mg/dl)
a Venous plasma glucose concentration.
b Measured two hours after ingestion of 75 g oral glucose load.
c If only fasting glucose concentration is measured, IGT cannot be excluded.
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RISK FACTORS FOR TYPE 2 DIABETES
Type 2 diabetes is caused by a combination of genetic factors and environmental 
aspects [2]. Several genetic variants that are associated with type 2 diabetes have been 
identified, however, their contribution to the development of type 2 diabetes is modest 
(5-10%) [10]. Other non-modifiable risk factors are for example advancing age, ethnicity, 
family history of diabetes, and maternal diabetes [1]. The rapidly increasing incidence 
rates of diabetes, however, suggest a particularly important role for environmental 
aspects in the development of diabetes. This paragraph summarises the evidence for 
the major risk factors of type 2 diabetes, namely overweight and obesity, unhealthy diet, 
and physical inactivity. 
Overweight and obesity
Overweight, and especially obesity, is a major risk factor for the development of type 2 
diabetes [11, 12], especially when the excess adiposity is centrally distributed [13]. In obese 
subjects, adipose tissue releases increased amounts of fatty acids, glycerol, hormones, 
pro-inflammatory cytokines, and other factors that are involved in the development 
of insulin resistance [13]. There is convincing evidence for the association between 
excessive weight gain, central adiposity, and the development of type 2 diabetes. This 
association has been shown in several longitudinal studies in different populations, 
with a striking increase in risk apparent with increasing levels of Body Mass Index, waist 
circumference, or waist-to-hip ratio [14]. The risk of developing type 2 diabetes is almost 
three times higher when being overweight and seven times higher when being obese 
compared with normal weight persons [15]. Several randomised controlled trials have 
shown that weight loss could reduce the risk of progression from IGT to type 2 diabetes, 
even when there is a relatively small reduction in weight [16-20].
Unhealthy diet
The composition of diet seems to be an important factor in the prevention of type 2 
diabetes. Both international and national guidelines recommend a diet with increased 
dietary fibre and whole grains intake and reduced calorie and saturated fat intake 
[14, 21-23]. A diet high in carbohydrates can have adverse metabolic consequences 
by raising triglycerides and reducing high-density lipoprotein (HDL) cholesterol 
[24]. Carbohydrates can be divided in whole grains and other less-refined complex 
carbohydrates (e.g. dietary fibre), and highly refined starches and sugars [25]. Several 
prospective studies showed a reduced risk for high intake of dietary fibre from grains on 
the development of type 2 diabetes [26-30]. The evidence for the association between 
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dietary fi bre and type 2 diabetes is graded as probable because it is not clear which form 
of dietary fi bre causes the effect [14]. 
The total amount of dietary fat has been shown to have only a minor, and in most 
studies even no effect on the risk of developing type 2 diabetes [14, 29, 31, 32]. There 
is, however, probable evidence for a moderate association between total fat intake 
and body weight [33]. The quality of dietary fat intake appears to be more important 
than the quantity [29]. Several reviews showed that saturated fat intake was associated 
with an increased risk of type 2 diabetes [29, 34, 35]. A recent systematic review, 
however, did not fi nd any clear associations between intake of saturated fat and type 
2 diabetes [33]. Epidemiologic studies generally did not fi nd an association between 
monounsaturated fatty acid (MUFA) intake and type 2 diabetes [27, 33, 36], but MUFA 
had a benefi cial effect on insulin sensitivity and fasting insulin concentration [33, 34]. 
There is possible evidence of a relationship between polyunsaturated fatty acid (PUFA) 
intake and reduced risk of type 2 diabetes [31, 32, 34, 35]. Furthermore, there is possible 
evidence that trans fatty acids are positively associated with a risk of type 2 diabetes 
[29, 34, 35]. Mechanisms underlying the relationship between dietary fat and risk of 
type 2 diabetes are still unclear, but potential mechanisms include alteration of cell 
membrane functioning, regulation of gene expression and enzyme activities, and 
influencing inflammation status [35].
Dietary protein intake is suggested to have positive effects on weight loss, weight 
maintenance, and glycaemic control due to its effect on satiety, appetite, and insulin 
sensitivity [37, 38]. In contrast, several long-term observational studies reported an 
association between high protein intake and increased risk of type 2 diabetes [39, 40]. 
Recently, a large European cohort study showed that high total and animal protein 
intake was associated with a modest elevated risk of type 2 diabetes [41]. Research 
suggests that the source of protein intake might be of relevance. Type 2 diabetes risk was 
associated with higher meat consumption, especially red and processed meat [42-44]. 
High intakes of dairy products, low-fat dairy products, and cheese were associated with 
a decreased risk of type 2 diabetes [45]. No consistent evidence exists on the association 
between fi sh consumption and the risk of type 2 diabetes, possibly due to heterogeneity 
among populations [46, 47].
Moderate alcohol intake (1-2 drinks per day) has been associated with reduced risk 
of type 2 diabetes [48, 49]. The mechanisms behind this association are unclear, but 
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there are several factors that may explain the relationship, including increases in insulin 
sensitivity after low levels of alcohol consumption [50]. A prospective study showed 
that moderate alcohol consumption combined with healthy lifestyle behaviours add 
to a decreased risk of type 2 diabetes [51].
In conclusion, there is no definite consensus on which dietary treatment is most 
appropriate to prevent development of type 2 diabetes and weight gain [37, 52]. 
Lifestyle interventions, however, have shown that an increased intake of dietary fibre 
and a reduced intake of total fat and saturated fat in combination with modest weight 
reduction and increased physical activity could reduce the risk of type 2 diabetes in 
subjects with glucose intolerance even many years after the end of the intervention 
[16-18, 53-56]. 
Physical inactivity
Physical inactivity is the fourth leading cause of global mortality [57] and data show 
that 31% of the world’s adult population is physically inactive [58]. Evidence shows that 
physical inactivity increases the risk of coronary heart disease, type 2 diabetes, and breast 
and colon cancer, and shortens life expectancy [59]. Additionally, physical activity is a key 
determinant of energy expenditure, thereby contributing to energy balance and weight 
control [57]. Worldwide it was estimated that physical inactivity causes 7% of the burden 
of disease from type 2 diabetes [59]. Several studies have shown that increased physical 
activity can reduce the risk of type 2 diabetes [16-18, 60, 61]. A potential mechanism for 
the beneficial effects of physical activity is that it increases glucose uptake into active 
muscles, which improves insulin sensitivity [62]. Furthermore, physical activity may help 
produce weight loss, thereby contributing to improved insulin sensitivity. The American 
Diabetes Association and the American College of Sports Medicine have stated that a 
combination of aerobic exercise training and resistance training should be undertaken 
to prevent type 2 diabetes in high-risk adults [63, 64]. In these guidelines, it is advised 
to perform at least 150 min/week of moderate-intensity aerobic physical activity, spread 
over at least three days per week with no more than two consecutive days without 
exercise. In addition, these guidelines suggest that moderate or vigorous resistance 
training that involves the major muscle groups should be undertaken at least twice 
weekly on non-consecutive days [63]. A recent meta-analysis showed that interventions 
with combined aerobic and resistance training might be the most efficacious exercise 
modality to improve glycaemic control and blood lipids compared to the isolated effects 
of either aerobic or resistance training [65]. 
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PREVENTION OF TYPE 2 DIABETES BY LIFESTYLE MODIFICATION
Type 2 diabetes can be prevented when modifi able risk factors are avoided. Lifestyle 
modifi cation, therefore, could be a successful strategy to tackle the diabetes epidemic. 
This paragraph summarises evidence on diabetes prevention from lifestyle interventions 
in experimental and real-world settings and their effects on the long term.
 
Lifestyle interventions in experimental settings
Over the last two decades many large-scale randomised controlled trials have shown 
that type 2 diabetes can be delayed or prevented by lifestyle intervention in many 
individuals at high risk. In 1986, the Chinese Da Qing IGT and diabetes study was one 
of the fi rst studies to investigate whether diet and exercise interventions in subjects 
with IGT could delay the development and reduce the incidence of type 2 diabetes 
[55]. Five hundred seventy-seven subjects with IGT were randomised into one of 
four groups: diet-only, exercise-only, diet plus exercise, or control group. Follow-up 
examinations were conducted over a 6-year period to identify subjects who developed 
type 2 diabetes. At six years, there was an overall reduction in the incidence of diabetes 
of 31% in the diet-only group, 46% in the exercise-only group, and 42% in the diet plus 
exercise group [55]. After 23 years of follow-up, diabetes incidence in the intervention 
group (all three active treatment groups combined) was signifi cantly lower than in the 
control group (73 vs. 90%) [56]. In the Finnish Diabetes Prevention Study (DPS) it was 
aimed to evaluate whether an intensive diet plus exercise programme could prevent or 
delay type 2 diabetes [16]. In this large trial, 522 subjects with overweight and IGT were 
randomised to either the lifestyle intervention group or the control group. The lifestyle 
intervention, with a median follow-up period of four years, involved tailored advice 
aimed at weight reduction, total and saturated fat intake reduction, and increased fi bre 
intake and physical activity. After four years of intensive intervention, the relative risk 
reduction was 58% [16]. Seven years after baseline, a 43% reduction in the relative risk 
was shown and after 13 years from baseline, there was a 38% risk reduction [53]. The US 
Diabetes Prevention Program (DPP) was developed to evaluate the effi cacy of both an 
intensive lifestyle intervention and standard lifestyle recommendations combined with 
metformin in preventing or delaying the development of type 2 diabetes [66]. A total 
of 3,234 subjects with elevated fasting and post-load plasma glucose concentrations 
were randomised into one of three groups: lifestyle modifi cation group, metformin, or 
control group. The lifestyle modifi cation programme consisted of a 16-lesson curriculum 
covering diet, exercise, and behaviour modifi cation and was aimed to achieve and 
maintain a weight reduction of at least 7% of initial body weight, and to achieve and 
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maintain a level of moderate-intensity physical activity of at least 150 minutes per week. 
The mean follow-up period was 2.8 years. At the end of the study period, the lifestyle 
intervention reduced diabetes incidence by 58% and metformin by 31% compared with 
the control group [17]. Ten years after randomisation, diabetes incidence was reduced 
by 34% in the lifestyle group and 18% in the metformin group compared with the 
control group [54]. In the Netherlands, the Study on Lifestyle intervention and Impaired 
glucose tolerance Maastricht (SLIM) was designed to evaluate the effect of a combined 
diet and physical activity intervention programme on glucose tolerance in subjects with 
IGT [67, 68]. A total of 147 subjects were randomised to the lifestyle intervention group 
or the control group. The lifestyle intervention, with a mean follow-up period of 4.1 years 
(range 3-6 years), consisted of personal advice on dietary intake and physical activity 
and participants were encouraged to participate in a combined aerobic and resistance 
exercise programme. This study has shown 58% reduction in diabetes risk after three 
years of intervention and 47% reduction at the end of the intervention [18, 68].
Lifestyle interventions in real-world settings
The evidence from studies in experimental settings calls for translation and 
implementation of diabetes prevention programmes in real-world settings to guide 
diabetes prevention policies. As real-world settings are complex and limited in finances 
and resources, it is a challenge to implement cost-effective and sustainable interventions 
[69-71]. Real-world diabetes prevention programmes have been investigated in several 
studies. Multiple reviews showed significant reductions in weight but inconclusive 
results for metabolic indicators of diabetes risk, such as blood glucose or HbA1c [70-
74]. In 2003-2008, the Finnish National Program for the Prevention of Type 2 Diabetes 
(FIN-D2D) was one of the first large-scale nationwide diabetes prevention programme 
in the world, aimed to include prevention of diabetes and reduction of cardiovascular 
risk factor levels among high-risk individuals in daily routines in health care centres 
and occupational health care clinics [75]. Altogether 10,149 individuals at high risk of 
diabetes were identified and followed up for one year. The lifestyle intervention consisted 
of either individual counselling visits or group sessions, focused on weight control, 
dietary intake, and exercise. After one-year follow-up, weight loss was on average 1.1 kg, 
waist circumference reduced by 1.3 cm, blood pressure decreased, and the lipid profile 
changed in a less atherogenic direction. Altogether 17.5% of the subjects lost ≥5% weight. 
Diabetes risk reduced by 69% in the group who lost ≥5% weight compared with the 
group who maintained weight [75]. The US DPP has been translated and implemented 
in many real-world settings like community environments and health care facilities. 
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Ali et al. summarised 28 lifestyle interventions that were modelled on the DPP [76]. 
These programmes consisted of individual or group sessions, or a combination of both, 
and the median study duration was twelve months. Across all studies, mean weight 
change was -3.99% at 12-month follow-up [76]. In the Netherlands, several studies 
were conducted in primary health care settings. Most of these studies showed modest, 
albeit non-signifi cant, changes in body weight and no changes in risk factors like dietary 
intake and physical activity [77-80]. 
Maintenance of lifestyle modifi cation
To ensure diabetes prevention, lifestyle modifi cations need to be maintained in the 
long term. Lifestyle interventions that were conducted in experimental settings have 
shown that reduced diabetes risk can be sustained over long term, up to 23 years after 
baseline [53, 54, 56]. However, current evidence for sustainability and long-term clinical 
benefi ts of lifestyle interventions in real-world settings is limited [70, 73, 81]. It has been 
shown that maintaining weight loss reduced diabetes incidence [19, 20], however, it 
is well-known that weight regain is common [82, 83], even in successful lifestyle 
interventions [53, 54]. Factors that might facilitate maintenance of behaviour change 
are social support, self-effi cacy, and relapse prevention strategies, while comorbidities, 
lack of time, and psychological stress are perceived as barriers for maintenance [84-86].
EXPLAIN INTERVENTION EFFECTIVENESS
A comprehensive evaluation approach is required, as interventions in real-world 
settings are often complex and not delivered in tightly controlled environments [87, 
88]. Within this approach, the scope of evaluation research needs to be broaden from 
assessing only effectiveness to also getting insight in intervention characteristics 
(e.g. setting, delivery mode, intervention provider), intervention components (e.g. 
behaviour change techniques and strategies), and intervention implementation [89, 
90]. This will provide insight in the so-called ‘black-box’, that is identify aspects that 
explain what works, how, and why [87, 88]. Therefore, studies need to include a process 
evaluation to establish the validity of the hypothesised causal processes for behaviour 
change, and taxonomies can be used to describe behaviour change techniques used to 
modify these processes [90]. Several systematic reviews on dietary or physical activity 
interventions (or both), showed that greater intervention effectiveness was associated 
with targeting both diet and physical activity [90], mobilising social support [90], and 
the use of behaviour change techniques (e.g. self-monitoring, relapse prevention, and 
individual tailoring) [90-92]. Furthermore, effectiveness was associated with using 
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self-regulatory techniques (goal setting, self-monitoring, and providing feedback on 
performance) [90, 92] and providing higher intensity interventions [74, 90, 93]. There 
were no clear associations between intervention effectiveness and setting, delivery 
mode, delivery provider, or study population [74, 90, 93]. 
ECONOMIC EVALUATION OF TYPE 2 DIABETES PREVENTION
In addition to insight into effective intervention components, it is also important to 
gain insight into costs and benefits of lifestyle interventions for several reasons. Firstly, 
diabetes causes a large economic burden [1] and resources are limited [69]. Secondly, 
policymakers need to be provided with information to make a decision whether or not 
to sustain and implement lifestyle interventions in the real world [94]. A review found 
evidence for cost-effectiveness of diabetes prevention interventions in experimental 
settings [95], including the DPP and DPS lifestyle interventions [96, 97]. Also the Dutch 
SLIM study proved to be cost-effective: the cost-effectiveness ratio for the lifestyle 
intervention was € 3,900-5,500 per QALY [98]. Although evidence is accumulating 
that lifestyle modification may be cost-effective in prediabetic patients, information 
on cost-effectiveness of interventions implemented in community and primary health 
care settings is limited [99]. Evidence from well-conducted pragmatic trials is needed 
to gain insight into cost-effectiveness of diabetes prevention interventions in real-world 
settings. Nowadays, this information becomes more and more available. Recently, a 
systematic review found that diet and physical activity programmes, mostly based 
on the DPP and DPS studies, were cost-effective from a health care perspective [99]. 
However, a Dutch study that investigated the cost-effectiveness of a primary care lifestyle 
intervention for prevention of type 2 diabetes and cardiovascular disease showed that 
the intervention was cost-saving without being effective [100]. Another Dutch study, 
on the prevention of weight gain among employees, failed to reveal cost-effectiveness 
too [101]. It should be considered that comparing results of economic evaluations is 
difficult because of the diverse nature of lifestyle interventions and methodological 
differences [102].
THE SLIMMER STUDY: RATIONALE AND OBJECTIVES
Although prevention of type 2 diabetes by lifestyle modification has been shown to 
be effective, translation and implementation of a (cost-)effective diabetes prevention 
programme in Dutch primary health care was lacking at the start of this study. Therefore 
the SLIMMER study (SLIM iMplementation Experience Region Noord- en Oost-
Gelderland) was started in which the SLIM intervention, revealing a 47% risk reduction 
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[18], was translated to Dutch primary health care. The SLIMMER study was aimed to 
reduce the risk of developing type 2 diabetes by improving lifestyle behaviour in subjects 
at high risk. The SLIMMER study was a randomised, controlled intervention study, carried 
out in Apeldoorn and Doetinchem, two cities in the eastern part of the Netherlands, 
by a consortium of Wageningen University and the community health service Noord- 
en Oost-Gelderland. The project was coordinated by the community health service 
in close collaboration with both municipalities. The SLIMMER intervention, which 
resembled the SLIM intervention [18], was a 10-month combined lifestyle intervention 
consisting of a dietary and physical activity component, including case management 
and a maintenance programme. The SLIMMER intervention was implemented in Dutch 
public health and primary health care, involving general practitioners and their practice 
nurses, dieticians, physiotherapists, and sports clubs.
The overall objectives of the SLIMMER study were (1) to translate the SLIM intervention 
into the SLIMMER intervention and implement this SLIMMER intervention in Dutch 
primary health care, and (2) to investigate the effectiveness of the SLIMMER intervention 
in Dutch primary health care. 
During the fi rst phase of the SLIMMER study (2008-2010), the evidence-based SLIM 
intervention [18] was translated into the SLIMMER intervention (Figure 1.1). This 
was done in a joint decision-making process between SLIM intervention developers 
and local health care professionals. This translational process has been described by 
Jansen et al. [103]. During the second phase (2010-2011), the SLIMMER intervention 
was pilot-tested (n = 31) in the municipality of Apeldoorn, using a one group pre-test 
post-test design. During the last phase (2011-2014), a large-scale implementation of the 
SLIMMER intervention (n = 316) was conducted, using a randomised controlled design. 
A maintenance programme has been developed and integrated into the 10-month 
SLIMMER intervention, which has been described by Elsman et al. [104]. Process, effect 
and economic evaluations have been performed. 
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•Translation 
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•SLIMMER 
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2011-2014 
•SLIMMER 
evaluation 
study  
Figure 1.1. Timeline of the SLIMMER project.
In this thesis the following research objectives are addressed:
1.  To describe and investigate the feasibility and impact of the SLIMMER intervention 
in Dutch primary health care (Chapters 2 and 3). 
2.  To investigate the effectiveness of the SLIMMER intervention in Dutch primary 
health care on behavioural determinants, eating and physical activity behaviour, 
health, and quality of life (Chapters 4 and 5).
3.  To examine the implementation of the SLIMMER intervention in Dutch primary 
health care (Chapter 6).
4.  To assess the cost-effectiveness of the SLIMMER intervention in Dutch primary 
health care (Chapter 7).
OUTLINE OF THIS THESIS 
This thesis is based on a pilot study and a randomised controlled trial conducted 
between 2010 and 2014 in Apeldoorn and Doetinchem in the Netherlands in adults at 
high risk of developing type 2 diabetes.
 
Chapter 2 gives an overview of the translation of the SLIM diabetes prevention 
intervention to a Dutch real-world setting, with special attention for the roles of 
general practitioners and other professionals in implementing lifestyle intervention 
programmes in primary health care. Furthermore, it is discussed what is known from 
literature about translation of trials to primary health care and what the role perception 
is of professionals working in primary health care. 
Chapter 3 describes the effect of the SLIMMER pilot study (n = 31) on the feasibility and 
desired impact. Furthermore, refi nements are identifi ed that are made prior to further 
implementation and evaluation. 
Chapter 4 presents the background and methods of the SLIMMER randomised 
controlled trial investigating the effectiveness of an intensive lifestyle intervention in 
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primary health care. A logic model of change which links intervention activities with 
intervention outcomes in a logical order is given, as well as a detailed description of 
the study design, setting, study population, lifestyle intervention programme, and the 
evaluation design. 
Chapter 5 describes results of the randomised controlled trial (n = 316) in which 
effectiveness of the SLIMMER intervention on clinical and metabolic risk factors, dietary 
intake, physical activity, and quality of life after 12 months was assessed. In addition, 
results on maintenance of effects after 18 months are described. 
Chapter 6 presents results of the process evaluation, using an extensive evaluation plan 
with quantitative and qualitative methods. This chapter describes how the SLIMMER 
intervention was delivered and received in Dutch primary health care and how this 
could explain intervention effectiveness. 
Chapter 7 describes the economic evaluation of the SLIMMER intervention. Cost-
effectiveness of the SLIMMER intervention compared with usual health care was 
assessed from both a societal and health care perspective. Sensitivity analyses were 
performed to assess cost-effectiveness using different input parameters.
Chapter 8 summarises the main fi ndings of this thesis and discusses methodological 
issues. The results are discussed in a broader perspective and implications for primary 
health care, Dutch health policy, and future research are given.
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Chapter 2
Translating the SLIM diabetes prevention 
intervention into SLIMMER: implications for the 
Dutch primary health care
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ABSTRACT
All over the world, prevalence and incidence rates of type 2 diabetes mellitus are rising 
rapidly. Several trials have demonstrated that prevention by lifestyle intervention is 
(cost-) effective. This calls for translation of these trials to primary health care. This article 
gives an overview of the translation of the SLIMMER diabetes prevention intervention to 
a Dutch real-life setting and discusses the role of primary health care in implementing 
lifestyle intervention programmes. Currently, a 1-year pilot study, consisting of a 
dietary and physical activity part, performed by three GPs, three practice nurses, three 
dieticians and four physiotherapists is being conducted. The process of translating 
the SLIM lifestyle intervention to regular primary health care is measured by means 
of the process indicators: reach, acceptability, implementation integrity, applicability 
and key factors for success and failure of the intervention. Data will be derived from 
programme records, observations, focus groups and interviews. Based on these results, 
our programme will be adjusted to fit the role conception of the professionals and the 
organization structure in which they work. 
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INTRODUCTION
All over the world, prevalence and incidence rates of type 2 diabetes mellitus (T2DM) 
are rising rapidly [1]. This trend is also seen in the Netherlands. It is expected that the 
number of people with diagnosed diabetes will double to 1.3 million in 2025, accounting 
for 8% of the total population [2]. This rising problem contributes to a large disease 
and economic burden. In 2005, the costs for diabetes care amounted to a total of 813.8 
million Euros, accounting for 1.2% of the total health care costs in the Netherlands [3]. 
In addition, ~30% of the Dutch population aged ≥60 years suffers from pre-diabetes 
[impaired glucose tolerance (IGT) and/or impaired fasting glucose] and approximately 
one-third to two-thirds of them are expected to develop T2DM within 6 years [4].
Theoretically, over 50% of the expected increase in the number of diabetes patients 
can be avoided by prevention, especially when focussing on high-risk groups with 
pre-diabetes [2]. Several international trials have demonstrated a 29-67% reduction in 
the incidence of T2DM for adults with IGT who participated in lifestyle interventions 
targeting dietary behaviour and activity pattern [5-9]. The potential for cost savings due 
to such interventions is also considerable. Roumen et al. [10] concluded in their review 
that, in general, the implementation of lifestyle intervention as a therapy to prevent and 
postpone T2DM and its complications looks promising, and cost-effectiveness seems 
acceptable.
The Dutch SLIM study (Study on Lifestyle intervention and Impaired glucose tolerance 
Maastricht) was designed to investigate whether a combined diet and physical activity 
intervention programme could improve glucose tolerance in subjects with a high risk 
for developing T2DM. In total, 147 subjects with IGT were randomly allocated to either 
the intervention or control group. The intervention programme, based on the Diabetes 
Prevention Study (DPS), was developed in 1999, using a combination of theories, such 
as Stages of Change model [11] and the Theory of Planned Behaviour [12], and tools 
such as motivational interviewing [13] and goal setting. The intervention group received 
personal dietary advice by a skilled dietician, trained in motivational interviewing an 
goal setting, based on the Dutch guidelines for a healthy diet, during a 1-hour counselling 
session every 3 months. Additionally, subjects were advised to increase their level of 
physical activity to at least 30 minutes a day for at least 5 days a week. A body weight 
loss of 5-7% was the objective. Moreover, subjects were encouraged to participate in a 
combined aerobic- and resistance exercise programme at an intensity of at least 70% of 
their maximal peak oxygen consumption (VO2max). Control subjects were only briefly 
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informed about the beneficial effects of a healthy diet and physical activity, whereas 
no individual advice was provided [14, 15]. The SLIM study was effective in improving 
dietary composition, increasing VO2max and reducing diabetes risk by 47% over a mean 
period of 4.1 years at costs generally acceptable to society [15-17]. 
Internationally, more examples of diabetes prevention interventions are available. 
The Finnish DPS was the first large, well-controlled long-term lifestyle intervention to 
prevent diabetes. A total of 522 middle-aged, overweight subjects with IGT [based on 
two oral glucose tolerance tests (OGTTs)] were randomly allocated to either a control 
or intervention group. The control group received only general advice about healthy 
lifestyle at baseline. The intervention group had seven individual sessions with a study 
nutritionist during the first year and a session every 3 months thereafter aimed at 
reducing weight by consuming a healthy diet. Intervention subjects were also guided 
individually to increase their physical activity. After a mean follow-up time of 3.2 years, 
the risk of diabetes was reduced by 58% in the intervention group. After an extended 
follow-up time of in total 7 years, the relative risk reduction was still 43% [7]. Furthermore, 
the lifestyle intervention was estimated to be cost saving for the health care payer and 
highly cost-effective for society as a whole [18]. 
The US Diabetes Prevention Program (DPP) compared the efficacy of an intensive 
lifestyle intervention (intervention group) with standard lifestyle recommendations 
(control group). A total of 3234 high-risk subjects with IGT and slightly elevated 
fasting plasma glucose (FPG) were recruited. Lifestyle intervention in this study was 
primarily undertaken by case managers called lifestyle coaches. The main goal of the 
DPP was to achieve and maintain a 7% weight reduction by consuming a healthy, 
low-calorie low-fat diet and to engage in physical activities of moderate intensity 
≥150 minutes/week. The lifestyle intervention commenced with a 16-session core 
curriculum with basic information about nutrition, physical activity and behavioural 
self-management, followed by a post-core adherence/maintenance phase. The DPP 
showed a 58% risk reduction at 2.8 years mean follow-up [19]. Furthermore, the 
lifestyle intervention showed to be cost-effective from both a health system and a 
societal perspective [20, 21].
Although diabetes prevention studies are available, they are not easily applicable in 
public health practice. This is due to the fact that experimental trials are designed to 
answer scientific questions on the relation between lifestyle and diabetes. They are 
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designed to secure a high internal validity, not to achieve a high external validity. They 
are therefore carried out under strictly controlled conditions that do not resemble 
everyday real-life. Thus, implementing these interventions in daily practice may 
require changes in, e.g. subject screening and selection; intervention frequency and 
duration; intervention strategy and materials and skills of professionals who deliver 
the intervention. These changes do have implications for the intervention (cost-) 
effectiveness.
In this article, we give an overview of the translation of the SLIM diabetes prevention 
intervention to a Dutch real-life setting, with special attention for the roles of GPs and 
other professionals in implementing lifestyle intervention programmes in primary 
health care. We will discuss what is known from literature about translation of trials 
to primary health care, and the role conception of professionals working in primary 
health care; how the SLIM lifestyle intervention will be translated into the SLIMMER 
intervention in order to be applicable in a Dutch primary health care setting and what 
the role of primary health care professionals is in implementing lifestyle interventions. 
TRANSLATING TRIALS INTO PRIMARY HEALTH CARE
Recently, all over the world, diabetes prevention trials are being implemented into 
daily practice. One example is the translation of the Finnish DPS to several Finnish 
and Australian primary health care community and workplace settings. The Finnish 
‘National Program for the Prevention of Type 2 Diabetes’ (FIN-D2D), based on the DPS, 
has been implemented in health care centres and occupational health care outpatient 
clinics [22]. Altogether 2798 individuals at high risk for diabetes were identifi ed in the 
general population by nurses with the Finnish diabetes risk score (FINDRISC; scoring 
≥15 points). High-risk individuals underwent an oral glucose tolerance test; the nurse 
or GP referred eligible individuals to a lifestyle intervention that focussed on weight 
management and physical activity. Several intervention alternatives were provided, 
like group intervention, individual intervention and self-initiated actions. The lifestyle 
interventions were delivered mostly by public health nurses in collaboration with 
local multi-professional teams. After 1 year of follow-up, the study showed benefi cial 
changes in cardiovascular disease risk factors and glucose tolerance in both sexes [22, 
23]. Furthermore, the Finnish ‘Good Ageing in Lahti Region’ (GOAL) study, also based 
on the DPS, was implemented in primary health care centres [23]. In each primary 
health care centre, patients with already-identifi ed risk factors were referred to the 
study nurse. Risk status was screened with the FINDRISC score; patients with a score 
37766 Duijzer.indd   33 31-12-15   11:50
34
≥12 point were recruited to the trial [24]. The intervention consisted of six sessions 
of task-oriented socio-behavioural group counselling by public health nurses over a 
period of 8 months. The study showed that a significant risk reduction at 12 months in 
weight, body mass index and serum total cholesterol was maintained at 36 months [25]. 
A comparable lifestyle intervention, based on the Finnish GOAL study, was conducted 
in Australian primary health care setting: the Greater Green Triangle (GGT) Diabetes 
Prevention Project. Patients were opportunistically screened by study nurses at local 
general practices with the FINDRISC score (scoring ≥12 points). The intervention was 
delivered by trained study nurses, dieticians and physiotherapists and found reductions 
in risk factors approaching those observed in clinical trials [26]. The DPS was also 
implemented in a Finnish airline company. Finnair employees were invited for an annual 
health examination, including physical examinations, laboratory tests, questionnaires 
and counselling by an occupational health nurse or physician [23]. The FINDRISC score, 
fasting blood glucose and/or glucose tolerance test were used to classify participants as 
having a low, increased or high risk of T2DM. Those with an increased or high risk were 
referred to a diabetes nurse or a nutritionist for individual counselling. Results of the 
effectiveness are not yet available [23]. 
Also the US DPP lifestyle intervention has been translated to a variety of settings, 
including YMCAs (Young Men’s Christian Associations), churches, primary care 
practice settings and health care settings [27]. Prevention screening assessments 
included collection of medical and family history, fasting lipid and glucose levels, 
blood pressure, height, weight and waist circumference. The goals and key learning 
objectives of the DPP curriculum have been maintained, but modifications to the 
DPP lifestyle intervention on implementation were made, including offering group 
delivery rather than individual delivery, reducing the number of core-curriculum 
sessions from 16 to 12, concentrating on healthy-food choices rather than the food 
pyramid specifically, emphasizing initially on fat intake and calories instead of fat 
intake only and introducing pedometer use during core sessions instead of during 
maintenance phase. The manual was also updated to reflect current standards 
[27]. The findings show improvements in dietary and physical behaviour that are 
comparable to those achieved in the DPP [27-31]. 
In short, international studies translated clinical diabetes prevention trials to a 
specific context, taking the health care system of the country concerned into account, 
as recommended by the IMAGE evidence-based guidelines on type 2 diabetes 
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prevention [32]. However, although international and Dutch effective studies exist, 
translation to Dutch practice is still lacking. 
TRANSLATING SLIM INTO SLIMMER
In the Netherlands, a project has been started to implement the SLIM intervention in 
a real-life setting. This project is called SLIMMER (SLIM iMplementation Experience 
Region gelre-ijssel) and consists of three steps: (i) translation of the SLIM intervention 
to practice, together with professionals from prevention and primary health care, (ii) 
implementation of the modifi ed intervention in a 1-year pilot study by three general 
practices, guided by process evaluation and (iii) extension of the SLIMMER intervention 
in primary health care, guided by effect evaluation and cost-effectiveness analyses.
In this article, we focus on the second step, the fi rst step will be described in detail in a 
separate article currently under construction. In short, a modifi ed Delphi technique was 
used with the aim of reaching a consensus between SLIM researchers and local health 
care professionals on the adaptations needed to make the SLIM intervention applicable 
in a Dutch real-life setting. In three rounds, key elements of the SLIM intervention were 
identifi ed, rated for applicability and adapted.
Pilot implementation, guided by process evaluation
In the second step, we will test the adapted SLIMMER intervention for its actual 
applicability in a Dutch primary health care setting. For this, a 1-year pilot study is 
currently being conducted in three general practices. A process evaluation is included, 
in order to assess reach, acceptability, implementation integrity, applicability and key 
factors for success and failure of the intervention. Elaborated information and data 
will be given in a forthcoming article on the results of the pilot study. Therefore, here 
subjects and methods will be described briefly.
Recruitment of subjects
Participants for the pilot were recruited by three GPs in the municipality of Apeldoorn 
(Figure 2.1) from their patient registration database in August and September 2010. 
Apeldoorn has been selected as pilot municipality because it can be considered as an 
average, middle-sized Dutch city (population 156000), representative for Dutch real-
life setting in general. The three selected GPs were assumed to be representative for 
their professional group in Apeldoorn and are considered as local pioneers in the fi eld 
of diabetes prevention. Each GP selected a sample of patients aged 40-65 years with 
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impaired fasting glucose (fingerprick fasting capillary blood glucose >5.6 and <6.0 
mmol/l or fasting venous blood glucose >6.1 and <6.9 mmol/l). Exclusion criteria were: 
not being able to speak the Dutch language; cognitive dysfunction or any co-morbidity 
that made participation in a lifestyle intervention impossible.
Figure 2.1. Map of the Netherlands with pilot municipality Apeldoorn.
The GPs sent all eligible patients a letter and flyer to inform them about the 
SLIMMER programme and to invite them for an information meeting. Two weeks 
after sending the invitation letter, practice nurses called the patients to invite them 
again for the information meeting and to motivate them to participate if necessary. 
A short non-response survey was conducted in case patients were not willing to 
participate. Finally, an information meeting was organized by the practice nurse in 
collaboration with the GP, a dietician and a physiotherapist. During this meeting, 
patients were given all details of the programme. They were also introduced to the 
professionals involved in the programme. After the information meeting, patients 
gave their written informed consent.
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Lifestyle intervention programme
The adapted SLIMMER intervention resembles the SLIM intervention (described in the 
introduction). In short, the programme consists of a dietary and physical activity part 
(Table 2.1). Six times per year, a skilled dietician gives personal dietary advice (30-60 
minutes per visit; in total 4 hours/year per participant) based on the Dutch guidelines 
for a healthy diet 2006 [33]. Individual consults instead of group-based consults are 
used because this is in accordance with the Dutch regular primary health care. The 
Dutch guidelines for a healthy diet refer to a carbohydrate intake of >50% of energy 
consumed (E%), a total fat intake of 30-35 E%, a saturated fat intake of <10 E%, a fi bre 
intake of >30 g/day and a protein intake of 1.2 g/kg body weight per day. Topics that 
are being discussed during visits are the Dutch guidelines for a healthy diet, artifi cial 
sweeteners and special occasions, e.g. a party. If desired, spouses can join the visits. 
In addition, the dietician organizes a group session aimed at sharing experiences, 
motivating each other and discussing the topic of label reading. Subjects are being 
encouraged to quit smoking, and if necessary drink less alcohol. A body weight loss of 
5-10% is the objective. Furthermore, the dietician encourages subjects to increase their 
physical activity level to at least 30 minutes a day for at least 5 days a week. The dietician 
uses motivational interviewing to assist individuals aiming to achieve a positive attitude 
towards changes in diet and physical activity. Goals for behavioural change are being set 
every visit, evaluated in the next visit and, if necessary, adjusted.
The physical activity part consists of a combined aerobic- and resistance exercise 
programme at the physiotherapist’s practice, in which subjects participate at an intensity 
of at least 60-90% of their maximal peak oxygen consumption (VO2max). The training 
sessions with a duration of 1 hour are group-based and supervised by a physiotherapist. 
Subjects have free access to these training sessions and are stimulated to participate for 
at least 1 hour/week. In addition, the physiotherapist gives individual advice on how to 
increase daily physical activity (walking, cycling, swimming or running), based on the 
PACE questionnaire (adapted version based on van Sluijs et al. [34]), and goals are set.
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Table 2.1. Details of the SLIMMER lifestyle intervention programme.
Lifestyle intervention programme – 1 year
Dietary intervention
•	 Six times/year individual nutrition advice by dietician
•	 Based on Dutch dietary guidelines
•	 One group session on label reading
•	 Goal: 5-10% weight reduction
Physical activity intervention
•	 Weekly group sessions by physiotherapist
•	 Combined aerobic- and resistance exercise programme
•	 Individual advice on physical activity in daily life
•	 Goal: increase physical activity to at least 30 minutes/day on at least 5 days/week
Process evaluation
Process evaluation will be performed to investigate how the intervention was 
implemented, what activities occurred under what conditions, by whom and with what 
level of effort. Process measures, among others based on the indicators as defined by 
Nutbeam [35], are:
•	 Reach: did the programme reach all of the target population?
•	 	Acceptability: is the programme acceptable to the target population and the 
health professionals who delivered the intervention?
•	 	Implementation integrity: was the programme implemented as planned? Why or 
why not?
•	 	Applicability: does the programme fit into the health care structure, the social 
and cultural environment, the organizational system of local health and welfare 
organizations and professional working standards?
•	 Key factors for success and failure.
To investigate programme reach, programme records are used to assess the number 
of implemented activities and the number of attending participants. Dropouts and 
unreached eligible subjects are examined to assess whether this group differs from 
those participating and to identify reasons for non-participation.
To assess acceptability, implementation integrity and applicability, multiple methods 
will be used: observations, semi structured interviews and focus groups. Key factors for 
success and failure will be derived from all methods used in the process evaluation.
Based on literature and observation methods used in other interventions, a structured 
observation method has been developed. The following activities of the pilot 
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intervention will be observed: the information meeting for patients and the visits to the 
practice nurse, dietician and physiotherapist. The following aspects of these activities 
will be studied: acceptability and appropriateness of the location; the use of materials; 
course of the meeting or visit (which parts were discussed, when and how well?); 
involvement, communication and skills of the professionals; enthusiasm, motivation 
and appreciation of participants and the mood and feelings of the observer.
In addition, focus group sessions will be used to assess acceptability of the intervention 
to professionals as well as participants and implementation integrity of the intervention. 
Focus group sessions will be held with participating professionals (GPs and practice 
nurses, dieticians and physiotherapists) and participating patients separately. An item 
list will be developed to guide these sessions. Questions relate to experiences with 
several parts of the intervention, the use of materials, communication, barriers and 
facilitations. An experienced focus group leader will guide the focus group sessions. 
Furthermore, semi structured interviews will be held with some of the professionals and 
participants to obtain more in-depth information on acceptability, implementation 
integrity, applicability and key factors for success and failure. An item list will be 
developed to guide the interviews, covering topics like expectations, experiences and 
suggestions for modifi cations. One of the researchers will guide the interviews.
Measures of health effects are also included in the pilot study to evaluate whether the 
measurements will be acceptable to the patients in the effectiveness study (Step 3 in 
the translational process). The following measurements are included: body weight, 
waist and hip circumference, FPG values, blood pressure, medical history, aerobic 
fi tness (SteepRamp test), motivation for physical activity (PACE questionnaire) and 
dietary behaviour. Other effect measures, like glucose and cholesterol, are not included 
because measuring these indicators is not the aim of the pilot study. 
Data of the process evaluation will be used in order to optimize the programme for the 
Dutch real-life setting. Finally, the intervention will be expanded, guided with an effect 
evaluation and cost-effectiveness analyses, including all the above-mentioned health 
indicators (this is Step 3 of the translational process).
THE POSITION OF PRIMARY HEALTH CARE
Primary health care professionals have an important role in implementing lifestyle 
intervention programmes. Hiddink et al. [36] recognized that GPs are trusted sources 
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of nutrition information by adults because they had a high referral score, high perceived 
expertise and they reached nearly all segments of the population. This view is shared 
by the Heelsum Collaboration on Nutrition in Primary Care, as described by van 
Weel: ‘opportunity through regular contacts with patients (continuity of care), central 
position in the health care system and trust with “their” patients’ [37]. Over the last years, 
a tendency can be seen for the GP as nutrition counsellor towards gatekeeper of the 
health care system, working together with other professionals from primary health 
care and public health [38-41]. Generally, GPs have an interest in nutrition and perceive 
themselves as being able to give dietary advice in the treatment and prevention of 
coronary heart disease [42]. However, GPs experience barriers for giving nutrition 
guidance to their patients, most importantly not being trained in nutrition, lack of 
time to address nutrition issues and GPs perception that patients lack motivation to 
change lifestyle and/or dietary patterns [43, 44]. These main barriers were also found 
by Kushner [45] and Helman [46]. Therefore, a promising possibility is to transfer the 
dietary and/or physical activity advice to other disciplines in primary health care in order 
to alleviate the responsibilities of the GP as is done in SLIMMER. In addition, we see a 
movement towards synergy between primary health care and public health over the 
last years [41]. This has been expanded in the sixth Heelsum International Workshop 
themed ‘Practice-based evidence for weight management: alliance between primary 
care and public health’ [47]. 
Within combined lifestyle interventions, it is important that one professional has the 
lead and the overview over the programme. This is indicated as case management. The 
case manager should work together with all the professionals involved in the alliance 
between primary health care and public health. Which professional should have the 
role of case manager in combined lifestyle interventions is a matter of discussion. In 
a Dutch lifestyle intervention, the BeweegKuur programme, the lifestyle advisor is the 
pivot of the intervention. Often the lifestyle advisor is a practice nurse, who is designing 
an individual exercise programme and providing coaching and supervision [48]. Also 
in the UK Counterweight programme, it is the practice nurse who plays a key role in 
the delivery of the lifestyle intervention, with initial guidance, training and facilitation 
by weight management advisors (all state-registered dieticians, who are proactive, 
creative and specially trained in health promotion and obesity management) [49]. In 
the US DPP, the intervention is undertaken by lifestyle coaches. The majority of these 
lifestyle coaches are registered dieticians, registered nurses and diabetes educators 
but also social workers, exercise specialists, pharmacists, physicians, psychologists and 
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emergency services technicians [27]. In the SLIMMER intervention, it is the GP who 
acts as a spider in the web, given his/her role as gatekeeper of the health care system, 
and works together with allied forces. GPs select eligible subjects and refer them to 
dieticians because they are one of the most important nutritional information sources 
for GPs [50]. In addition, GPs refer the subjects to physiotherapists for physical activity 
advice and support. GPs have the fi nal responsibility for the quality of the delivered care, 
but practice nurses are the case managers in the SLIMMER intervention. They motivate 
subjects to participate in the intervention programme and they are in contact with the 
dieticians and physiotherapists. Which professional is in the best position of being a 
case manager depends on several factors like type of lifestyle intervention activities, 
time, money, interest, expertise and competences.
Regarding the collaboration between primary health care professionals and public 
health, both the community health service and local authorities are important partners 
within the last profession. The community health service may act as coordinator of 
the lifestyle intervention programme and has the health promotion expertise that 
is needed. The local authorities can bring several partners, from different disciplines 
and professions, together. Furthermore, they can secure the lifestyle intervention 
programme into local policy.
 
The tendency towards an alliance between primary health care and public health 
especially fi ts to the Dutch health care system. Currently, the Dutch primary health care 
sector and prevention sector are two different worlds since they are based on separate 
laws and fi nancial systems. However, one of the main topics of the Dutch Public Health 
Act is to join forces of primary health care and public health, so that prevention is 
incorporated in the health care system [51]. Also Green [52] described the urgent need 
for an alliance between primary health care and public health. Avendonk et al. [53] 
described how the Dutch College of General Practitioners evaluated the situation and 
published the guidelines for obesity. Therefore, we consider the accomplishment of 
an alliance between primary health care and public health, such as established in the 
SLIMMER intervention, as a promising development and a necessary step in diabetes 
prevention. 
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CONCLUSION
Several trials, such as SLIM, DPS and DPP, have demonstrated that prevention of 
diabetes by lifestyle intervention is (cost-) effective. However, translation of diabetes 
prevention trials to Dutch real-life setting is lacking. Therefore, the SLIMMER project 
was developed in order to translate the SLIM intervention into Dutch daily practice, 
together with professionals from prevention and primary health care. Currently, the 
adapted SLIMMER intervention is being implemented in a pilot study and guided 
with a process evaluation in order to assess reach, acceptability, implementation 
integrity,  applicability and key factors for success and failure. Based on these results, 
the programme will be optimized to fit the role conception of the professionals and the 
organization structure in which they work. Especially in the Dutch health care system, 
we consider collaboration between professionals from primary health care and public 
health needed now more than ever to combat the rising problem of diabetes.
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Feasibility and potential impact of the adapted 
SLIM diabetes prevention intervention in a 
Dutch real-life setting: the SLIMMER pilot study
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ABSTRACT
Objective
Pilot-testing of the adapted Study on Lifestyle intervention and Impaired glucose 
tolerance Maastricht (SLIM) and to determine its feasibility and likelihood of achieving 
desired impact. 
Methods
Pilot intervention study (a 10-month combined lifestyle intervention) using a one group 
pre-test post-test design with on-going process measures (i.e. reach, acceptability, 
implementation integrity, and applicability) and several health outcomes (e.g. body 
weight). 
Results
In total, 31 subjects participated in the SLIMMER (SLIM iMplementation Experience 
Region Noord- en Oost-Gelderland) intervention. Participant weight loss was  -3.5 
kg (p = 0.005). Both participants and health care professionals (i.e. practice nurses, 
dieticians, and physiotherapists) were satisfied with the intervention. The intervention 
was implemented as planned and appeared to be suitable for application in practice. 
Refinements have been identified and will be made prior to further implementation 
and evaluation. 
Conclusion
Implementation of the SLIMMER intervention is feasible in a Dutch real-life setting and 
it is likely to achieve desired impact. Practising and optimising the intervention creates 
local support for SLIMMER among stakeholders. 
Practice implications
Performing a pilot study on the basis of a structured approach is a meaningful step 
in the process of optimising the feasibility and potential impact of an evidence-based 
intervention in a real-life setting.
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INTRODUCTION
Many experimental studies, such as the Finnish Diabetes Prevention Study (DPS), the US 
Diabetes Prevention Program (DPP), and the Dutch Study on Lifestyle intervention and 
Impaired glucose tolerance Maastricht (SLIM), have shown that moderate changes in diet 
and physical activity (PA) lead to a substantial and sustained reduction in the incidence of 
type 2 diabetes mellitus for individuals with impaired glucose tolerance (IGT) [1-8]. This 
evidence calls for an increase in the implementation of lifestyle interventions in public 
health practice in order to maximise possible health gains for individuals with IGT in 
society. Interventions which have been developed in experimental settings, however, are 
not necessarily suitable for implementation in real-life settings because these settings 
differ substantially [9-11]. Translation of lifestyle interventions from research to practice 
is, therefore, needed whereby effectiveness must be preserved. On the other hand, 
adaptations are inevitable within this translational process from research to practice, 
and this may have unknown consequences for the effectiveness of the intervention. 
Translations from experimental interventions to real-life settings have previously been 
shown to be feasible. However, they appeared to have limited clinical benefi ts, possibly 
due to less control, less intensive methods, or practical issues of noncompliance [11, 12]. 
No experimental interventions have to date been translated to real-life settings in The 
Netherlands. For this project, the evidence-based SLIM intervention was translated into 
the SLIMMER intervention, which is designed to be applicable in a Dutch real-life setting 
[13]. To this end, the fi ve-step guidance of McKleroy et al. has been applied, providing a 
systematic approach to adapt the intervention to and imbed it in a real-life setting while 
maintaining the scientifi c integrity that makes the intervention effective [14]. Firstly, 
core elements of the SLIM intervention were identifi ed (step 1: assess) and consensus 
on suggested adaptations was achieved between SLIM intervention developers and 
local health care professionals in a joint decision making process (step 2: select). These 
adaptations were then incorporated in the new SLIMMER manual (step 3: prepare). These 
fi rst three steps of McKleroy’s guidance [14] have been described in detail elsewhere 
[15]. The next step in the adaptation process is to pilot-test the adapted intervention. 
The aim of this article is to describe the pilot-testing of the adapted SLIM intervention 
and to determine its feasibility (i.e. reach, acceptability, implementation integrity, and 
applicability) and likelihood of achieving desired impact. This was done in a 10-month 
lifestyle intervention, guided by process and outcome evaluation. The results from this 
pilot-test will be used to refi ne the adaptation and will serve as input for McKleroy’s fi nal 
and fi fth step [14] of implementation and evaluation. 
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METHODS
This pilot study is part of a larger project called SLIMMER (SLIM iMplementation 
Experience Region Noord- en Oost-Gelderland (formerly called Region Gelre-IJssel)), 
which aims to implement an effective diabetes prevention intervention in a Dutch real-
life setting. 
Study design
This 10-month pilot intervention study ran from August 2010 until July 2011, using a 
one group pre-test post-test design with on-going process measures. Both qualitative 
and quantitative data collection approaches were used to investigate the feasibility of 
SLIMMER and the likelihood of achieving its desired impact. The study received ethical 
approval from the Medical Ethical Committee of Wageningen University. 
Participants 
Participants for the pilot study were recruited from August to September 2010 by 
three general practitioners (GPs) in the municipality of Apeldoorn from their patient 
registration database. Each GP selected a random sample of patients from the database 
aged 40 through 65 years with impaired fasting glucose (finger prick fasting capillary 
blood glucose >5.6 and <6.0 mmol/l or fasting venous plasma glucose >6.1 and <6.9 
mmol/l [16]). Exclusion criteria were: not being able to speak and understand the 
Dutch language; cognitive dysfunction; or any comorbidity that made participation in 
a lifestyle intervention impossible. Recruitment of the participants has been described 
in detail elsewhere [13]. In short, GPs sent eligible patients a letter and flyer to inform 
them about the SLIMMER intervention and to invite them to an information meeting 
in their neighbourhood with all health care professionals involved (GP, practice nurse, 
dietician, and physiotherapist). Two weeks after sending the invitation letter, practice 
nurses called the patients to invite them to the information meeting again, and to 
motivate them to participate if necessary. During the information meeting, patients 
were given all details of the programme and afterwards they gave their written informed 
consent. A short non-response survey was conducted in case patients were not willing 
to participate. 
Lifestyle intervention programme
The SLIMMER intervention resembled the SLIM intervention [17] and consisted of a 
dietary and physical activity component. In addition, the SLIMMER intervention fitted 
in with daily routines of Dutch GPs, practice nurses, dieticians, and physiotherapists. 
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Therefore, only minimal training, provided during a special two-hour SLIMMER kick-off 
training, was required to assure adequate delivery of the intervention by the health care 
professionals. Relevant details of the SLIMMER intervention are described below and 
additional details can be found elsewhere [13, 15]. 
Dietary intervention
Dietary recommendations were based on Dutch dietary guidelines [18]. A dietician 
gave tailored dietary advice during six individual consultations within the 10-month 
intervention period (30–60 min per consultation; in total 4 h per participant). If desired, 
spouses could join consultations. In addition, the dietician organised one group session 
aimed at sharing experiences, motivating each other, and discussing the topic of label 
reading. Subjects were encouraged to drink less alcohol, quit smoking if necessary, 
increase daily physical activity, and to participate in the physical activity intervention. 
The dietician, trained in motivational interviewing [19], assisted individuals to achieve 
a positive attitude towards changes in diet and physical activity. Goals for behaviour 
change were set every consultation, evaluated in the next consultation, and if necessary 
adjusted. The objective of the dietary intervention was to adopt, step by step, a 
sustainable healthy dietary pattern according to Dutch dietary guidelines. 
Physical activity intervention
The physical activity intervention consisted of a combined aerobic and resistance 
exercise programme (proportion 2:1) at the physiotherapist’s practice. Weekly 
training sessions with a duration of 1 h were group-based and supervised by a skilled 
physiotherapist. Sports groups were formed based on day and time preferences of the 
subjects and availability of the physiotherapists. Subjects had free access to the training 
sessions and were stimulated to participate for at least 1 h per week. In addition, the 
physiotherapist gave tailored advice on how to increase physical activity in daily life (e.g. 
bicycling, walking, gardening) and goals were set. The objective of the physical activity 
intervention was to increase the physical activity level of the participants to at least 30 
min a day during at least fi ve days a week. 
Outcome and process measures
An outcome and process evaluation was performed to investigate feasibility and 
likelihood of the intervention. Several health outcomes and four process measures 
commonly used in process evaluations were included: reach, acceptability, 
implementation integrity, and applicability [20-23]. Process evaluation data were 
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collected and used to optimise the intervention programme. Outcome and process 
measures are described below. A detailed evaluation plan including measures and time 
points of data collection is provided in Additional file 3.1. 
Outcome measures
Health care professionals performed health measures at baseline (T0) and at the end 
of the intervention (T1) to assess likelihood of achieving desired impact. Fasting plasma 
glucose was measured by practice nurses using a finger prick according to guidelines 
of the Dutch College of General Practices [16]. Furthermore, practice nurses measured 
blood pressure twice on the left arm with an electronic monitor. The average of two 
measurements was recorded. Dieticians measured body weight to the nearest 0.1 kg 
and height to the nearest 0.5 cm. Body Mass Index (BMI) was measured as the ratio 
of weight and height squared (kg/m2). Waist and hip circumference were measured 
by dieticians to the nearest 0.5 cm. Waist circumference was obtained at the level 
midway between the lowest rib and the iliacal crest. Hip circumference was measured 
as the maximum circumference over the buttocks. Waist and hip measurements were 
performed in duplicate and the average of two measurements was recorded. Medication 
use was recorded by practice nurses in each of the following categories: hypertension, 
hypercholesterolemia, hypertriglyceridemia, and cardiovascular diseases. Fitness was 
measured using the SteepRamp Test [24, 25]. Physiotherapists performed this test on 
a calibrated cycle ergometer. After 3 min of unloaded cycling (at 25 W), the load was 
increased by 25 W every 10 s. Subjects were instructed to cycle with a pedal frequency 
between 60 and 80 rounds per minute (rpm). The test ended when pedal frequency fell 
below 60 rpm. Obtained maximal workload (the maximum short exercise capacity), 
time cycled at that load, and heart rate at the end of the test were reported. Maximal 
oxygen uptake (VO2max) was estimated as follows: VO2max (l/min) = 0.0067 SteepRamp 
Wmax + 0.358 [24, 25]. Participants filled in questionnaires on perceived health, 
smoking, and physical activity. Perceived health was measured with the question ‘‘How 
would you rate your health, in general?’’ with answer categories poor, fair, good, very 
good, and excellent. This question was taken from the Short-Form Health Survey (SF-
36), which has been shown to be a practical, reliable, and valid tool for both general and 
chronic disease populations in The Netherlands [26, 27]. Smoking was measured with 
the question ‘‘Do you smoke (sometimes)?’’ with answer categories yes, no but I used to 
(more than 15 years ago), no but I used to (less than 15 years ago), and no I never smoked. 
Physical activity was measured with the question ‘‘On how many days per week are you 
usually physically active for at least 30 minutes?’’ with answer categories ranging from 
37766 Duijzer.indd   52 31-12-15   11:50
53
3
less than one day per week to 7 days per week. Questions on smoking and physical 
activity were measured according to standards of the national surveillance system for 
adults and the elderly in The Netherlands [28]. These national standards are based on 
best available scientifi c insights, experiences of local community health services, and 
expert opinions. Alcohol intake, fruit intake, and vegetable intake were assessed by a 
validated food frequency questionnaire [29]. 
Process measures
Reach was defi ned as ‘the proportion of intended target audience that participated in 
the intervention’. Data on socio-demographic characteristics of participants and non-
participants were collected according to standards of the national surveillance system 
for adults and the elderly in The Netherlands [28]. 
Acceptability was defi ned as ‘the extent to which participants and health care 
professionals (i.e. practice nurses, dieticians, and physiotherapists) are satisfi ed 
with the intervention’. Participants’ acceptability was assessed using questionnaires 
and evaluation forms. Furthermore, a focus group meeting (n = 10, duration of 1.5 
h) was conducted to collect more in-depth information on acceptability [30]. Two 
participants of each sports group were randomly selected and invited by one of the 
researchers (GD). In case a participant was not able or willing to participate, another 
randomly selected participant was invited. A semi-structured focus group guide was 
developed. An experienced focus group leader (CdR) guided the meeting and one of 
the researchers (GD) assisted the focus group leader and took notes. Acceptability of 
health care professionals was assessed using telephone semi-structured interviews 
(practice nurses, n = 3, average duration of 17 min) and face-to-face semi-structured 
interviews (dieticians, n = 3, and physiotherapists, n = 4, average duration of 67 min). All 
health care professionals that implemented the SLIMMER intervention were invited to 
the interviews by one of the researchers (GD) and they were all willing to participate. A 
semi-structured interview guide was developed and all interviews were conducted by 
one of the researchers (GD). 
Implementation integrity was defi ned as ‘the extent to which the intervention was 
implemented as planned’. Professionals’ implementation integrity was assessed by 
semi-structured inter-views (n = 10), as described above. Furthermore, a structured 
observation method was developed to track several intervention activities and aspects. 
The observations were performed by one of the researchers (GD). 
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Applicability was defined as ‘the extent to which an intervention process can be 
implemented in the real-life setting’. Semi-structured interviews with professionals 
were conducted (n = 10), as described above. 
Information on intervention optimisation was obtained from the collected process 
data as described above. Refinements in the adaptation process will be made prior to 
further implementation and evaluation in a real-life setting, the fifth step of McKleroy’s 
guidance [14]. 
Analyses
Quantitative data were analysed using IBM SPSS Statistics version 19. Non-participants 
were compared with participants for gender, age, perceived health, and education level, 
using an independent samples t-test. Ten-month changes in health outcomes were 
assessed using paired samples t-tests for continuous variables, McNemar’s chi-square 
tests for categorical variables, and Wilcoxon signed-rank tests for ordinal variables. 
Relative effect sizes were calculated using Cohen’s d [31], Qualitative data were analysed 
using an inductive approach [32]. The focus group discussion with participants and 
interviews with dieticians and physiotherapists were tape-recorded and transcribed. 
During interviews with practice nurses and observations, notes were taken and then 
transcribed. Transcripts were coded into topics and read multiple times by the first 
author until themes emerged. 
RESULTS
Reach
The SLIMMER pilot study included a total of 31 participants (i.e. a response rate of 57%), 
with an average of 10 patients per GP practice (range 6–13). On average, participants were 
54 years old, had a low level of education (46%), and a family history of diabetes (63%; 
see Table 3.1). Twenty of the 54 patients did not respond to the invitation (Figure 3.1). 
Reasons for this non-response were lack of time (28%), lack of interest (24%), reporting 
of ‘I already have a healthy lifestyle’ (17%), not reached by practice nurse (14%), not able 
due to physical or mental problems (10%), and reporting of ‘It is of no importance to 
me’ (7%). Three more patients were excluded because they no longer had impaired 
fasting glucose. Non-participants were slightly older, perceived their health as being 
better, and were lower educated than participants (Table 3.1). During the SLIMMER pilot 
study, two participants dropped out (i.e. a drop-out rate of 7%) because of personal 
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circumstances and health constraints. In total, 13 health care professionals worked 
together to implement the SLIMMER intervention: three GPs, three practice nurses, 
three dieticians, and four physiotherapists. They jointly organised three information 
meetings, at which 23 participants were present (i.e. a participation rate of 74%). On 
average participants received 5.2 (SD 1.7; range 0–6) consultations by dieticians and 
34.1 (SD 16.7; range 0–64) sports lessons. Dieticians organised three group meetings at 
which 21 participants were present (i.e. a participation rate of 68%). 
Invitation letter sent out to 
eligible patients (n = 54) 
Willing to participate 
(n = 34) 
Started with intervention 
(n = 31) 
Finished intervention 
(n = 29) 
Non-response (n = 20) 
Not meeting inclusion 
criteria (n = 3) 
Drop-outs (n = 2) 
Figure 3.1. Participant flow diagram of the SLIMMER pilot intervention.
Health outcomes
At the end of the intervention, self-reported days of physical activity (i.e. at least 30 min/
day physically active) increased from four to fi ve (p = 0.005; Table 3.2). No changes in 
alcohol, fruit, and vegetable intake were observed. Minor changes in medication use 
were observed. On average, body weight was 3.5 kg lower and signifi cant reductions in 
waist and hip circumference were noted. Fasting glucose increased slightly, albeit non-
signifi cantly. Diastolic blood pressure, but not systolic blood pressure, was signifi cantly 
reduced. VO2max signifi cantly improved after the intervention (p < 0.001). Perceived 
health increased signifi cantly (p = 0.005). 
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Acceptability, implementation integrity, applicability, and intervention optimisation
The participants’ questionnaire on acceptability was completed by 90% at baseline and 
77% at follow-up and all attending participants filled in the short evaluation form after 
the group meeting with the dietician. On average, participants evaluated the overall 
intervention programme with a 7.7 (SD 0.6) out of 10 and the individual intervention 
elements were positively evaluated by most participants (Table 3.3). 
In general, participants and professionals were satisfied with the intervention 
programme, although some improvements were mentioned. Overall, the intervention 
was implemented as planned. Some parts of the protocol, however, were omitted or 
adjusted by health care professionals. This mostly concerned measurements and 
planning aspects regarding intervention elements. The intervention appeared suitable 
for application in practice as most health care professionals indicated that it was not 
very different from their regular functioning and professional performance. However, 
there were some organisational difficulties. 
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Table 3.1. Baseline characteristics of participants (N = 31) and non-participants (N = 23) of the SLIMMER pilot 
interventiona,b.
Participants Non-participants
Gender
 Male
 Female
(n = 31)
15 (48)
16 (52)
(n = 23)
10 (43)
13 (57)
Age (mean (SD)) (n = 31) 
54.1 (8.5) years
(range 36-68y)
(n = 23)
58.3 (4.6) years
(range 48-66y)
Perceived health
 Poor / Fair
 Good
 Very good / Excellent
(n = 28)
9 (32)
19 (68)
0 (0)
(n = 16)
2 (12)
11 (69)
3 (19)
Education levelc
 None / primary education
 Low education
 Intermediate education
 High education
(n = 28)
2 (7)
11 (39)
6 (22)
9 (32)
(n = 14)
3 (22)
8 (57)
2 (14)
1 (7)
Ethnicity
 Native
 Non-native
(n = 27)
25 (93)
2 (7)
Marital status
 Married / cohabitating
 Unmarried
 Divorced 
 Widowed 
(n = 28)
25 (89)
1 (4)
2 (7)
0 (0)
Employment status
 Fulltime job
 Part time job
 No paid job
(n = 28)
13 (47)
6 (21)
9 (32)
Family history of diabetes
 Yes
 No
(n = 27)
17 (63)
10 (37)
History of hyperglycaemia 
 Yes
 No
(n = 15)
7 (47)
8 (53)
a Data are n (%) unless otherwise indicated.
b Missing values because of incomplete measurements and drop-out of n = 2.
c Education level was based on the highest level of education completed and divided in four categories: none/
primary (primary school or less), low (lower vocational education), intermediate (medium vocational education, 
high school), and high (higher vocational education, university).
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Table 3.2. Ten-month changes in health outcomes of the SLIMMER pilot intervention (N = 31).
na Baseline ∆ T1-T0
b p-value Effect size
Physically active (number of days per week) 22 4 (2.2) +1 (1.5) 0.005 0.49
Alcohol intake (g/day) 23 7.1 (8.5) -0.82 (3.0) 0.206 -0.09
Dietary intake (g/day)
 Fruit intake
 Vegetable intake
23
149.0 (103.9)
165.4 (90.7)
-1.23 (84.1)
-20.6 (80.0)
0.945
0.231
-0.01
-0.26
Smoking (n) 23 6 -2 0.500 -0.22
Medication use (n)
 Hypertension
 Hypercholesterolemia
 Hypertriglyceridemia
 Cardiovascular diseases
28
18
10
0
6
0
+1
+1
-2
1.000
1.000
−
0.625
0
0.06
−
-0.19
Body weight (kg) 24 85.9 (17.9) -3.5 (5.4) 0.005 -0.20
BMI (kg/m2) 23 29.0 (4.1) -1.2 (1.9) 0.006 -0.30
Waist circumference (cm) 23 104.4 (13.7) -4.2 (5.1) 0.001 -0.31
Hip circumference (cm) 23 109.8 (7.9) -2.8 (4.3) 0.005 -0.34
Fasting plasma glucose (mmol/l) 28 6.1 (0.5) 0.3 (0.8) 0.062 0.51
Blood pressure (mmHg)
 Systolic
 Diastolic
28
134.9 (10.3)
84.6 (8.3)
-4.4 (14.5)
-5.9 (8.8)
0.118
0.001
-0.36
-0.74
SteepRamp Test
 VO2max (l/min)
27
2.3 (0.6) +0.4 (0.4) <0.001 0.58
Perceived health (n)
 Poor / Fair
 Good
 Very good / Excellent
23
8
15
0
-6 
+4
+2
0.005 n.a.c
a Missing values because of incomplete measurements and drop-out of n = 2.
b Change between baseline (T0) and follow-up (T1), data are expressed as mean (SD) or n.
c n.a. = not applicable.
Looking in detail at acceptability, implementation integrity, and applicability, seven 
themes emerged. Most of these themes were related to intervention elements (i.e. 
information meeting, physical activity intervention, dietary intervention). In addition, 
the themes measurements and the need for a coordinating professional were identified. 
Additional file 3.2 provides a detailed overview of all seven themes. Based on these 
themes, improvements will be made to refine the adaptation process. Both the themes 
and the improvements are described below. 
1.  The information meeting was positively evaluated by both participants and 
professionals, but the organisation of such a meeting proved to be time-
consuming and costly for both participants and professionals. The information 
meeting will be replaced by brochures, providing all details of the SLIMMER 
intervention programme. 
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2.  The formation of physical activity groups was an important aspect of the physical 
activity intervention. In practice, the formation of these groups was logistically 
more diffi cult than expected. Therefore, instead of forming groups based on 
day and time preferences of participants, groups will be formed based only on 
the availability of physiotherapists. It is expected that limiting the options for 
participants will speed up the formation of physical activity groups. 
3.  The nutrition intervention included a fi xed number of six consultations but it 
appeared that more flexibility in the number of consultations was desired by 
both participants and dieticians. More flexibility, therefore, will be provided by 
determining a minimum of fi ve and a maximum of eight consultations with a 
maximum of 4 h per participant. 
4.  Several important fi ndings were related to measurements conducted by health 
care professionals. It appeared that in practice, some measurements were not 
performed according to the protocol or not easily applicable, and that different 
devices were used. Therefore, measurements will be shifted from health care 
professionals to a research centre for the future cost-effectiveness evaluation 
study. Furthermore, fasting plasma glucose will be measured using a venepuncture 
because this might be more reliable than a fi nger prick [33], and the SteepRamp 
Test will be replaced by the six-minute walk test [34] because the SteepRamp Test 
was diffi cult to perform and was not suitable for all participants. 
5.  It was identifi ed that there was a need for an independent health care professional 
who could take action towards professionals and participants in case of diffi culties. 
The practice nurse, therefore, will be designated as case manager of the project to 
motivate and stimulate participants and to facilitate contact between dieticians 
and physiotherapists. 
6.  Monitoring (i.e. repeated measurements during the intervention) appeared to be 
important to both participants and professionals as it contributes to participants’ 
motivation and professionals’ evaluation purposes. Monitoring of behaviour change, 
therefore, will be expanded and described more explicitly in the SLIMMER manual. 
7.  The importance of maintaining a healthy lifestyle and how to achieve this was 
recognised by both the participants and the professionals. Suggestions for a 
maintenance programme were provided by both participants and professionals 
and some health care professionals have already taken initiatives themselves. 
Therefore, a maintenance programme will be added to the lifestyle intervention 
programme to guide participants in the process of maintaining lifestyle behaviour 
change in an independent and sustainable manner. 
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Table 3.3.  Participants’ acceptability of SLIMMER pilot intervention elements (N = 31)a.
Intervention elements Mean participants’ acceptability (SD)
Information meeting (n = 21)
Gradeb 
The information meeting was very useful to mec
I learned a lot from the information meetingc
I understood the information I receivedc
7.5 (0.8) (range 7-10)
4.2 (0.4) (range 4-5)
3.2 (0.6) (range 2-4)
4.0 (0.4) (range 3-5)
Consultations by dietician (n = 24)
By participating in SLIMMER…
I had a motivation to start eating healthyc
I could focus on eating more healthyc
3.7 (0.9) (range 2-5)
3.7 (0.8) (range 2-5)
Group meeting by dietician (n = 21)
Gradeb 8.2 (0.7) (range 7-9)
Sports lessons by physiotherapist (n = 24)
By participating in SLIMMER…
I had a motivation to be physically activec
I could be physically active with a goalc
I liked to take part in sports together with othersc
4.0 (0.9) (range 1-5)
3.8 (0.9) (range 1-5)
4.1 (0.7) (range 2-5)
Overall intervention (n = 23)
Gradeb 7.7 (0.6) (range 7-9)
a Missing values because of incomplete measurements and drop-out of n = 2.
b Grading on a scale ranging from 1 to 10.
c Scale from 1 (I totally disagree) to 5 (I totally agree). 
DISCUSSION AND CONCLUSION
Discussion
In this pilot-test of the adapted SLIM intervention, the aim was to determine the 
feasibility and likelihood of achieving the desired impact. Several improvements 
in health outcomes were observed. Furthermore, as indicated in the findings, this 
SLIMMER pilot study was successful in both the inclusion and retention of patients 
from a high-risk group for diabetes. Both participants and professionals were satisfied 
with the SLIMMER intervention. Overall, the intervention was implemented as planned 
and appeared to be suitable for application in practice. Some improvements regarding 
measurements, planning aspects of intervention elements, and organisational matters 
were mentioned. Refinements in the adaptation process will be made prior to further 
implementation and evaluation. 
Results of this SLIMMER pilot study are comparable to results of the effective SLIM study 
[35]. Improvements in body weight, BMI, waist circumference, and VO2max were slightly 
higher in the SLIMMER pilot study than in the SLIM study, whereas fasting plasma 
glucose slightly increased in the pilot study compared to a decrease in the SLIM study 
(+0.3 mmol/l vs. -0.1 mmol/l) [35]. However, results of the SLIMMER study should be 
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interpreted with caution as results are only based on a pilot study with a small sample 
size. The main goal of this pilot study was to test feasibility of the SLIMMER intervention 
in practice. Further investigation of effectiveness of the intervention is needed. The 
SLIMMER intervention may be more successful in primary health care than other 
interventions because of the intensity of this SLIMMER intervention, the deployment of 
health care professionals with specifi c expertise and skills rather than general lifestyle 
coaches, and the group-based sports lessons which contribute to social support. 
Several lessons were learned based on the quantitative and qualitative results of this 
pilot study. Firstly, this pilot study showed that a structured approach with outcome 
and process measurements is appropriate to test and optimise the feasibility of an 
intervention. As indicated by Dombrowski et al., performing a pilot study is important 
and meaningful because challenges for refi nement become clear [36]. Furthermore, a 
pilot study can be valuable as practising and optimising the intervention might increase 
chances for success [37]. Secondly, local support among stakeholders is created by 
initiating a local steering committee who takes responsibility for the implementation 
process of the intervention. Thirdly, a case manager should be appointed to enhance 
participant compliance and the feasibility of the implementation. A recent Dutch study 
showed that practice nurses are highly involved in diabetes care and that patients 
are satisfi ed with this care [38]. Because of this and the fact that general practices 
act as gatekeepers of the health care system and work together with allied forces [13, 
39], practice nurses seem to be in the best position to be case managers. Fourthly, 
monitoring appeared to be an important aspect of the intervention. The need for 
monitoring was also recognised in several other studies [36, 40]. Fifthly, including a 
maintenance programme appeared to be important, as losing weight is relatively 
easy, whereas maintaining weight loss is a more diffi cult task [36, 41, 42]. Sixthly, it 
seemed that non-participants were slightly older, perceived their health as better, and 
were lower educated than participants. This indicates that special attention should 
be given to recruitment and retention of subjects with a lower socio-economic status. 
Furthermore, translating fi ndings of this pilot study to other ethnic groups should be 
done with caution, as most participants were Dutch. 
The small study size is a limitation, although this is acceptable for a pilot study [14, 37]. 
Furthermore, all data were collected and analysed by one researcher which could cause 
subjectivity in qualitative data interpretation. The researcher, however, was aware of this, 
worked in a structured way, and discussed analyses and results with two co-authors. 
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Conclusion
This pilot study shows that implementation of the SLIMMER diabetes prevention 
intervention is feasible in a Dutch real-life setting and that it is likely to achieve 
the desired impact. Moreover, practising and optimising the intervention creates 
local support among stakeholders. Results of this pilot study have led to several 
improvements regarding measurements, planning aspects of intervention elements, 
and organisational matters that facilitate the next step of implementation and 
evaluation of the SLIMMER intervention. 
Practice implications
This study shows that performing a pilot study on the basis of a structured approach is 
a meaningful step in the process of optimising the feasibility and potential impact of 
an evidence-based intervention in a real-life setting. Implementation of the SLIMMER 
intervention in Dutch real-life setting is feasible and it is likely to achieve the desired 
impact. 
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 I c
ou
ld
 b
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 p
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 d
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 d
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 p
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 p
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t l
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 re
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ra
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oe
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pr
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na
l f
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ki
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da
rd
 o
f G
Ps
, p
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ic
e n
ur
se
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di
et
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ia
ns
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 p
hy
sio
th
er
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D
oe
s t
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 p
ro
gr
am
m
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r o
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le
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he
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 d
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en
ce
s b
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ur
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ng
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ki
ng
 st
an
da
rd
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l r
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e l
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lit
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 m
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in
te
rv
ie
w
s
•	
	du
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l fi
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 Th
em
es
 o
n 
ac
ce
pt
ab
ili
ty
, im
pl
em
en
ta
tio
n 
in
te
gr
ity
, a
nd
 ap
pl
ica
bi
lit
y o
f p
ar
tic
ip
an
ts
 (n
 = 
10
) a
nd
 h
ea
lth
 ca
re
 p
ro
fe
ss
io
na
ls 
(n
 = 
10
) o
f t
he
 SL
IM
M
ER
 p
ilo
t i
nt
er
ve
nt
io
n.
Th
em
es
Ac
ce
pt
ab
ili
ty
Im
pl
em
en
ta
tio
n 
in
te
gr
ity
Ap
pl
ica
bi
lit
y
In
fo
rm
at
io
n 
m
ee
tin
g
Pr
of
es
sio
na
ls 
pe
rc
ei
ve
d 
th
e i
nf
or
m
at
io
n 
m
ee
tin
g 
as
 im
po
rt
an
t b
ec
au
se
 
it 
en
ab
le
d 
th
em
 to
 ex
pl
ai
n 
th
in
gs
 to
 p
at
ie
nt
s a
nd
 to
 g
et
 to
 kn
ow
 a
nd
 
m
ot
iv
at
e t
he
m
, f
ac
ili
ta
tin
g 
a 
co
ns
ci
ou
s d
ec
isi
on
 o
n 
w
he
th
er
 to
 p
ar
tic
ip
at
e 
or
 n
ot
.
Pr
of
es
sio
na
ls 
pe
rc
ei
ve
d 
th
e r
ol
e o
f t
he
 G
P 
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po
rt
an
t b
ec
au
se
 a
 G
P 
ha
s 
na
tu
ra
l a
ut
ho
rit
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ip
an
ts
 co
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ue
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io
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he
r e
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na
tio
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 d
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in
g 
th
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fo
rm
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io
n 
m
ee
tin
g.
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rt
ic
ip
an
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pi
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th
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m
po
rt
an
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th
e m
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tin
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ng
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t b
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m
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t b
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ra
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ra
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at
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 b
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 p
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d 
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m
s w
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ip
an
ts
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 d
id
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 se
ek
 co
nt
ac
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 ea
ch
 
ot
he
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 p
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ip
an
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er
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d 
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e n
ut
rit
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n 
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og
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m
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e b
ut
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o 
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e n
ot
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ed
. 
H
av
in
g 
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e p
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e n
ur
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 m
an
ag
er
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to
 th
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ro
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 th
at
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ep
er
 o
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 h
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 ca
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em
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 p
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at
io
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t p
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y o
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pe
at
ed
 
m
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su
re
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en
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co
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, p
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al
 fi 
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es
s)
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ve
ra
ll,
 th
ey
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ca
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m
ot
iv
at
ed
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em
.
W
ai
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- a
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 m
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su
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en
ts
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in
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ro
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co
l.
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sio
na
ls 
di
ffe
re
d 
in
 ty
pe
 a
nd
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y o
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 p
er
fo
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ed
.
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t p
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us
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in
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ed
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at
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os
es
.
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ce
 p
ro
gr
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m
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M
M
ER
 p
ro
gr
am
m
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n 
w
hi
ch
 p
ar
tic
ip
an
ts
 a
re
 su
pp
or
te
d 
in
 m
ai
nt
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ni
ng
 a
 h
ea
lth
y l
ife
st
yl
e o
n 
th
ei
r o
w
n.
 T
he
y t
hi
nk
 it
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 th
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re
sp
on
sib
ili
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 o
f p
ar
tic
ip
an
ts
 to
 m
ai
nt
ai
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a 
he
al
th
y l
ife
st
yl
e.
Pa
rt
ic
ip
an
ts
 h
ad
 th
e i
nt
en
tio
n 
to
 co
nt
in
ue
 p
ra
ct
isi
ng
 so
m
e s
po
rt,
 a
lth
ou
gh
 
th
ey
 w
er
e a
fra
id
 o
f r
el
ap
sin
g 
in
to
 u
nh
ea
lth
y b
eh
av
io
ur
. T
he
y n
ee
d 
to
 b
e 
m
ot
iv
at
ed
, a
nd
 w
an
t t
o 
pr
ac
tis
e s
po
rt
 w
ith
 so
m
eo
ne
 e
lse
. T
he
y e
nj
oy
ed
 
ex
pe
rie
nc
in
g 
sp
or
ts
 o
th
er
 th
an
 fi 
tn
es
s.
Pa
rt
ic
ip
an
ts
 w
an
te
d 
to
 b
e m
on
ito
re
d 
by
 so
m
eo
ne
 af
te
r t
he
 in
te
rv
en
tio
n,
 fo
r 
ex
am
pl
e a
 p
ra
ct
ic
e n
ur
se
, e
ve
ry
 th
re
e m
on
th
s. 
Pr
of
es
sio
na
ls 
al
so
 th
ou
gh
t 
m
on
ito
rin
g 
by
 p
ra
ct
ic
e n
ur
se
s w
as
 a
 g
oo
d 
id
ea
.
Ph
ys
io
th
er
ap
ist
s l
et
 p
ar
tic
ip
an
ts
 ex
pe
rie
nc
e 
sp
or
ts
 o
th
er
 th
an
 fi 
tn
es
s (
e.
g.
 N
or
di
c W
al
ki
ng
 
or
 sq
ua
sh
).
Pr
of
es
sio
na
ls 
al
re
ad
y o
ffe
re
d 
ha
nd
le
s t
o 
pa
rt
ic
ip
an
ts
 to
 
m
ai
nt
ai
n 
a 
he
al
th
y l
ife
st
yl
e:
 e.
g.
 
di
et
ic
ia
ns
 o
ffe
re
d 
co
nt
in
ua
tio
n 
of
 co
ns
ul
ta
tio
ns
 p
ai
d 
by
 h
ea
lth
 
in
su
ra
nc
e,
 a
nd
 a
 h
al
f-y
ea
rly
 
ch
ec
k;
 p
hy
sio
th
er
ap
ist
s o
ffe
re
d 
sp
or
ts
 o
th
er
 th
an
 fi 
tn
es
s, 
a 
lis
t 
w
ith
 sp
or
ts
 cl
ub
s, 
fi t
ne
ss
 a
t a
 
re
du
ce
d 
pr
ic
e,
 a
nd
 a
 o
ne
-o
n-
on
e 
co
nv
er
sa
tio
n 
to
 id
en
tif
y t
he
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Chapter 4
SLIMMER: a randomised controlled trial of 
diabetes prevention in Dutch primary health 
care: design and methods for process, e�fect, 
and economic evaluation
G Duijzer, A Haveman-Nies, SC Jansen, J ter Beek, GJ Hiddink, EJM Feskens
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ABSTRACT
Background
Implementation of interventions in real-life settings requires a comprehensive 
evaluation approach. The aim of this article is to describe the evaluation design of the 
SLIMMER diabetes prevention intervention in a Dutch real-life setting.
Methods/Design
The SLIMMER study is a randomised, controlled intervention study including subjects 
aged 40 through 70 years with impaired fasting glucose or high risk of diabetes. The 
10-month SLIMMER intervention involves a dietary and physical activity intervention, 
including case management and a maintenance programme. The control group 
receives usual health care and written information about a healthy lifestyle. A logic 
model of change is composed to link intervention activities with intervention outcomes 
in a logical order. Primary outcome is fasting insulin. Measurements are performed at 
baseline and after 12 and 18 months and cover quality of life, cardio-metabolic risk 
factors (e.g. glucose tolerance, serum lipids, body fatness, and blood pressure), eating 
and physical activity behaviour, and behavioural determinants. A process evaluation 
gives insight in how the intervention was delivered and received by participants and 
health care professionals. The economic evaluation consists of a cost-effectiveness 
analysis and a cost-utility analysis. Costs are assessed from both a societal and health 
care perspective. 
Discussion
This study is expected to provide insight in the effectiveness, including its cost-
effectiveness, and delivery of the SLIMMER diabetes prevention intervention conducted 
in Dutch primary health care. Results of this study provide valuable information for 
primary health care professionals, researchers, and policy makers. 
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BACKGROUND
Diabetes mellitus is one of the most challenging health problems of the 21st century 
[1]. Randomised controlled trials of lifestyle interventions have shown that a healthy 
diet and increased physical activity reduce the incidence of type 2 diabetes mellitus 
(T2DM) in impaired glucose tolerance patients [2-5]. This evidence calls for translation 
and implementation of diabetes prevention programmes in real-life settings to guide 
diabetes prevention policies. As real-life settings are complex and limited in fi nances 
and resources, it is a challenge to implement effective and sustainable interventions 
[6-8]. Multiple reviews that included studies conducted in several real-life settings, 
showed signifi cant reductions in weight and waist circumference but inconclusive 
results for metabolic indicators of diabetes risk, such as blood glucose or HbA1c [7-10]. 
A comprehensive evaluation approach is required, as interventions in real-life settings 
are often complex and not delivered in tightly controlled environments [11, 12]. Within 
this approach, the scope of evaluation research needs to broaden from assessing only 
effectiveness to also getting insight in the delivery of an intervention. This will provide 
insight in the so-called ‘black box’, that is identify aspects that explain what works, how, 
and why [11, 12]. Therefore, studies need to include a process evaluation to establish the 
validity of the hypothesised causal processes for behaviour change and taxonomies can 
be used to describe behaviour change techniques used to modify these processes [13].
To date no effective diabetes prevention programme has been implemented in Dutch 
primary health care [14-17]. Therefore, the Study on Lifestyle intervention and Impaired 
glucose tolerance Maastricht (SLIM), revealing a 47% risk reduction [5], was translated 
into the SLIMMER intervention (SLIM iMplementation Experience Region Noord- en 
Oost-Gelderland). Translation of this intervention was done in a joint decision making 
process between SLIM intervention developers and local health care professionals 
[18]. Pilot-testing of the adapted intervention showed that implementation of the 
SLIMMER intervention was feasible in a Dutch real-life setting and that it was likely 
to achieve desired impact [19]. These results serve as input for the next step of broader 
implementation and evaluation of the intervention in a real-life setting.
The aim of this article is to describe the evaluation design of the SLIMMER diabetes 
prevention intervention in a Dutch real-life setting. This was done using a logic model 
describing the hypothesised causal pathway, including process indicators, behavioural 
determinants, and behavioural and health outcomes. The SLIMMER study will address 
37766 Duijzer.indd   73 31-12-15   11:50
74
the following research questions:
1.  Which effects can be measured regarding behavioural determinants, eating and 
physical activity behaviour, health, and quality of life? (effect evaluation)
2. How is SLIMMER delivered and received in a real-life setting? (process evaluation)
3.  How can results be interpreted in terms of costs and benefits? (economic 
evaluation)
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Figure 4.1. Logic model of change for the SLIMMER intervention.
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METHODS/DESIGN
Logic model
For this study, a logic model of change is composed to link intervention activities, their 
mechanisms of change (i.e. behavioural determinants), expected behaviours, and 
intervention outcomes in a logical order. A logic model facilitates the understanding 
of intervention effectiveness and provides insights for further improvements [20, 21]. 
Figure 4.1 shows the logic model of change for the SLIMMER intervention. The overall 
aim of the intervention is to prevent or postpone T2DM and its consequences and to 
increase quality of life. On the long-term, improvement in fasting insulin is taken as the 
primary outcome, whereas improvements in cardio-metabolic risk factors (e.g. glucose 
tolerance, serum lipids, body fatness, and blood pressure) are defined as secondary 
outcomes. Improvements in eating behaviour and physical activity behaviour are 
intermediate outcomes. Eating behaviour is measured as nutrient intake and food 
intake. Physical activity behaviour is operationalised as mode, frequency, duration, 
intensity, and activity score. Improvements in intention, attitude, social influences, self-
efficacy, motivation, action control, and skills are formulated as initial outcomes. These 
outcomes are achieved if sufficient outputs are delivered in terms of recruitment, reach, 
dose delivered, dose received, acceptability, implementation integrity, applicability, 
and context.
Study design
The SLIMMER study is a randomised, controlled intervention study, carried out in 
the Netherlands by a consortium of Wageningen University (WU, Wageningen) and 
the Community Health Service Noord- en Oost-Gelderland (GGD NOG, Apeldoorn). 
The total duration of the study is 1.5 years with an intervention period of 10 months. 
Recruitment of participants took place from October 2011 to September 2012. After 
baseline measurements, participants are randomly allocated to the intervention 
or control group, using block randomisation on the level of general practitioners 
(GPs) and stratification for gender. Couples are allocated to the same group to avoid 
contamination. Randomisation was performed by an independent dietician of the 
division of Human Nutrition (WU, Wageningen). The SLIMMER study has been 
registered with ClincalTrials.gov (Identifier NCT02094911) since March 19, 2014. The 
WU Medical Ethics Committee approved the study protocol and all subject gave their 
written informed consent before the start of the intervention. 
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Setting
This study is carried out in Apeldoorn and Doetinchem, two average, middle-sized 
Dutch cities, located in the eastern part of the Netherlands. The SLIMMER intervention 
is implemented in Dutch public health and primary health care, involving GPs and their 
practice nurses, dieticians, physiotherapists, and sports clubs. Within the study setting, 
GPs are organised in a formal network to deliver coordinated diabetes care. The majority 
of dieticians is employed by a home care organisation, only few are self-employed. No 
regional organisation or network for physiotherapists exists. All GPs have natural referral 
lines with at least one dietician and in most cases with one physiotherapy practice in 
the neighbourhood. This existing structure is used for implementation of the SLIMMER 
intervention. Furthermore, the project is coordinated by the community health service in 
close collaboration with both municipalities. Sports clubs are organised in a municipal sports 
stimulation organisation, which has an important role in the maintenance programme.
Sample size calculation
The sample size calculation for this study is estimated based on changes in fasting 
insulin, observed in SLIM after one year [22]. In the SLIM study, mean difference in 
fasting insulin between groups was 2.9 mU/l with a standard deviation of 5.3 mU/l [22]. 
Because SLIMMER is conducted in a real-life setting instead of a controlled setting, it is 
estimated to achieve 75% of this result, that is an expected difference in fasting insulin 
between intervention and control group of 2.175 mU/l. Because we expect a larger SD 
in real-life setting, we use 6 mU/l. To adjust for clusters (i.e. general practices), an intra-
cluster correlation of 0.055 is used [23]. Based on results of SLIM [22] and the SLIMMER 
pilot study [19], we expect a drop-out rate of 10%. Assuming an alpha of 0.05, power of 
80%, and two-sided test, a sample size of 145 subjects per group is required.  
Study population
GPs and practice nurses have selected patients aged 40 through 70 years suffering from 
impaired fasting glucose (IFG: i.e. fasting plasma glucose concentration 6.1-6.9 mmol/l 
[24]) in the past fi ve years from their patient registration database. Patients are recruited 
using either laboratory glucose test or the Dutch Diabetes Risk Test [25]. Patients are 
considered for participation if they still suffer from IFG or if the test score indicates an 
elevated or high risk of T2DM (i.e. a score op ≥7 points). Inclusion and exclusion criteria 
(Table 4.1) are checked by GPs using electronic medical records. GPs have invited eligible 
patients to participate in the SLIMMER study. A short non-response survey is conducted 
in case patients are not willing to participate.
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Lifestyle intervention programme
The SLIMMER intervention resembles the SLIM intervention [5], which was based on 
the Finnish Diabetes prevention Study [4]. The SLIM intervention used a combination 
of theories, such as Stages of Change model [26] and Theory of Planned Behaviour 
[27], and tools, such as motivational interviewing [28] and goal setting. SLIMMER 
is a 10-month combined lifestyle intervention consisting of a dietary and physical 
activity component, including case management and a maintenance programme. The 
SLIMMER intervention conforms regular functioning and professional performance of 
Dutch GPs, practice nurses, dieticians, and physiotherapists. Minimal training and a 
detailed manual are provided during a two-hour SLIMMER kick-off training for health 
care professionals. In total, 25 general practices, 11 dieticians, nine physiotherapy 
practices, and 15 sports clubs are participating in the SLIMMER study. An overview of 
core tasks and competences of these professionals is given in Additional file 4.1. Details 
of the lifestyle intervention programme are described below.
Table 4.1. Inclusion and exclusion criteria for the SLIMMER study.
Inclusion 
criteria
Age 40 through 70 years
Impaired fasting glucose (IFG; i.e. fasting plasma glucose concentration 6.1-6.9 mmol/l) [24] in the 
past 5 years according to the patient registration database, 
OR risk score ≥7 points based on the Dutch Diabetes Risk Test [25]
Willing and able to participate in the study for at least 1.5 years
Able to speak and understand the Dutch language
Exclusion 
criteria
Known diabetes mellitus
Any chronic illness that makes 1.5-years survival improbable, interferes with glucose tolerance, or 
makes participation in a lifestyle intervention impossible
Any severe cardiovascular disease (including history of cardiac dysrhythmia), unless general 
practitioner gives agreement
Medication known to interfere with glucose tolerance (mainly systemic glucocorticoids and 
pituitary gland/hypothalamus hormones)
Any mental or physical disability that will hinder participation in a lifestyle intervention
Severe psychiatric disease
Patients showing bad compliance in the past
Participation in another regular vigorous exercise and/or dietary programme, i.e.:
•	 	Intensive physical activity programme: any physical activity programme offered by a 
physiotherapist and/or patients sporting at least three times a week at own initiative
•	 	Intensive dietary programme: patients who visited a dietician at least three times during 
the last year
Patients who participated in the SLIMMER pilot study
Dietary intervention
The dietary intervention is consisting of tailored dietary advice during individual 
consultations and one group session and is aimed to adopt, step by step, a sustainable 
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healthy dietary pattern according to the Dutch dietary guidelines [29]. Furthermore, it 
is aimed to help participants to achieve 5-10% weight loss. Dietary recommendations 
are based on Dutch dietary guidelines [29], focussed on people at risk of developing 
diabetes. Dietary advice is given by a dietician from primary health care, trained in 
motivational interviewing [28] and using positive feedback. The number of consultations 
is flexible, ranging from fi ve to eight (30-60 minutes per consultation; maximum of 
4 hours per participant), and dependent on needs of participants. If desired, spouses 
could join consultations. In addition, the dietician organises one group session aimed 
at sharing experiences, motivating each other, and discussing the topic of label reading. 
Subjects are encouraged to drink less alcohol, quit smoking if necessary, increase daily 
physical activity, and to participate in the physical activity intervention. To stimulate 
self-management of participants, goals for behaviour change are set each consultation, 
evaluated in the next consultation, and if necessary adjusted. Halfway and at the end 
of the intervention, behaviour change is more extensively evaluated by dieticians to 
motivate participants, prevent drop-out, an discuss progression and goals. 
Physical activity intervention
The physical activity intervention is consisting of a combined aerobic and resistance 
exercise programme at the physiotherapist’s practice and is aimed to obtain and 
maintain an active lifestyle, that is moderate-intensity physical activity for at least 30 
minutes per day on at least fi ve days a week. Physical activity recommendations are 
based on Dutch guidelines for physical activity and type 2 diabetes [30]. Participants 
have free access to group-based training sessions and are stimulated to participate for 
at least one hour per week (maximum of two hours per week). Training sessions are 
given by a physiotherapist from primary health care and tailored to individual needs, 
desires, and opportunities. In addition, physiotherapists give tailored advice on how 
to increase physical activity in daily life (e.g. bicycling, walking) and goals are set. After 
three, six and ten months, behaviour change is monitored by physiotherapists (e.g. 
weight, waist circumference, and body fat percentage) aimed to motivate participants, 
prevent drop-out, and discuss progression and goals.
Case management
Practice nurses are appointed as case managers of the intervention programme to 
enhance participant compliance and the feasibility of the implementation. They 
refer participants to the dietician and physiotherapist at the start of the intervention. 
Furthermore, they have the overview of the programme and work together with 
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dieticians and physiotherapists. Four weeks after the start of the intervention and 
halfway the intervention, practice nurses contact dieticians, physiotherapists, 
and participants of the intervention group to facilitate contact among health care 
professionals, to detect and solve problems, and to motivate and support participants.
Maintenance programme
A maintenance programme is added to the combined lifestyle intervention to 
guide participants in the process of maintaining lifestyle behaviour change in an 
independent and sustainable manner. This maintenance programme includes 1) 
intermediate evaluations (e.g. measurement of weight, waist circumference, and body 
fat percentage) by dieticians and physiotherapists to provide feedback and stimulate 
self-management; 2) sports clinics at local sports clubs to introduce participants to 
different sports activities; 3) final interviews with dieticians and physiotherapists at the 
end of the intervention to give positive feedback, discuss behaviour maintenance, and 
to set goals; 4) return visit with dieticians and physiotherapists to motivate and support 
participants in maintaining a healthy lifestyle; and 5) monitoring by practice nurses (i.e. 
discuss and monitor behaviour change during consultations at the general practice).
Control group
Subjects in the control group receive usual health care as provided by GPs and practice 
nurses. Furthermore, they receive a minimal intervention at the start of the study, 
consisting of written information about beneficial effects of a healthy diet and increased 
physical activity, whereas no individual advice or programme is provided. No additional 
appointments are scheduled, apart from visits for follow-up measurements.
Outcomes
Clinical assessments are performed by trained research assistants in research centres 
in Apeldoorn and Doetinchem. Furthermore, process and economic data are collected. 
Participants are measured at baseline (T0), after the intervention (12 months, T1), and six 
months after ending the intervention (18 months, T2). At each time point, participants are 
invited to two sessions on different days: one in the morning and one in the afternoon. 
Additional file 4.2 gives an overview of indicators, methods, and time points of the data 
collection.
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E�fect evaluation
Socio-demographic characteristics
Participants fi ll in questionnaires on socio-demographic characteristics. Data on age, 
gender, education, ethnic background, marital status, job status, and smoking are 
collected according to standards of the national surveillance system for adults and the 
elderly in the Netherlands [31]. These national standards are based on best available 
scientifi c insights, experiences of local community health services, and expert opinions. 
Family history of diabetes is measured with a question from the Dutch Diabetes Risk 
Test [25]. Data on disease history are collected based on questions from the CoDAM 
study (Cohort study Diabetes and Atherosclerosis Maastricht) [32]. Non-response data 
(i.e. age, gender, reason for non-participation, perceived health, and education) are 
collected during the recruitment period by practice nurses.
Overall outcomes
Quality of life is assessed by the Short-Form Health Survey (SF-36), which proved to be 
a practical, reliable, and valid tool for both general and chronic disease populations in 
the Netherlands [33, 34]. 
Long-term outcomes
A standard oral glucose tolerance test (OGTT; glucose load 75 g) is performed by a trained 
nurse after at least 10 hours of fasting. Fasting and 2 h plasma glucose levels, HbA1c, and 
serum lipids (cholesterol (total, HDL, and LDL), and triglycerides) are determined at SHO 
laboratory in Velp, the Netherlands. For fasting and 2 h serum insulin, all blood samples 
are analysed within one run after 18 months. An index for insulin resistance is calculated 
from fasting plasma glucose and insulin concentration, using the homeostasis model 
assessment (HOMA index) [35]. Body mass index (BMI) is calculated as the ratio of 
weight and height squared (kg/m2). Waist circumference is obtained at the level 
midway between the lowest rib and the iliacal crest. Hip circumference is measured 
as the maximum circumference over the buttocks. Body fat percentage is measured by 
bio-impedance analysis (Tanita BC-418). Physical fi tness is measured by the six-minute 
walk test [36], measuring the distance that participants walk within six minutes, which 
is an indicator of physical functional capacity. This is simple, safe, and inexpensive sub-
maximal exercise test [37]. In addition to distance, heart beat rate after six minutes 
and rating of perceived exertion are obtained using the 6-20 category Borg scale  [38]. 
Blood pressure and heart beat rate at rest are measured using the Omron Digital 
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Blood Pressure Monitor HEM-907. Self-reported use of medication (name, frequency, 
and duration of medication use) is determined using a questionnaire [39]. Diabetes 
incidence is based on data of self-reported medication use which are verified by GPs. 
Cardiovascular events are based on self-reported data measured by a questionnaire 
[32]. Procedures of measurements are described in protocols. 
Intermediate outcomes
Eating behaviour is operationalised as nutrient intake and food intake. Nutrient intake is 
assessed by a validated Food Frequency Questionnaire (FFQ) [40, 41]. FFQs are checked by 
trained research assistants. Average daily nutrient intakes are calculated by multiplying 
frequency of consumption by portion size and nutrient content per gram using the 
Dutch food composition table of 2006 [42]. Six food intake behaviours are formulated 
based on Dutch food-based dietary guidelines [43] and common dietician practices in 
the SLIMMER pilot study [19]: 1) eating 200 grams of fruit every day; 2) eating 200 grams 
of vegetables every day; 3) eating more whole grain bread; 4) eating less unhealthy 
snacks; 5) replacing fat bread spreads with lean bread spreads; and 6) drinking less soft 
drinks. These food intake behaviours are measured by an FFQ [40, 41]. Physical activity 
behaviour is measured using the Short Questionnaire to Assess Health-enhancing 
physical activity (SQUASH), including questions on commuting activities, leisure time 
activities, household activities, and activities at work [44]. Physical activity behaviour 
is operationalised as mode, frequency, duration, intensity, and activity score (i.e. total 
minutes of activity * intensity score). The SQUASH is a short, simple, reliable, and valid 
measure for categorising adults to their level of physical activity [44, 45]. In addition, 
a question on sedentary behaviour is added, based on the Activity Questionnaire for 
Adults and Adolescents (AQuAA) [46]. 
Initial outcomes
A questionnaire is developed to measure behavioural determinants, as no validated 
questionnaires are available to measure determinants of specific nutrition and physical 
activity behaviours in adults at high risk of T2DM. To inform the development of the 
questionnaire, the Theoretical Domains Framework [47, 48] is used in which behaviour 
change techniques, used in the SLIMMER intervention, are linked to behavioural 
determinants. The final questionnaire contains items on intention, attitude, social 
influences, self-efficacy, motivation, action control, and skills. Items are based on 
questions and scales described by Fishbein and Ajzen [49], Lakerveld et al. [50], and 
Helmink et al. [51].
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Process evaluation
To assess how the SLIMMER intervention is delivered and received in a real-life setting, 
data from both participants and health care professionals are collected. A process 
evaluation plan is designed based on strategies of Steckler and Linnan [52], Saunders et 
al. [53], Nutbeam [54], and Wang et al. [55]. Process measures include recruitment, reach, 
dose delivered, dose received, acceptability, implementation integrity, applicability, 
and context. These process measures are assessed using the project logbook, non-
response surveys, participant questionnaires, registration forms, attendance lists, and 
semi-structured interviews with health care professionals. 
Economic evaluation
Costs and effects of the SLIMMER intervention are compared with those of the usual 
care. Economic evaluation is performed from a societal perspective, taking all costs 
and benefi ts into account. In addition, a health care perspective is considered, in 
which only direct medical costs are taken into account. As in the effect evaluation, a 
time horizon of 1.5 years is used. Both a cost-effectiveness analysis (CEA) and a cost-
utility analysis (CUA) are performed. The CEA presents clinical outcomes in terms of 
reduction of fasting insulin. The CUA presents outcomes in terms of quality-adjusted 
life years (QALYs), determined by the SF-6D health state classifi cation, a preference-
based single index derived from the SF-36 [56, 57]. Intervention costs, health care costs, 
medication costs, patient costs, as well as productivity losses are assessed. In order to 
estimate intervention costs, time spent by different types of staff involved (practice 
nurses, dieticians, physiotherapists, providers of sports clinics, and project coordinator) 
and materials are identifi ed by means of the project logbook, attendance lists, and 
registration forms. Volumes of health care use, medication use, absence from work, and 
other expenses are identifi ed by means of participant questionnaires and registration 
forms. Costs associated with resources used are valued following Dutch guidelines for 
costing research within health economic evaluations [58, 59]. If no standard cost prices 
are available, cost estimates from literature are used. All costs are expressed as year 
2012 Euros. Where necessary, costs are indexed to the baseline year, as suggested in 
the Dutch manual [58, 59]. Costs and effects in the second year are discounted at Dutch 
standard discounting rates of 4% (costs) and 1.5% (effects).
Data analysis
Quantitative data analyses are performed following the intention-to-treat procedure. If 
necessary, data are transformed and analyses are adjusted for baseline measurements 
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and possible differences between groups at baseline. To adjust for clustering on GP level, 
multilevel analyses are performed. To determine differences in effects between groups, 
multivariate analysis techniques are performed. Two-sided P values are calculated and 
a significance level of 0.05 is applied.
Qualitative data analyses are performed using an inductive approach [60]. Interviews 
with health care professionals are audiotaped and transcribed verbatim. All transcripts 
are read by two researchers individually to identify frequently emerging themes. These 
themes are used to create a coding scheme for analysis of data. Quotes are used to 
describe aspects of how the intervention is delivered and received.
Differences in costs and effects between intervention and control group are expressed as 
incremental cost-effectiveness ratios (ICERs). ICERs are plotted on a cost-effectiveness 
plane, a four quadrant diagram with a horizontal axis representing effect differences 
between the intervention and control group and the vertical axis representing costs 
differences between groups. In addition, a cost-effectiveness acceptability curve is 
constructed, which shows the probability that the SLIMMER intervention is cost-
effective for a range of cost-effectiveness thresholds. Sensitivity analyses are conducted 
to assess robustness of results.
DISCUSSION
Implementation of diabetes prevention interventions in real-life settings requires 
a comprehensive evaluation approach. The design of the SLIMMER intervention 
described in this paper offers an appropriate evaluation strategy. Firstly, the logic model 
will facilitate understanding of the intervention effectiveness by assessing outcomes 
at several levels. Furthermore, the randomised design was adapted to be suitable for 
application in primary health care practice by incorporating block randomisation on GP 
level. Secondly, more attention is given to the process of intervention delivery, which is 
important for real-life, and thus less standardised, interventions. Thirdly, the economic 
evaluation will provide policy makers with valuable information on costs and benefits 
of an intervention.
In conclusion, this study is expected to provide insight in the effectiveness, including 
its cost-effectiveness, and delivery of the SLIMMER diabetes prevention intervention 
conducted in Dutch primary health care. Furthermore, it is expected that this study will 
facilitate our understanding on intervention components and characteristics that are 
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associated with effectiveness. Results of this study provide valuable information for 
primary health care professionals, researchers, and policy makers. 
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Additional fi le 4.1. Overview of core tasks and competences of primary health care professionals involved in the 
SLIMMER intervention.
1. PRACTICE NURSE
Goal
To select eligible patients with a high risk of type 2 diabetes mellitus (T2DM) from 
the electronic patient registration database and motivate them to participate in the 
SLIMMER study. Practice nurses inform patients on the risk of developing diabetes and 
how to reduce this risk by a healthy lifestyle. 
Core tasks
1.  To select patients with a high risk of T2DM, based on inclusion and exclusion 
criteria.
2.  To inform patients about risk factors of T2DM and the importance of a healthy 
lifestyle; to motivate patients to participate in the SLIMMER study; to advise 
patients, taking into account their environment, needs, and opportunities.
3.  To act as case manager to enhance participant compliance and the feasibility 
of the implementation. Practice nurses contact dieticians, physiotherapists, 
and participants of the intervention group to facilitate contact among health 
care professionals, to detect and solve problems, and to motivate and support 
participants.
Competences 
•	 Stimulating patients towards a healthy lifestyle
•	 Good conversation and motivational skills
•	 Good listening skills
•	 Good coaching skills
•	 Monitoring progress of participants
•	 Being able to empathise with specifi c situation of participants
•	 Good coordination skills regarding role of case manager
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2. DIETICIAN
Goal
To guide participants towards an improved dietary pattern, based on Dutch dietary 
guidelines and focussed on people at risk of developing diabetes. Aim is to adopt a 
sustainable healthy dietary pattern step by step.
Core tasks
1.  To carry out intakes to gather relevant information (e.g. dietary pattern, 
experiences, needs, environment) and set goals together with participants.
2.  To formulate dietary advices to discuss during the individual consultations. It is 
important to support and motivate participants, to make an inventory of barriers 
and facilitators, and to set goals together with participants. 
3.  To organise a group session, aimed at sharing experiences, motivating each other, 
and discussing the topic of label reading (practice with comparing products on fat 
and sugar content). 
Competences
•	 Conducting anamnesis of current dietary pattern
•	 Formulating tailored dietary advice
•	 Being able to empathise with specific situation of participants
•	 Stimulating participants towards a healthy lifestyle
•	 Good conversation and motivational skills (motivational interviewing techniques)
•	 Recognising and analysing barriers for healthy nutrition behaviour
•	 Applying dietary guidelines adequately
•	 Giving information on relation between nutrition and glucose tolerance
•	 Collecting data on dietary advice, progress and condition of participants
•	 Monitoring dietary pattern and compliance to dietary advices
•	 Detecting and tackling problems with new dietary pattern
•	 Building confidence with participants
•	 	Improving participants’ self-consciousness by listening and asking the right 
questions
•	 Guiding participants in a step-by-step behaviour change
•	 Helping participants get insight into their motivation
•	 Teaching participants new skills in a creative manner
•	 Organising and executing group session
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3. PHYSIOTHERAPIST 
Goal
To guide participants towards an improved physical activity pattern, based on Dutch 
guidelines for physical activity and type 2 diabetes. Aim is to obtain and maintain an 
active lifestyle, that is moderate-intensity physical activity for at least 30 minutes per 
day on at least fi ve days a week, and (re-)discover pleasure of being physically active.
Core tasks
1.  To carry out an intake to get insight in physical activity pattern, wishes, knowledge, 
opportunities, and experiences of participants.
2.  To conceive a tailored physical activity programme based on information of the 
intake, consisting of weekly, group-based training lessons with both aerobic and 
resistance exercise. Besides individual coaching during the lessons, attention will 
be given to the group and team wise activities.
3.  To stimulate and advise on tailored physical activity in daily life, taking into 
account opportunities and barriers of participants.
4.  To guide participants to local sports clubs to maintain lifestyle behaviour 
change in an independent and sustainable manner. During the physical activity 
intervention, attention will be given to the period after ending the intervention. 
Competences
•	 Being aware of Dutch guidelines for physical activity and type 2 diabetes
•	 Conducting anamnesis of current physical activity pattern
•	 	Advising and stimulation of participants towards a healthy physical activity 
pattern
•	 Giving information on relation between physical activity and glucose tolerance 
•	 Stimulating participants to participate in the SLIMMER exercise intervention
•	 Stimulating and advising participants to additional physical activity in daily life
•	 Detecting and tackling problems regarding the exercise intervention
•	 Monitoring compliance to physical activity advices
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Chapter 5
E�fect and maintenance of the SLIMMER 
diabetes prevention lifestyle intervention 
in Dutch primary health care: a randomised 
controlled trial
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ABSTRACT
Objective
To assess the effectiveness of the SLIMMER combined dietary and physical activity 
lifestyle intervention on clinical and metabolic risk factors, dietary intake, physical 
activity, and quality of life after 12 months, and to investigate whether effects sustained 
six months after the active intervention period ended.
Research Design and Methods
SLIMMER was a randomised controlled intervention, implemented in Dutch public 
health and primary health care. In total, 316 subjects aged 40–70 years with increased 
risk of type 2 diabetes were randomly allocated to the intervention group (10-month 
dietary and physical activity programme) or the control group (usual health care). All 
subjects underwent an oral glucose tolerance test and physical examination, and filled 
in questionnaires. Identical examinations were performed at baseline and after 12 and 
18 months. Primary outcome was fasting insulin.
Results
The intervention group showed significantly greater improvements in anthropometry 
and glucose metabolism. After 12 and 18 months, differences between intervention and 
control group were -2.7 kg (95% CI: -3.7;-1.7) and -2.5 kg (95% CI: -3.6;-1.4) for weight, and 
-12.1 pmol/l (95% CI: -19.6;-4.6) and -8.0 pmol/l (95% CI: -14.7;-0.53) for fasting insulin. 
Furthermore, dietary intake, physical activity, and quality of life improved significantly 
more in the intervention group than in the control group.
Conclusions
The Dutch SLIMMER lifestyle intervention is effective in the short and long term in 
improving clinical and metabolic risk factors, dietary intake, physical activity, and 
quality of life in subjects at high risk of diabetes.
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INTRODUCTION
Universal consensus exists on the need to translate and implement evidence from 
landmark clinical trials on combined lifestyle interventions to prevent type 2 diabetes 
in real-world settings [1]. Recent reviews on studies conducted in such settings showed 
limited results, with signifi cant reductions in weight and waist circumference but 
inconclusive results for metabolic indicators of diabetes risk, such as blood glucose or 
HbA1c [2-4]. Furthermore, current evidence on the sustainability and long-term clinical 
benefi ts of such interventions is limited [2-4]. To date, no evidence-based diabetes 
prevention interventions have been effectively implemented in Dutch primary health 
care [5, 6], while the Study on Lifestyle intervention and Impaired glucose tolerance 
Maastricht (SLIM), conducted in an experimental setting, had earlier revealed a 47% 
diabetes risk reduction [7]. We therefore used the SLIM intervention as a starting 
point for implementation and translated this into the SLIMMER intervention (SLIM 
iMplementation Experience Region Noord- en Oost-Gelderland). This translation was 
done jointly by SLIM intervention developers and local health care professionals [8]. 
Pilot-testing of the adapted intervention showed its implementation was feasible 
in Dutch primary health care and that it was likely to achieve the desired impact [9]. 
These results served as input for the broader implementation and evaluation of the 
intervention [10]. In this study, we assess the effectiveness of the SLIMMER intervention 
on clinical and metabolic risk factors, dietary intake, physical activity (PA), and quality 
of life after 12 months. Moreover, the aim is to investigate whether effects sustained six 
months after the active intervention period ended. 
RESEARCH DESIGN AND METHODS
Study design
The SLIMMER study’s design and 10-month lifestyle intervention programme have 
been described in detail elsewhere [10]. In short, SLIMMER was a randomised, 
controlled intervention study, conducted in the cities of Apeldoorn and Doetinchem 
(the Netherlands). It was implemented in Dutch public health and primary health care, 
involving 25 general practices – general practitioners (GPs) and their practice nurses –, 
11 dieticians, 16 physiotherapists, and 15 sports clubs. The study protocol was approved 
by the Wageningen University Medical Ethics Committee, and all subjects gave their 
written informed consent before the study started. 
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Study population
Study subjects were recruited by GPs and practice nurses from their patient registration 
database, using either a laboratory glucose test or the Dutch Diabetes Risk Test [11]. The 
inclusion criteria were 1) aged between 40 and 70 years at screening, 2) impaired fasting 
glucose (IFG; 6.1-6.9 mmol/l) [12] or an elevated/high risk of type 2 diabetes (a Diabetes 
Risk Test score of ≥7 points) [11], 3) willing and able to participate in the study for at least 1.5 
years, and 4) able to speak and understand the Dutch language. Exclusion criteria were, 
amongst others, known diabetes and any severe cardiovascular or psychiatric disease. 
Criteria were checked using electronic medical records. Recruitment took place between 
October 2011 and September 2012 in three consecutive groups for logistical reasons.
In total, 1,009 individuals aged 40–70 years without diabetes mellitus were initially 
identified from the patient registration database (Figure 5.1). Of these, 590 (58%) 
fulfilled all criteria and were invited to participate. In total, 316 subjects (54%) were 
willing to participate and underwent an oral glucose tolerance test (OGTT) and physical 
examination at baseline. 
After baseline measurements, participants were randomly allocated to the intervention 
or control group (allocation ratio 1:1), using block randomisation at GP level and 
stratification for sex. Couples were allocated to the same group to avoid contamination. 
An independent dietician from the Division of Human Nutrition, Wageningen University, 
performed the randomisation. One of the researchers (GD) assigned participants to the 
intervention or the control group.
Intervention
The SLIMMER combined lifestyle intervention resembled the SLIM intervention [7], 
which was based on the Finnish Diabetes Prevention Study [13], and consisted of a dietary 
and a PA component, delivered by primary health care professionals (GPs, practice 
nurses, dieticians, and physiotherapists) [10]. Furthermore, case management and a 
maintenance programme were included. The dietary intervention consisted of tailored 
dietary advice given by a dietician, during five to eight individual consultations and one 
group session. The aim was to adopt, step by step, a sustainable, healthy dietary pattern 
according to the Dutch dietary guidelines [14]. Furthermore, the intervention aimed to 
help overweight participants to achieve 5–10% weight loss. The PA intervention was 
delivered by physiotherapists as weekly group-based combined aerobic and resistance 
training sessions, based on the Dutch guidelines for PA and type 2 diabetes [15]. The aim 
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was to obtain and maintain an active lifestyle, which includes moderate-intensity PA for 
at least 30 minutes per day on at least fi ve days a week. Furthermore, case management 
was performed by practice nurses (contacting intervention participants and health 
care professionals by phone) to enhance participant compliance and feasibility of 
implementation. 
Intervention group at 12 
months (post-intervention)
Fasting insulin: 140
Body weight: 143
Questionnaire: 144
Control group at 12 months 
(post-intervention)
Fasting insulin: 136
Body weight: 144
Questionnaire: 140
Intervention group at 18 
months (maintenance)
Fasting insulin: 121
Body weight: 128
Questionnaire: 131
Control group at 18 months 
(maintenance)
Fasting insulin: 129
Body weight: 133
Questionnaire: 133
Intervention group at baseline 
N = 155 (49%)
Fasting insulin: 155
Body weight: 154
Questionnaire: 155
Control group at baseline 
N = 161 (51%)
Fasting insulin: 161
Body weight: 161
Questionnaire: 161
Initial identification from GPs’ patient 
registration database (subjects 40–70 years 
without diabetes)
N = 1009
Invitation by GP
N = 590 (58%)
Randomisation after baseline measurement
N = 316 (54%)
N = 419 (42%)
Reasons:
- Not fulfilling criteria
- Not responding to laboratory
glucose test or Diabetes Risk
Test
N = 274 (46%)
Reasons:
- Lack of time (25%)
- Lack of interest (22%)
- Reporting ‘I already exercise
enough’ (11%)
- Reporting ‘It is of no
importance to me’ (10%)
- Not being able due to illness
or handicap (9%)
- Other reasons (23%)
Figure 5.1. Flow diagram.
In addition to the core dietary and PA intervention, a maintenance programme was 
delivered, starting in the last phase of the 10-month intervention period and lasting 
up to three months thereafter. This programme comprised sports clinics at local sports 
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clubs, concluding meetings with the dietician and physiotherapist, and a return session 
with the physiotherapist, dietician, and the PA group [16]. This programme was added 
to guide participants in the process of maintaining lifestyle behaviour change in an 
independent and sustainable manner.
Control group subjects received usual health care as provided by GPs and practice nurses 
(yearly monitoring of blood glucose, according to the guidelines of the Dutch College of 
General Practices) [17]. Furthermore, at baseline they received written information on 
the beneficial effects of a healthy diet and increased PA. No additional appointments 
were scheduled, apart from visits for follow-up measurements.
Data collection and outcomes
Baseline measurements were taken between February and October 2012. All study 
subjects underwent an oral glucose tolerance test (OGTT) and physical examination, 
and filled in questionnaires. Identical examinations were performed at baseline, after 
12 months (at the end of the intervention), and after 18 months (six months after the 
end of the intervention; see Additional file 5.1). These procedures have previously been 
described in detail [10]. 
The primary outcome was fasting insulin, determined on the basis of a standard OGTT 
with a glucose load of 75g, performed by trained nurses after at least 10 hours of fasting. 
Fasting and 2-h plasma glucose levels, HbA1c, and serum lipids (cholesterol (total, HDL, 
and LDL) and triglycerides) were determined at SHO laboratory in Velp, the Netherlands. 
For fasting insulin, all blood samples were analysed within one run after 18 months. 
An index for insulin resistance was calculated from fasting plasma glucose and insulin 
concentration, using the homeostasis model assessment (HOMA-IR) [18]. Diabetes was 
classified based on World Health Organisation recommendations [12, 19] and standards 
of the American Diabetes Association [20]. Normoglycaemia was defined as fasting 
glucose <6.1 mmol/l and 2-h glucose <7.8 mmol/l; isolated IFG was defined as fasting 
glucose 6.1–6.9 mmol/l and 2-h glucose <7.8 mmol/l; impaired glucose tolerance was 
defined as fasting glucose <7.0 mmol/l and 2-h glucose 7.8–11.0 mmol/l; and diabetic 
values were defined as fasting glucose ≥7.0 mmol/l, 2-h glucose ≥11.1 mmol/l, HbA1c 
≥6.5%, or using diabetes medication. Clinical assessments were performed by trained 
research assistants in research centres in Apeldoorn and Doetinchem according to 
standardised procedures. BMI was calculated as the ratio of weight and height squared 
(kg/m2). Waist circumference was obtained at the level midway between the lowest 
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rib and the iliac crest. Blood pressure was measured using the Omron Digital Blood 
Pressure Monitor HEM-907.
Socio-demographic characteristics (age, sex, education level, ethnic background, 
smoking, and family history of diabetes) were collected by participant questionnaires. 
These data were collected according to standards of the national surveillance system 
in the Netherlands [21] and an existing questionnaire [11]. Self-reported medication 
use was determined using a questionnaire [22]. Non-response data (age, sex, reason 
for non-participation, perceived health, and education level) were collected during the 
recruitment period by practice nurses.
Dietary intake (nutrient intake and food intake) was assessed by a validated 
Food Frequency Questionnaire (FFQ) [23]. FFQs were checked by trained research 
assistants. Average daily nutrient intakes were calculated by multiplying frequency of 
consumption by portion size and nutrient content per gram using the 2011 Dutch food 
composition table [24]. Food intake behaviours were formulated based on Dutch food-
based dietary guidelines [25] and common dietician practices in the SLIMMER pilot 
study [9]. Adherence to the Dutch dietary guidelines [14] was calculated, based on the 
Dutch Healthy Diet Index (DHD-index) [26]. The original DHD-index consisted of 10 
components representing the guidelines, whereas for the current study we adapted the 
index and included eight components: PA, vegetable, fruit, fi bre, fi sh (EPA and DHA), 
saturated fat, trans-fatty acids, and alcohol. Two components (‘acidic drinks and foods’ 
and ‘sodium’) were excluded because no data were available on these components. Per 
component, the score ranged between 0 and 10, resulting in a total score between 0 (no 
adherence) and 80 (complete adherence).
PA was measured using the validated Short QUestionnaire to Assess Health-enhancing 
physical activity (SQUASH) [27]. The durations (minutes per week) of total and 
light-, moderate-, and vigorous-intensity physical activities were calculated. Level of 
compliance with the PA guidelines (moderate-intensity PA for at least 30 minutes per 
day on at least fi ve days a week) was represented as inactive (0 days), semi-active (1–4 
days), or norm-active (at least 5 days) [28]. Furthermore, physical fi tness was measured 
as the distance covered in metres during the six-minute walk test [29].
Quality of life was assessed by the Short-Form Health Survey (SF-36), which has 
proved to be a practical, reliable, and valid tool for both general and chronic disease 
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populations in the Netherlands [30]. The questions were organised into one item on 
health transition and eight scales for, respectively, physical functioning, role limitations 
due to physical health problems, bodily pain, general health perceptions, vitality, social 
functioning, role limitations due to emotional problems, and general mental health. 
The eight scales were converted to a 0–100 scale indicating worst to best possible 
health. Scores were summarised into the physical component summary score and the 
mental component summary score. 
Statistical analysis 
A sample size of 145 subjects per group was required to detect differences between 
groups in fasting insulin, assuming an alpha of 0.05, power of 80%, two-sided test, and 
an expected drop-out rate of 10%. After exclusion of subjects because of missing data 
on fasting insulin or BMI at baseline or 12 months (n=16 in the intervention group and 
n=25 in the control group), data collected from 275 subjects were used for statistical 
analysis. Participants who dropped out were not substantially different from the 
completers in baseline characteristics, except that drop-outs were more often divorced 
than completers (25% vs. 6% in the intervention group and 28% vs. 5% in the control 
group). Furthermore, the HOMA-IR was higher in intervention drop-outs than in 
completers (3.1 ± 2.8 vs. 2.0 ± 1.1, p = 0.053), whereas this was lower in control drop-outs 
than in completers (1.5 ± 0.6 vs. 2.0 ± 1.2, p = 0.015). 
Continuous variables are presented as mean ± SD and categorical variables as 
percentages. Natural log transformations were used in the event of skewed distributions. 
Differences within groups were tested for statistical significance with paired samples 
t tests for normally distributed variables and Wilcoxon signed-rank tests for non-
normally distributed variables. Differences between groups were tested for statistical 
significance with independent samples t tests for normally distributed variables and 
Mann-Whitney tests for non-normally distributed variables, χ2 tests, and ANCOVA 
adjusting for baseline value, sex, recruitment phase, and medication use if applicable. 
Additional analyses showed similar results when subjects on medication were excluded. 
We included an interaction term in the ANCOVA models to test whether the association 
between treatment and outcome measures differed by sex. All primary analyses were 
performed according to the intention-to-treat principle: participants were analysed in 
the groups to which they were originally randomly assigned, regardless of whether or 
not they actually participated in the intervention. All analyses were performed using 
IBM SPSS Statistics version 22.
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RESULTS
Baseline results
Study subjects and non-responders (those who were not willing to participate) were 
similar in terms of sex, age, and education level. However, 90% of the non-responders 
perceived their health as good or even better, against 79% of the study subjects. The 
most important reasons for non-response were lack of time (25%), lack of interest 
(22%), reporting ‘I already exercise enough’ (11%), reporting ‘It is of no importance to 
me’ (10%), and not being able due to illness or handicap (9%). 
Table 5.1 shows the baseline characteristics of the 275 subjects. No differences in baseline 
characteristics between study groups were found. On average, subjects were 61 years old, 
and most had a low education level, were Dutch, and had a family history of diabetes. 
Of the total, 48% were overweight  (BMI ≥25 and <30 kg/m2), 42% were obese (BMI ≥ 
30 kg/m2), and 15% had a cardiovascular disease in the past (data not shown). Dietary 
intake was similar between groups both in terms of nutrient intake and food intake, 
and both groups had similar adherence to the Dutch dietary guidelines. Moderate-to-
vigorous-intensity PA was comparable between groups and 80% of participants were 
classifi ed as norm-active. Health-related quality of life was comparable in both groups, 
with scores around 50 for both physical and mental component scores.
Results on clinical and metabolic risk factors
Table 5.2 summarises changes in clinical and metabolic risk factors after 12 and 18 
months. Benefi cial changes were observed in the intervention group compared with 
the control group. At 12 months, mean weight reduction was 3.4% in the intervention 
group and 0.3% in the control group (p < 0.001). Furthermore, waist circumference 
reduction was greater in the intervention group. Fasting insulin declined more in the 
intervention group than in the control group (-12.6 vs. 0.6 pmol/l, p = 0.005). Also, greater 
improvements were seen in fasting glucose (-0.2 vs. -0.01 mmol/l), 2-h glucose (-0.5 vs. 
0.2 mmol/l), HbA1c (-0.15 vs. -0.07%), and HOMA-IR (-0.29 vs. 0.02) in the intervention 
group than in the control group (p < 0.05). Compared to baseline, more subjects had 
normoglycaemia (19% vs. 25% in the intervention group and 15% vs. 20% in the control 
group) and fewer intervention subjects (32% vs. 27%) than control subjects (28% vs. 
31%) had diabetic values. 
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Table 5.1. Baseline characteristics of participants in the SLIMMER intervention (n = 275)a.
INT (n = 139) CON (n = 136)
Socio-demographics
Sex (n, %)
 Male
 Female
75 (54)
64 (46)
69 (51)
67 (49)
Age (years) 61.1 ± 6.1 61.2 ± 6.6
Education level (n, %)b
 Low
 Middle
 High
74 (53)
39 (28)
26 (19)
73 (54)
26 (19)
37 (27)
Ethnicity (n, %)
 Dutch
 Western non-Dutch
 Non-western non-Dutch
123 (88)
12 (9)
4 (3)
123 (90)
9 (7)
4 (3)
Family history of diabetes (n, %)
 No
 First degree 
 Second degree 
46 (33)
66 (48)
27 (19)
57 (42)
62 (46)
17 (12)
Smoking status (n, %)
 Yes
 Ex-smoker
 No, never
21 (15)
86 (62)
32 (23)
26 (19)
78 (57)
32 (24)
Clinical and metabolic risk factors
Weight (kg) 89.5 ± 17.0 87.8 ± 15.2
BMI (kg/m2) 30.2 ± 4.5 29.9 ± 4.8
Waist circumference (cm)
 Male 
 Female
109.3 ± 12.2
101.0 ± 12.0
107.4 ± 10.2
100.0 ± 12.9
Fasting glucose (mmol/l) 6.6 ± 0.6 6.6 ± 0.6
2-h glucose (mmol/l)c 8.2 ± 2.8 8.0 ± 2.5
Fasting insulin (pmol/l) 87.8 ± 48.2 86.0 ± 52.8
HOMA-IR 2.0 ± 1.1 2.0 ± 1.2
HbA1c (% (mmol/mol)) 5.8 ± 0.4
(40.3 ± 3.9)
5.8 ± 0.4
(40.1 ± 4.0)
Total cholesterol (mmol/l) 5.5 ± 1.1 5.5 ± 1.2
HDL cholesterol (mmol/l) 1.5 ± 0.4 1.4 ± 0.4
LDL cholesterol (mmol/l) 3.5 ± 1.0 3.6 ± 1.0
Triglycerides  (mmol/l) 1.7 ± 0.9 1.6 ± 0.8
Blood pressure (mmHg)c
 Systolic 
 Diastolic
133.0 ± 15.5
77.5 ± 10.7
131.0 ± 13.5
75.6 ± 8.7
Dietary intake
Energy intake (kcal/d) 1986.3 ± 576.1 2040.7 ± 634.2
Saturated fat (en%) 11.8 ± 2.2 11.9 ± 2.3
Fibre (g/1000 kcal) 11.0 ± 2.6 11.1 ± 2.4
Alcohol (en%) 4.8 ± 5.7 4.3 ± 5.2
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INT (n = 139) CON (n = 136)
Fruit intake incl. fruit juices (g/d) 186.1 ±119.9 206.5 ± 140.0
Vegetable intake (g/d) 149.3 ± 96.6 137.8 ± 84.7
Fibre intake from total bread intake (%) 5.6 ± 1.0 5.8 ± 1.2
Fat intake from total bread spread intake (%) 21.0 ± 6.4 19.6 ± 6.1
Snack intake (kcal/d) 278.5 ± 208.2 323.0 ± 272.7
Soft drink intake (kcal/d) 56.3 ± 69.6 48.5 ± 60.1
Dutch Healthy Diet index (0–80 scale) 58.8 ± 9.5 58.7 ± 9.0
Physical activity (PA)
Total PA (min/week) 2254 ± 1337 2306 ± 1232
Light PA (min/week) 1307 ± 1094 1331 ± 970
Moderate PA (min/week) 593 ± 692 559 ± 552
Vigorous PA (min/week) 354 ± 427 417 ± 450
Physical fi tness (m)c 454.0 ± 58.0 455.5 ± 57.7
Quality of life
Physical component score 50.1 ± 8.2 49.8 ± 7.9
Mental component score 50.1 ± 10.3 50.7 ± 8.1
a Data are n (%) or mean ± SD. 
b Education level was based on the highest level of education completed and divided in three categories: low (no, 
primary or lower secondary school), middle (higher secondary school or intermediate vocational school), and 
high (higher professional education or university level).
c 2-h glucose INT n = 138, CON n = 136; systolic blood pressure INT n = 138, CON n = 135; diastolic blood pressure INT 
n = 138, CON n = 135; physical fi tness INT n = 138, CON n = 136.
No signifi cant differences in serum lipids between groups were observed. Systolic and 
diastolic blood pressure reduced in both groups. However, no signifi cant differences 
between groups were noted.
No differences in outcomes were observed between subjects recruited by laboratory 
glucose test (n = 130) or by Diabetes Risk Test (n = 110), except for fasting glucose at 12 
months: in subjects recruited by laboratory glucose test, fasting glucose was signifi cantly 
lower in the intervention group than in the control group (β = -0.4, 95%CI -0.6;-0.1), 
whereas there was no effect on fasting glucose in subjects recruited by Diabetes Risk 
Test (β = -0.0, 95%CI -0.2;0.2; p for interaction=0.016; Additional fi le 5.2).
At 18 months, reductions in weight, waist circumference, fasting glucose, 2-h glucose, 
fasting insulin, HbA1c, and HOMA-IR were sustained in favour of the intervention group 
(Table 5.2). Even more subjects than at 12 months had normoglycaemia (44% in the 
intervention group and 38% in the control group). 
Table 5.1. Continued
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Results on dietary intake and PA 
At 12 months, intake of energy, fat, and saturated fat was reduced; intake of fi bre increased 
more in the intervention group than in the control group (Table 5.3). No signifi cant 
differences in intake of protein, carbohydrates, and alcohol between groups were 
observed. Fruit intake increased signifi cantly in the intervention group but decreased 
in the control group. No signifi cant difference in vegetable intake between groups was 
found. Generally, similar results were observed when food groups were expressed per 
1000 kcal. The DHD-index score improved signifi cantly more in the intervention group 
than in the control group (3.6 vs. 0.3, p < 0.001, Table 5.3). 
At 18 months, no effect on energy and protein intake was found, whereas intake of fat and 
saturated fat reduced even more than at 12 months in the intervention group compared 
with the control group (Table 5.3), especially in men (data not shown). Furthermore, 
the effect on fi bre intake continued at 18 months. No signifi cant difference in fruit 
intake between groups was observed anymore, in contrast to vegetable intake, which 
was signifi cantly higher in the intervention group than in the control group (15.7 vs. 2.2 
g, p = 0.039). Also at 18 months, the DHD-index score was signifi cantly higher in the 
intervention group than in the control group.
At 12 months, the intervention group spent more time on vigorous activities compared 
with baseline, whereas this decreased in the control group (65.7 vs. -80.2 min/week, p 
= 0.006; Table 5.3). Furthermore, the intervention group improved more on physical 
fi tness than the control group (covered distance 25.1 vs. 2.3 m, p <0.001). 
At 18 months, the intervention group further increased time spent on vigorous activities. 
However, the control group also slightly improved (Table 5.3). Especially women in the 
intervention group spent more time on vigorous activities than women in the control 
group (at 12 months p for interaction = 0.055, and at 18 months p for interaction = 0.051). 
Furthermore, the improvement in physical fi tness was maintained in favour of the 
intervention group (Table 5.3).
Results on quality of life 
At 12 months, the item ‘health transition’ and the sub-scales ‘physical functioning’ and 
‘general mental health’ improved in the intervention group compared with the control 
group (p < 0.05; Table 5.4). Additional analyses showed that the sub-scale ‘role limitations 
due to physical health problems’ improved in women in the intervention group but not in 
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men (p for interaction = 0.014). No significant differences in physical component score or 
mental component score between groups were observed (Table 5.4).
At 18 months, the effect on health transition continued and, additionally, significant 
effects were found for ‘general health perceptions’, ‘role limitations due to emotional 
problems’, and ‘social functioning’ in favour of the intervention group (Table 5.4). 
Moreover, the mental component score significantly improved in the intervention 
group compared with the control group (2.4 vs. -0.1), but no effect was found on the 
physical component score.
CONCLUSIONS
The aim of this study was to assess the effectiveness and maintenance of the SLIMMER 
lifestyle intervention after 12 and 18 months in Dutch primary health care. It was shown 
that the SLIMMER intervention improved body weight, clinical and metabolic risk 
factors, dietary intake, physical activity, and quality of life. Furthermore, it was shown 
that most of these improvements sustained at 18 months. 
It is often shown that the effectiveness of lifestyle interventions in real-world settings 
is limited compared with experimental settings [3], due to the real world’s complexity 
and limited finance and resources [31]. The SLIMMER lifestyle intervention, however, 
showed a weight reduction of 3.0 kg after 12 months, which is comparable with that in 
the original SLIM study (-2.8 kg) [7]. Furthermore, our study found better improvements 
in several clinical and metabolic risk factors, such as weight, BMI, waist circumference, 
fasting and 2-h glucose, and HbA1c, compared with most other real-world programmes 
[3-5]. These results were found in two primary health care settings that are representative 
of Dutch primary health care. 
Weight reduction during our study can be indicated as modest. However, it might be 
relevant, as several studies have shown that even modest weight reduction can reduce 
the risk of diabetes [32, 33]. In the US Diabetes Prevention Program, it was shown 
that diabetes incidence can be reduced by around 16% for each kilogram of weight 
lost [32]. Given the weight loss seen in the SLIMMER intervention group compared 
with the control group, we would expect around a 43% reduction in type 2 diabetes 
attributable to weight loss at 12 months, and a 40% reduction at 18 months, which is 
comparable with the 47% risk reduction in the SLIM study [7]. A review of 36 studies 
assessing diabetes prevention in real-world settings revealed a 26% risk reduction, 
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which is lower than our results, possibly because of the less intensive nature of many 
included interventions [4]. 
Weight reduction is maintained at 18 months. This is remarkable, as it is well known that 
weight regain following the end of an intensive lifestyle programme is common within 
fi ve years [34], even in successful lifestyle interventions [35, 36]. This result might partly 
be explained by the inclusion of a maintenance programme following the intensive 
lifestyle programme. It is suggested that such a maintenance programme could 
enhance intervention effectiveness because of the use of specifi c behaviour change 
techniques such as goal-setting, self-monitoring, and relapse prevention [37]. However, 
data on weight loss maintenance in real-world trials is limited, as very few studies report 
outcomes beyond 12 months [4]. Our study investigated maintenance after six months. 
However, benefi ts over extended follow-up should be further investigated.  
Our results indicate that the SLIMMER intervention was successful in improving overall 
dietary patterns and several nutrient intakes, such as total fat, saturated fat, and fi bre 
intake. Furthermore, vigorous physical activities were more improved in the intervention 
group than in the control group. The Dutch Aphrodite lifestyle intervention found 
benefi cial effects only for total physical activities and fi bre intake [5]. A systematic review 
of diabetes prevention interventions in the real world, however, concluded that, overall, 
changes in diet and PA are poorly reported, and that more research is needed [4]. 
Several factors in our lifestyle programme compared to others could have contributed 
to intervention effectiveness. Firstly, the SLIMMER intervention was highly intensive, 
with weekly sports lessons and regular dietary consultations for 10 months. Several 
reviews found that increased intervention effectiveness was associated with higher 
intervention intensity [3, 4, 37]. Secondly, lifestyle advice in our study was provided by 
dieticians and physiotherapists rather than by the more general lifestyle coaches in 
other studies, such as GPs or practice nurses (or both) and lay community educators 
[37]. Specialist professionals are more specifi cally educated for, and more experienced 
in, delivering nutritional or physical activity advice, and this may have contributed 
to intervention effectiveness. Moreover, several international reviews concluded 
that a wide staff range delivers effective interventions [4, 37]. Thirdly, the thorough 
preparation of the SLIMMER intervention may have contributed to its effectiveness 
[38]. Much attention was paid to carefully translating the intervention programme 
to the real world in a joint decision-making process with intervention developers and 
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local health care professionals [8], followed by pilot-testing of the adapted intervention 
programme [9] prior to implementation and evaluation. 
The randomised design, comprehensive evaluation approach (outcomes at several 
levels), and validated methods to measure dietary intake and PA allow us to draw solid 
conclusions on the SLIMMER intervention’s effectiveness. By investigating outcomes at 
several levels (dietary intake and PA alongside clinical and metabolic risk factors), we 
now have more insight into determinants contributing to diabetes prevention, such as 
intakes of fat, saturated fat, and fibre, and vigorous activities. Although we observed 
beneficial changes in quality of life, many were non-significant. Therefore, a disease-
specific questionnaire might have been used rather than the SF-36 questionnaire, as 
such a generic instrument is less responsive to changes in health-related quality of life 
[39].
Risk scores might be good tools to screen people at high risk of type 2 diabetes in primary 
health care. They are non-invasive, easy, and cheap compared with fasting plasma 
glucose measurements. The Diabetes Risk Test used in the current study is based on the 
FINDRISC questionnaire, which has been shown to be capable to predict undiagnosed 
diabetes and prediabetes [40]. As shown in our study, intervention subjects improved 
weight and glucose tolerance, independent of manner of recruitment (fasting plasma 
glucose or Diabetes Risk Test). This is in line with Ashra et al.’s review [4].
In summary, this study has shown that the Dutch SLIMMER lifestyle intervention is 
effective in the short and long term in improving clinical and metabolic risk factors, 
dietary intake, physical activity, and quality of life in subjects at high risk of diabetes. 
More insight into longer-term effects of the intervention on maintenance and cost-
effectiveness is needed and important for sustainable diabetes prevention. The results 
provide valuable information for primary health care professionals, researchers, and 
policymakers.
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T1 
Post
Measurements 
 OGTT
 Physical examination
 Questionnaires
Intervention group 
Core programme 
 10-month dietary and physical
activity intervention
Maintenance programme 
 Sports clinics
 Concluding meetings
T0 
Pre
Measurements 
 Oral Glucose Tolerance Test (OGTT)
 Physical examination
 Questionnaires
Randomisation 
Control group 
 Usual care
 Written information on healthy
lifestyle
T2 
6 months post
Measurements 
 OGTT
 Physical examination
 Questionnaires
Maintenance programme 
 Return visit
Additional fi le 5.1. Timeline of the SLIMMER intervention.
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ABSTRACT
Background
A comprehensive evaluation approach is required to identify the combination of most 
effective intervention components for preventing type 2 diabetes. A process evaluation 
can enhance confidence in conclusions about intervention effectiveness. The aim of this 
article is twofold: first, to investigate how the SLIMMER intervention was delivered and 
received in Dutch primary health care, and, second, how this could explain intervention 
effectiveness. 
Methods
SLIMMER was a randomised controlled trial for diabetes prevention, implemented in 
Dutch primary health care. The intervention consisted of a 10-month combined dietary 
and physical activity intervention, including case management and a maintenance 
programme. In total, 316 subjects at increased risk of developing type 2 diabetes were 
included. A process evaluation including quantitative and qualitative methods was 
conducted. Data on process indicators (recruitment, reach, dose received, acceptability, 
implementation integrity, and applicability) were collected in semi-structured interviews 
with health care professionals (n = 45) and intervention participant questionnaires (n 
= 155).
Results
It was possible to recruit the intended high-risk population, and the SLIMMER 
intervention was very well received by both participants and health care professionals. 
The intervention programme was to a large extent implemented as planned and 
was applicable in Dutch primary health care. Higher dose received and participant 
acceptability were related to improved health outcomes and dietary behaviour, but not, 
however, to physical activity behaviour.  
Conclusions
This study showed that it is feasible to implement a diabetes prevention intervention 
in Dutch primary health care. Higher dose received and participant acceptability 
were associated with improved health outcomes and dietary behaviour, but not with 
physical activity behaviour. Furthermore, targeting both diet and physical activity, 
using behaviour change techniques, focusing on behaviour maintenance, tailoring 
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the intervention, and using a multidisciplinary approach might have facilitated 
intervention effectiveness. Using an extensive process evaluation plan to gain insight 
into how an intervention is delivered and received is a valuable way of identifying 
intervention components that contribute to implementation integrity and effective 
prevention of type 2 diabetes in primary health care. 
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BACKGROUND
Over the last two decades, many large-scale randomised controlled trials have shown 
that type 2 diabetes can be delayed or prevented by lifestyle intervention in individuals 
at high risk of developing type 2 diabetes [1-8]. Many of these interventions have been 
implemented in real-world settings and have shown significant reductions in weight 
but inconclusive results for metabolic indicators of diabetes risk [9-12]. However, 
implementation of interventions in the real world is often complex, as they are not 
delivered in controlled environments and thus are influenced by a multitude of factors 
(e.g. limited resources and finance). Therefore, a comprehensive evaluation approach 
is required to identify the combination of most effective intervention components for 
preventing type 2 diabetes [9, 10, 13, 14]. The scope of the evaluation approach needs to 
be broadened from only assessing effectiveness to also getting insight into the delivery 
of an intervention, that is, elucidating the aspects that explain what works, how, and 
why [15, 16]. A process evaluation, therefore, can enhance confidence in conclusions 
about intervention effectiveness [17].
Several reviews have identified intervention components associated with increased 
intervention effectiveness. A review by Greaves et al. [18] showed that greater 
intervention effectiveness in dietary and physical activity (PA) interventions to prevent 
type 2 diabetes was associated with targeting both diet and PA, mobilising social 
support, using behaviour change techniques (e.g. self-monitoring, goal setting, relapse 
prevention, and individual tailoring), and having a clear plan to support maintenance 
of behaviour change. Also, providing higher intensity interventions was associated with 
greater intervention effectiveness [18, 19]. There were no clear associations between 
intervention effectiveness and setting, delivery mode (e.g. group-based, individual, or 
mixed), delivery provider, or study population [18, 19]. Another systematic review on 
interventions to increase PA in adults aged 55 to 70 years found no relationship between 
intervention effectiveness and delivery mode or intervention intensity. However, it 
was concluded that tailoring the intervention to participants may be important [20]. 
Furthermore, a meta-regression on weight management programmes showed that 
greater weight loss was associated with counting calories (self-monitoring), providing 
at least some contact with a dietician, and facilitating social comparisons [21]. 
In the Netherlands, the original Study on Lifestyle intervention and Impaired glucose 
tolerance Maastricht (SLIM) [4] was translated into the SLIMMER diabetes prevention 
intervention (SLIM iMplementation Experience Region Noord- en Oost-Gelderland) 
37766 Duijzer.indd   124 31-12-15   11:51
125
6
for Dutch primary health care [22], pilot-tested [23], implemented on a large scale 
and tested in a randomised controlled trial. This intervention proved to be effective: 
improvements in fasting insulin, weight reduction, dietary intake, and PA were found at 
the end of the intervention (12 months), and these were maintained at 18 months [24]. 
The aim of this article is twofold: fi rst, to investigate how the SLIMMER intervention 
was delivered and received in Dutch primary health care, and, second, how this could 
explain intervention effectiveness. This was done by conducting a process evaluation 
including several process measures (recruitment, reach, dose received, acceptability, 
implementation integrity, and applicability).
METHODS
Study design and setting
The SLIMMER study was a randomised controlled intervention study, carried out in 
Apeldoorn and Doetinchem, two average, middle-sized cities located in the eastern part 
of the Netherlands. The total duration of the study was 1.5 years with an intervention 
period of 10 months and measurements at baseline (T0), at the end of the intervention 
(12 months, T1), and six months after the end of the intervention (18 months, T2). The 
study took place between 2011 and 2014. The intervention was implemented in Dutch 
primary health care, involving general practitioners (GPs), practice nurses, dieticians, 
physiotherapists, and local sports clubs. Subjects were randomised to either the 
SLIMMER intervention or the control group. Subjects in the control group received usual 
health care as provided by GPs and practice nurses (this ranged from no consultations 
to 1–4 consultations per year) and written information on a healthy lifestyle. The study 
design and lifestyle intervention programme have been reported in detail elsewhere 
[25]. The study protocol was approved by the Wageningen University (WU) Medical 
Ethics Committee and all subjects gave their written informed consent before the 
start of the study. The SLIMMER study is registered with ClinicalTrials.gov (Identifi er 
NCT02094911).
Study population 
Study subjects were recruited by GPs and practice nurses from their patient registration 
database, using either a laboratory glucose test or the Dutch Diabetes Risk Test [26]. 
The inclusion criteria were 1) aged between 40 and 70 years at screening, 2) impaired 
fasting glucose (IFG; 6.1-6.9 mmol/l) [27] or an elevated/high risk of type 2 diabetes 
(a Diabetes Risk Test score of ≥7 points) [26], 3) willing and able to participate in the 
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study for at least 1.5 years, and 4) able to speak and understand the Dutch language. 
Exclusion criteria were, amongst others, known diabetes and any severe cardiovascular 
or psychiatric disease. Criteria were checked using electronic medical records. GPs 
invited eligible subjects to participate in the SLIMMER study, and a short non-response 
survey was conducted if subjects were not willing to participate.
Lifestyle intervention programme 
The SLIMMER intervention resembled the original SLIM intervention [4] and consisted 
of a 10-month combined dietary and PA lifestyle intervention, including case 
management and a maintenance programme. The SLIMMER intervention was suitable 
for application in practice, as it was not very different from the regular functioning and 
professional performance of Dutch GPs, practice nurses, dieticians, and physiotherapists 
[23]. Minimal training and a detailed implementation manual were provided during 
a two-hour SLIMMER kick-off training session for health care professionals (HCPs) 
involved in implementation of the intervention. This training was attended by 68% 
of general practices, 82% of dieticians, and all physiotherapy practices. HCPs that did 
not attend the training session were visited individually. HCPs indicated that they felt 
well informed and prepared to implement the intervention after this training session. 
The standardised SLIMMER intervention was tailored to participants’ individual needs. 
Details of the SLIMMER lifestyle intervention programme are given in Table 6.1 and 
described below. 
Dietary intervention
The dietary intervention consisted of individually tailored dietary advice given in five 
to eight individual consultations and one group session. The aim was to adopt, step by 
step, a sustainable healthy dietary pattern according to the Dutch dietary guidelines 
[28]. Furthermore, it was aimed to reduce body weight by 5–10%. Dietary advice was 
given by a primary health care dietician, trained in motivational interviewing and 
using positive feedback. Goals for behaviour change were set with participants at each 
consultation, evaluated in the next one, and adjusted if necessary. 
Physical activity intervention
The PA intervention consisted of a combined aerobic and resistance exercise programme, 
supervised by a physiotherapist. The aim was to obtain and maintain an active lifestyle, 
that is, moderate-intensity PA for at least 30 minutes per day at least five days a week. 
PA recommendations were based on Dutch guidelines for PA in type 2 diabetes patients 
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[29]. Participants had free access to group-based training sessions and were stimulated 
to participate for at least one hour per week (maximum of two hours per week; a total of 
40–80 lessons). In addition, physiotherapists gave individually tailored advice on how 
to increase PA during leisure time, and goals were set. 
Case management
Practice nurses were appointed as case managers of the intervention programme to 
enhance participant compliance and the feasibility of implementation. They referred 
participants to the dietician and the physiotherapist at the start of the programme. 
Furthermore, they contacted dieticians, physiotherapists, and intervention participants 
twice during the programme to facilitate contact among HCPs, detect and solve 
problems, and motivate and stimulate participants. 
Maintenance programme
A maintenance programme was added to the combined lifestyle intervention to guide 
participants in the process of maintaining lifestyle behaviour change in an independent 
and sustainable manner [30]. This maintenance programme was implemented during 
the last two months of the intervention period and consisted of 1) intermediate 
evaluations by dieticians and physiotherapists to provide feedback and stimulate 
self-management, 2) sports clinics at local sports clubs to introduce participants to 
several sports activities (the number of sports clinics ranged between two to seven per 
participant), 3) fi nal interviews with dieticians and physiotherapists to provide positive 
feedback and discuss behaviour maintenance (goal setting and self-monitoring) and 
relapse prevention, 4) a return visit with dieticians and physiotherapists three months 
after the end of the intervention to motivate and support participants in maintaining 
a healthy lifestyle. The fi fth and fi nal element of the maintenance programme was 
monitoring by practice nurses after the end of the intervention. This involved discussing 
and monitoring participants’ behaviour change during regular consultations at the 
general practice in the following months and years. This element was therefore beyond 
the scope of the process evaluation.
Data collection and outcomes
A process evaluation including quantitative and qualitative methods was conducted. 
Data from both HCPs and intervention participants were collected between baseline 
(T0) and the end of the intervention (T1), and during the return visit three months after 
the end of the intervention. 
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Process measures
A process evaluation plan was designed based on evaluation strategies of Steckler and 
Linnan [31], Saunders et al. [32], Nutbeam [33], and Wang et al. [34]. Process evaluation 
data were collected and used to investigate how the SLIMMER intervention was delivered 
and received in Dutch primary health care, and to explain intervention effectiveness. 
The following process measures were included and are described below: recruitment, 
reach, dose received, acceptability, implementation integrity, applicability, and context.
Recruitment was defined as procedures used to approach and attract participants [31]. 
Recruitment procedures and barriers were evaluated using semi-structured telephone 
interviews with practice nurses, three months after the intervention started (n = 19, 
average duration 27 min). All practice nurses involved in the implementation of the 
SLIMMER intervention were invited to these interviews by one of the researchers (GD). 
A semi-structured interview guide was developed, and all interviews were conducted 
by one of the researchers (GD).
Reach was defined as the proportion of the intended target audience that participated 
in the intervention [31]. To assess the number of subjects willing to participate, the 
project logbook was consulted. Data on socio-demographic characteristics of both 
participants and non-responders were collected with a survey according to Dutch 
national standards [35]. Drop-outs were defined as participants that had both no T1-
measurement for fasting insulin and/or BMI, and dropped out of the dietary and PA 
programme before the end of the intervention.
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Dose received was defi ned as the extent to which participants actively engaged in 
intervention activities [31]. The following items were assessed from registration forms: 
the number and total minutes of dietary consultations; the number of one-hour sports 
lessons, case management phone calls, and sports clinics; the number of participants 
attending fi nal interviews; the number of participants attending the dietary group 
meeting; and the number of participants attending the return visit.
Acceptability was defi ned as the extent to which participants and HCPs were satisfi ed 
with the intervention [32]. Participants’ acceptability of the intervention was assessed 
using evaluation forms after the dietary group meeting, sports clinics, and return 
visit, and questionnaires at the end of the intervention. HCPs’ acceptability of the 
intervention was assessed using semi-structured telephone interviews. All HCPs were 
invited by one of the researchers (GD) three months after starting the intervention 
(practice nurses, n = 19, average duration 27 min; dieticians, n = 11, average duration 34 
min; physiotherapists, n = 15, average duration 31 min) and at the end of the intervention 
(practice nurses, n = 11, average duration 23 min; dieticians, n = 9, average duration 28 
min; physiotherapists, n = 12, average duration 25 min). A semi-structured interview 
guide was developed, and all interviews were conducted by one of the researchers (GD). 
Acceptability of the intervention by participants and by HCPs was rated on a 7-point 
or a 10-point Likert scale. To make results comparable, all acceptability ratings were 
expressed as a percentage of maximum.
Implementation integrity was defi ned as the extent to which the intervention was 
implemented as planned [31, 33]. Applicability was defi ned as the extent to which 
the intervention process could be implemented in a real-world setting [34]. These 
measures were assessed by semi-structured interviews and questionnaires with HCPs 
as described above. 
Context was defi ned as aspects of the larger physical, social, and political environment 
that either directly or indirectly affect intervention implementation [31]. Participant 
questionnaires and semi-structured interviews with HCPs, as described above, were 
used to investigate aspects that affect intervention implementation. Our analysis 
regarding context aspects provided no additional information to that elicited in relation 
to acceptability, integrity, and applicability.
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Explain intervention effectiveness
To explain intervention effectiveness, associations between process measures (dose 
received and acceptability) and health outcomes and lifestyle behaviours (fasting 
insulin, weight, dietary intake, and PA) were investigated. Dose received was defined 
as attending dietary consultations (in minutes) and as attending sports lessons (in 
number of lessons). Participants’ acceptability of the total SLIMMER intervention (score 
1–10) was ascertained in a questionnaire at the end of the intervention (T1).
To assess health outcomes, clinical assessments were performed by trained research 
assistants in research centres in Apeldoorn and Doetinchem. This has been described 
in detail elsewhere [24, 25]. In short, participants were measured at baseline (T0) and 
after the intervention (T1). A standard oral glucose tolerance test (glucose load 75 g) was 
performed by a trained nurse after at least 10 hours of fasting. Fasting serum insulin, 
our primary outcome [25], was determined at SHO laboratory in Velp, the Netherlands. 
Dietary intake was assessed by a validated Food Frequency Questionnaire (FFQ) [36, 37]. 
The FFQs were checked by trained research assistants. Adherence to the Dutch dietary 
guidelines was calculated with an adapted Dutch Healthy Diet Index (DHD-index) 
[24, 38, 39], which included eight components, namely, PA, vegetable, fruit, fibre, fish 
(EPA and DHA), saturated fat, trans-fatty acids, and alcohol. Per component, the score 
ranges between zero and 10, resulting in a total score between zero (no adherence) and 
80 (complete adherence). PA was measured using the validated Short Questionnaire 
to Assess Health-enhancing physical activity (SQUASH), including questions on 
commuting activities, leisure time activities, household activities, and activities at work 
[40, 41]. The duration (minutes per week) of vigorous-intensity physical activities was 
calculated.
Data analysis
Quantitative data were analysed using IBM SPSS Statistics version 22 with complete cases 
for the item of interest (ranging from 78 to 155 intervention participants per analysis). 
Differences between intervention and control participants and non-responders (those 
who were invited but not willing to participate) were tested for statistical significance 
with independent samples t tests, one-way ANOVA, and Chi-square tests. Descriptive 
statistics were used to analyse dose received and acceptability and applicability scores. 
Associations between process measures and health outcomes and lifestyle behaviours 
were assessed with linear regression analysis, adjusted for baseline value, sex, and 
recruitment phase. 
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Qualitative data analyses were performed using an inductive approach [42]. Interviews 
with HCPs were audiotaped and transcribed verbatim. All transcripts were read by 
two researchers (EJIvD and GD) individually to identify frequently emerging themes 
within predefi ned topics, and these were discussed until agreement was reached. These 
themes were used to create a coding scheme in the qualitative data analysis software 
package Atlas.ti version 7.
RESULTS
Recruitment and reach
In total, 25 general practices (GPs and practice nurses), 11 dieticians, nine physiotherapist 
practices (including 16 physiotherapists), and 15 sports clubs were involved in the 
implementation of the SLIMMER intervention. Selection of patients from the GP 
registration database was perceived as diffi cult and time consuming by some practice 
nurses, but others perceived it as easy. Patients were often diffi cult to reach, but most 
practice nurses were persistent in trying to contact participants. Of the 590 subjects that 
were eligible and invited, 316 subjects (response rate 54%) were willing to participate. 
For those not willing to participate, the most important reasons for non-response were 
lack of time (25%), lack of interest (22%), reporting ‘I already exercise enough’ (11%), 
reporting ‘It is of no importance to me’ (10%), and not able due to illness or handicap (9%). 
No signifi cant differences in baseline characteristics between SLIMMER participants 
and non-responders were observed (Table 6.2). On average, participants were 61 years 
old and most of them were less educated, Dutch, and had a family history of diabetes. 
Of all participants, 48% were overweight (BMI 25–29.9 kg/m2) and 43% were obese 
(BMI ≥ 30 kg/m2). No signifi cant baseline differences between the intervention and the 
control group were found (Table 6.2). In total, 10 participants (7%) dropped out of the 
intervention, mostly during the fi rst ten weeks of the intervention period.
Dose received
Table 6.3 describes the dose of the SLIMMER intervention received by intervention 
participants. Overall, actual dose received was in line with the planned dose according 
to the manual. Most participants in the intervention group (84%) received fi ve or more 
individual consultations with the dietician. On average, 5.6 consultations with a total 
duration of 3.4 hours were attended. Participants attended on average 38 sports lessons 
of one hour with the physiotherapist. The goal of participating at least once a week (≥40 
times in total) in the PA intervention was achieved by 41% of participants. Regarding 
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the case management component of the intervention, 75% of participants indicated 
that they had contact at least once with the practice nurse, with 28% of participants 
having contact twice. More than two-thirds of the participants (71%) attended at least 
one sports clinic at a local sports club, with an average number of 2.3 clinics attended per 
participant. Sixty-one percent of participants attended the final interviews and received 
materials on maintenance, and 58% attended the return visit with the dietician and 
physiotherapist, three months after the end of the intervention. 
Acceptability
Overall, participants and HCPs were highly satisfied with the SLIMMER intervention, 
with mean acceptability ratings of 82 and 80, respectively (Table 6.4). Physiotherapists’ 
scores decreased a little over time, mostly because they experienced the organisation of 
sports clinics during the last phase of the intervention period as not always optimal (e.g. 
clinics at times deviating from regular sports lesson times). HCPs were convinced of the 
added value of the SLIMMER intervention, were positive about the communication with 
the project team and the multidisciplinary nature of the programme, and perceived 
the intensive guidance of participants as a strength. According to HCPs, inclusion 
criteria might be sharpened, as several participants already had a healthy lifestyle at 
the start of the intervention and therefore could not improve much more, resulting in 
low motivation in these participants. HCPs felt involved in the SLIMMER intervention, 
although practice nurses indicated that the focus of their involvement was mostly at the 
beginning of the project. Data on acceptance of the specific intervention components 
showed:
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Table 6.2. Baseline characteristics of participants (n = 316) and non-responders (n = 175) in the SLIMMER 
intervention.
Intervention group 
(n = 155)
Control group 
(n = 161)
Non-responders 
(n = 175)
n  (male/female)a 81/74 80/81 87/87
Age (years) 60.7 ± 6.4 61.0 ± 6.5 60.9 ± 7.0
Education (%)b,c
 Low
 Middle
 High
54
26
20
51
21
28
52
27
21
Perceived health (%)d
 Poor/fair
 Good
 Very good/excellent
21
68
11
21
70
9
10
74
16
Ethnicity (%)
 Dutch
 Western non-Dutch
 Non-Western non-Dutch
88
9
3
89
8
3
Employment status (%)
 No paid job
 Part-time job (<32 h/week)
 Full-time job (≥32 h/week)
54
18
28
52
22
26
Family history of diabetes (%)
 No
 First degree
 Second degree
32
49
19
42
45
13
BMI (kg/m2)e 30.4 ± 4.7 30.0 ± 4.8
Fasting insulin (pmol/l) 93.3 ± 64.3 82.5 ± 50.2
a Non-responders n = 174.
b INT n = 155, CON n = 160, and non-responders n = 96. 
c Education level was based on the highest level of education completed and divided in three categories: low 
(primary school or less, lower vocational education), middle (medium vocational education, high school), and 
high (higher vocational education, university).
d Non-responders n = 115.
e INT n = 154, CON n = 161.
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Table 6.3. Dose of the SLIMMER intervention components received by the intervention group (n = 155)a.
Intervention component Intervention manual Dose received
Dietary intervention
Individual consultations
Number 
Total time (hours)
5–8 (incl. intake)
Max. 4 hours
5.6 ± 1.4
3.4 ± 0.8
Group meeting (%) Attend 1 group meeting 67
Physical activity intervention
Number of sports lessons At least once a week = 40 times 38 ± 20.8
Case management
Phone calls by practice nurse (%)b
Never
Once
Twice
Twice 
24
48
28
Maintenance programme
Number of clinics 2–7 2.3 ± 1.9
Final interview (%)c Materials provided during last consultation 
with dietician 
61
Return visit (%) Attend 1 return visit 58
a Data are mean ± SD or %.
b n = 143.
c Based on the number of participants receiving materials on maintenance distributed during final interview.
Table 6.4. Acceptability (score 0–100) of the SLIMMER intervention by the intervention group (n = 144) and health 
care professionals (n = 44)a.
Participants Professionals
Overall 
Total SLIMMER intervention 82 ± 11b 80 ± 5
Dietary intervention
Individual consultations 77 ± 21 78 ± 6c
Group meeting 80 ± 8d
Physical activity intervention
Sports lessons 84 ± 20e 78 ± 7f
Case management
Contact with practice nurse 66 ± 21e
Maintenance programme
Indicates final interview with dietician as helpful (%) 76g
Indicates final interview with physiotherapist as helpful (%) 68g
Sports clinics 77 ± 20h
Return visit 80 ± 13g
a Data are mean ± SD or %.  
b n = 142; c n = 9 dieticians; d n = 99; e n = 143; f n = 8 physiotherapists; g n = 78, percentage of participants that perceived 
the advice during the final interview as helpful; h n = 118.
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Dietary intervention – In general, participants and dieticians were satisfi ed with the 
individual consultations with the dietician, with mean scores of 77 and 78, respectively 
(Table 6.4). Participants were also positive about the number of consultations, the 
guidance of the dietician, and the tailoring of advices. 
PA intervention – Both participants and physiotherapists were positive about the 
weekly sports lessons, scoring a mean appreciation of 84 and 78, respectively (Table 
6.4). Participants were satisfi ed with physiotherapists’ guidance and appreciated the 
programme being tailored to their personal needs. Furthermore, participants preferred 
group-based sports lessons. Four HCPs indicated that the fact that sports lessons were 
group-based was important for support and motivation.
Case management – Participants were reasonably satisfi ed with the contact with practice 
nurses (score of 66, Table 6.4). Several practice nurses indicated that, besides monitoring 
progress, showing their engagement with participants was an important aspect of 
phone calls with participants. 
Maintenance programme – Overall, participants perceived fi nal interviews with the 
dietician and physiotherapist as helpful (76% and 68%, respectively, Table 6.4), and they 
were satisfi ed with the sports clinics and return visit (score of 77 and 80, respectively, 
Table 6.4). They appreciated HCPs’ guidance during the return visit, and the fact that 
this meeting was group-based. Physiotherapists thought sports clinics were a good way 
to introduce participants to several sports and to reduce barriers to joining a sports club. 
Implementation integrity 
Dietary intervention – The number of consultations, time schedule, and topics to discuss 
were individually tailored to participants’ wishes and needs, and goals were set and 
evaluated during consultations. Some dieticians deviated from the Dutch dietary 
guidelines by advising a low-carbohydrate diet. Motivational interviewing was used 
by all dieticians, albeit to a varying extent, and all dieticians gave positive feedback to 
participants. Sometimes not all components of the group meeting were implemented 
because of lack of time.
PA intervention – Both aerobic and resistance exercises were incorporated and 
implemented according to the manual. Intensity of training and type of exercise 
were individually tailored on the basis of test results or physiotherapists’ judgement. 
Goals were set at the start of the PA intervention, and physiotherapists provided 
feedback during sports lessons. Tailored advice on PA in daily life was given. However, 
physiotherapists indicated that not all participants needed this stimulation. 
Furthermore, physiotherapists stated that they were able to give individual guidance 
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during sports lessons, unless groups were too large. Group cohesion was facilitated by 
most physiotherapists during joint exercises at the end of the sports lessons. 
Case management – Referral of participants to dieticians and physiotherapists was 
perceived as easy and normal by most practice nurses. Most practice nurses have had 
contact with HCPs and participants as part of their case management role. Sometimes, 
e-mails were used instead of phone calls to save time, and in some cases case 
management was omitted because of lack of time. Although case management was 
aimed at solving problems and motivating participants, practice nurses almost never 
had to do this. No contact and collaboration between HCPs other than the phone calls 
was reported.
Maintenance programme – Dieticians and physiotherapists provided feedback on 
participants’ progress during intermediate evaluations, according to the manual. 
Physiotherapists indicated that the intensity of sports clinics did not always match 
participants’ level of ability and that some sports clinics were less intensive than 
regular SLIMMER sports lessons. Furthermore, they suggested that it would be better 
to introduce sports clinics earlier in the programme to slowly familiarise participants 
with a variety of sports. All dieticians and physiotherapists conducted final interviews 
with participants and discussed maintenance of behaviour change by giving advice on 
self-monitoring (e.g. weigh yourself regularly) and goal setting (e.g. make an action 
plan). Furthermore, they informed participants about relapse prevention (e.g. contact 
HCP if needed). Overall, the return visit was implemented as planned according to the 
manual, and dieticians and physiotherapists perceived an equal distribution of tasks. 
However, not all suggested measurements were performed by all HCPs.
Applicability 
Most HCPs indicated that in general the SLIMMER intervention was not very different 
from their regular functioning and professional performance. Some practice nurses, 
however, indicated deviations from their daily practice, mainly regarding a different 
role perception in that they referred participants to dieticians and physiotherapists for 
lifestyle advice instead of providing this advice themselves. Some dieticians indicated 
that normally they were more flexible in planning consultations. Furthermore, 
dieticians perceived dietary consultations as difficult if participants themselves did 
not feel the need for these (compulsory) consultations or lacked motivation. All HCPs 
indicated that it was possible to implement SLIMMER in daily practice, although they 
foresaw financial barriers. Furthermore, they indicated that contact between dieticians 
and physiotherapists was limited because their respective networks do not overlap 
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and therefore better collaborations need to be built in order to be able to work in a 
multidisciplinary way. 
Explain intervention e�fectiveness
A higher dose of sports lessons, that is, higher attendance at the PA programme, was 
associated with increased weight loss (p = 0.001, Table 6.5). A higher dose of dietary 
consultations was associated with a higher DHD-index score, albeit non-signifi cantly 
(p = 0.067). Participants’ acceptability of the intervention was associated with benefi cial 
changes in fasting insulin (p = 0.044) and weight (p < 0.001). Neither dose received nor 
acceptability was associated with changes in vigorous activities. 
DISCUSSION
This process evaluation gave insight into how the SLIMMER intervention was delivered 
and received in Dutch primary health care and how this could explain intervention 
effectiveness. We were able to recruit the intended high-risk target population, and 
the SLIMMER intervention was very well received by both participants and HCPs. 
The intervention programme was to a large extent implemented as planned and was 
applicable in Dutch primary health care. Dose received and acceptability were related 
to health outcomes and dietary behaviour, but not, however, to PA behaviour.  
We designed and used an extensive process evaluation plan to evaluate implementation 
and provide insight into the effectiveness of the SLIMMER intervention. Nowadays, the 
value of process evaluation within trials is recognised, and recently the Medical Research 
Council developed guidance on process evaluation of public health interventions [17]. 
Several studies have investigated intervention implementation [43-48]; however, 
results are diffi cult to compare because a systematic approach to process evaluation 
has not been used, and consequently a wide range of process indicators and methods 
are reported in publications. 
Recruitment of participants was perceived as diffi cult and time consuming by some 
practice nurses. Issues related mainly to improper registration of blood glucose values 
in the patient registration database and to technical problems retrieving information 
from this database. However, the response rate (54%) was comparable with the 
SLIMMER pilot study (57%) [23].
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The high implementation integrity might be due to the careful and long initial period 
of translating [22] and pilot-testing the SLIMMER intervention [23] and the fact that 
we built on existing structures in primary health care. We believe that implementation 
becomes more successful if capacity is built and networks are formed among local 
partner organisations.
To ensure intervention effectiveness, it is essential to include the intervention 
components most strongly associated with effectiveness [18]. Our regression analysis 
showed that higher intervention intensity (dose received) was associated with weight 
loss and change in dietary behaviour, but not with change in PA behaviour. This is 
in line with results of several systematic reviews [18-20, 49], although other reviews 
found no associations with intervention intensity [21, 50]. As no clear evidence exists 
for a particular minimum threshold for intervention intensity [18], more research 
is needed to determine the optimum. In addition, our analysis showed that higher 
participant satisfaction was associated with increased weight loss. Appreciation of 
the programme might be important for intervention compliance. This in turn leads 
to a higher intervention intensity, which we have shown was associated with better 
outcomes.
The intervention effectiveness might also have been facilitated by other components 
incorporated in the SLIMMER intervention, as suggested Greaves et al.’s [18] review: 
targeting both diet and PA, using behaviour change techniques (goal setting, 
self-monitoring, relapse prevention), and focusing on behaviour maintenance. 
Furthermore, the high level of individual tailoring of the dietary and PA programme, 
which was appreciated by participants, might have contributed to effectiveness [20]. 
Also, deploying specialists – dieticians and physiotherapists – rather than generalists for 
lifestyle counselling may have contributed to intervention effectiveness.  A systematic 
review by van Dillen et al. [51] found GPs and practice nurses, who are considered 
generalists, able to provide lifestyle counselling in primary health care. However, they 
provided rather general lifestyle advices, and experienced lack of time and competency 
issues. Therefore, cooperation with specialists was needed and recommended [51]. 
Another systematic review suggested that a wide range of staff could deliver effective 
interventions [18]. Therefore, a multidisciplinary approach with both specialists and 
generalists, such as in our study, might be the best way to utilise expertise fully, thereby 
contributing to intervention effectiveness. 
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A limitation of the study might be the risk of recall bias by HCPs providing data on 
implementation of the intervention. Furthermore, interviews were conducted by the 
researcher who was also the contact person for HCPs during the study. However, HCPs 
were not hesitant to criticise the intervention and to mention points for improvement. 
Our study has several strengths. First, we used an extensive process evaluation plan, 
including several process indicators measured both quantitatively and qualitatively. 
This provided a profound understanding of the delivery of the intervention and gave 
insight into possible aspects that might explain intervention effectiveness. Second, 
triangulation is considered a strength of our study. By the combination of multiple 
methods (registration forms, questionnaires, semi-structured interviews), incorporating 
both participants and HCPs, and by two researchers analysing the data independently, 
the credibility and the validity of our results have been increased. Third, our study had 
a high response rate from participants and professionals who provided input for the 
process evaluation: 50–100% of participants provided data dependent on the item of 
interest, and almost all involved HCPs (90%) participated in interviews. 
CONCLUSIONS
In summary, this study has shown that it is feasible to implement a diabetes prevention 
intervention in Dutch primary health care. Higher dose received and participant 
acceptability were associated with improved health outcomes and dietary behaviour, 
but not with PA behaviour. Furthermore, targeting both diet and PA, using behaviour 
change techniques, focusing on behaviour maintenance, tailoring the intervention, 
and using a multidisciplinary approach might have facilitated effectiveness. Using an 
extensive process evaluation plan to gain insight into how an intervention is delivered 
and received is a valuable way of identifying intervention components that contribute 
to implementation integrity and effective prevention of type 2 diabetes in primary 
health care. 
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ABSTRACT
Background 
Although evidence is accumulating that lifestyle modification may be cost-effective 
in prediabetic patients, information on the cost-effectiveness of interventions 
implemented in public health and primary health care settings is limited. Evidence 
from well-conducted pragmatic trials is needed to gain insight into the realistic cost-
effectiveness of diabetes prevention interventions in real-world settings.
Objective
To assess the cost-effectiveness of the SLIMMER lifestyle intervention targeted at 
patients at high risk of developing type 2 diabetes compared with usual health care in 
a primary care setting.
Research Design and Methods
Three hundred and sixteen high-risk subjects were randomly assigned to the SLIMMER 
lifestyle intervention or to usual health care. Costs and outcome assessments were 
performed at the end of the intervention (12 months) and six months thereafter 
(18 months). Costs were assessed from a societal perspective. Patients completed 
questionnaires to assess health care utilisation, participant out-of-pocket costs, and 
productivity losses. Quality Adjusted Life Years (QALY) were calculated based on the 
SF-36 questionnaire. Cost-effectiveness planes and acceptability curves were generated 
using bootstrap analyses.
Results
The cost-effectiveness analysis showed that the incremental costs of the SLIMMER 
lifestyle intervention were €547 and that the incremental effect was 0.02 QALY, 
resulting in an incremental cost-effectiveness ratio (ICER) of 28,094/QALY. When cost-
effectiveness was calculated from a health care perspective, the ICER decreased to 
13,605/QALY, with a moderate probability of being cost-effective (56% at a willingness 
to pay (WTP) of €20,000/QALY and 81% at a WTP of €80,000/QALY).
Conclusions 
The SLIMMER lifestyle intervention to prevent type 2 diabetes had a low to moderate 
probability of being cost-effective, depending on the perspective taken. 
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INTRODUCTION
Nowadays, diabetes is recognised as a major public health problem as it leads to a high 
disease and economic burden, with 5.1 million deaths and a health expenditure of USD 
548 billion (11% of total health expenditure) globally in 2013 [1]. Diabetes is associated 
with an unfavourable lifestyle, including obesity, poor diet, and physical inactivity [1]. 
Although evidence is accumulating that lifestyle modifi cation may be cost-effective 
in prediabetic patients, information on the cost-effectiveness of interventions 
implemented in public health and primary health care settings is limited [2]. Evidence 
from well-conducted pragmatic trials is needed to gain insight into the realistic cost-
effectiveness of diabetes prevention interventions in real-world settings. The Dutch SLIM 
intervention, revealing a 47% diabetes risk reduction [3], proved to be cost-effective [4]. 
This intervention has been translated from the experimental setting into a real-world 
intervention, called SLIMMER [5-7]. The aim of the current study is to assess the cost-
effectiveness of the SLIMMER lifestyle intervention compared with usual health care in 
a primary care setting. We recently reported the effects of the SLIMMER intervention: 
signifi cantly greater improvements in anthropometry, glucose metabolism, dietary 
intake, physical activity, and quality of life were seen in the intervention group than in the 
control group, both at 12 and at 18 months [8]. Here, we report on the cost-effectiveness 
analysis conducted alongside this pragmatic randomised trial.
RESEARCH DESIGN AND METHODS
Study design
The design of the SLIMMER study has been published in detail elsewhere [6]. In short, 
the SLIMMER study is a randomised controlled trial carried out in Dutch primary health 
care between 2011 and 2014. We performed an economic evaluation from a societal 
perspective. 
Study population and setting
Twenty-fi ve general practices (general practitioners (GPs) and practice nurses) recruited 
patients aged between 40 and 70 years at increased risk of diabetes, defi ned as having 
impaired fasting glucose (IFG; 6.1-6.9 mmol/l [9]) or an elevated/high risk of type 
2 diabetes (a Diabetes Risk Test score of ≥7 points [10]). The study was conducted 
in the Dutch cities Apeldoorn and Doetinchem. The SLIMMER intervention was 
implemented in primary health care, involving GPs and their practice nurses, dieticians, 
physiotherapists, and local sports clubs. The study protocol was approved by the 
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Wageningen University Medical Ethics Committee, and all subjects gave their written 
informed consent before the start of the study. The SLIMMER study is registered with 
ClinicalTrials.gov (Identifier NCT02094911).
Randomisation procedure
After baseline measurement, 316 participants were randomly allocated to the intervention 
or to the control group, using block randomisation at GP level and stratification for sex. 
Spouses were allocated to the same group to avoid contamination. An independent 
dietician from the Division of Human Nutrition, Wageningen University, performed the 
randomisation. 
Lifestyle intervention
The SLIMMER lifestyle intervention resembled the SLIM intervention [3] and consisted 
of a dietary and physical activity intervention, including case management and a 
maintenance programme. The dietary intervention consisted of five to eight individual 
consultations and one group session with a dietician during 10 months. The physical 
activity intervention was delivered by physiotherapists as weekly group-based training 
sessions for 10 months. Furthermore, case management was performed by practice 
nurses and consisted of keeping in contact with both health care professionals and 
intervention participants throughout the intervention period. In addition to this core 
programme, a maintenance programme was delivered during the last phase of the 
intervention period and continued up to three months after the end of the intervention. 
This maintenance programme comprised of sports clinics at local sports clubs and 
concluding meetings with the dietician and physiotherapist during the core programme 
of 10 months, and a return session with the dietician, physiotherapist, and the physical 
activity group three months after the end of the intervention [11].
Control group
The control group received the usual health care provided by GPs and practice nurses, 
i.e. yearly monitoring of blood glucose, according to the guidelines of the Dutch College 
of General Practitioners [12]. Furthermore, at baseline, the control subjects received 
written information on the beneficial effects of a healthy diet and increased physical 
activity. 
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Data collection and outcomes
Measurements
Participants visited the research centre for measurements at baseline, directly after the 
intervention (12 months), and at 18 months. Participants completed questionnaires at 
each visit to assess health care utilisation, participant out-of-pocket costs, productivity 
losses, and quality of life. The present cost-effectiveness analysis (CEA) includes effects 
and costs over the total 18-month study period.
Volumes of resources used
Data on volumes of health care utilisation (general practitioner, dietician, physiotherapist, 
consultations at outpatient clinic, and hospitalisation), use of medication, and 
participant out-of-pocket costs (sports club memberships and sports equipment) were 
obtained from participant questionnaires. Productivity losses (related to both absence 
from work (absenteeism) and less productivity while working (presenteeism)) were 
measured using the Short Form Health and Labour Questionnaire (SF-HLQ) [13]. 
Cost prices
We used 2012 price levels and indexed prices when necessary using the consumer price 
indices from Statistics Netherlands [14]. Discounting was not applied because of the 
short timeframe of 18 months. A detailed description of cost prices is given in Additional 
fi le 7.1.
Intervention costs
Bottom-up micro-costing analysis was used to estimate intervention costs. Selection and 
recruitment of participants cost €37 per participant. Intervention materials were valued 
using charges paid. Training of GPs and practice nurses and supervision by a project 
coordinator cost €133 per participant. The volumes of individual and group dietary 
sessions, physical activity sessions, and the return session were collected by attendance 
registration. These volumes were multiplied by unit prices for each component of the 
lifestyle intervention. Cost prices per unit were retrieved from the Dutch guideline for 
costing analysis in health care [15, 16].
Utilities and quality adjusted life years (QALY)
The Short-Form Health Survey (SF-36) [17, 18] was used to assess quality of life at every 
visit to the research centre. Health utilities were determined by the SF-6D health state 
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classification [19], a preference-based single index derived from the SF-36. QALYs were 
calculated by multiplying health utilities by the amount of time a participant spent in 
a particular health state. Transitions between health states were linearly interpolated.
Statistical analyses
Intention to treat analyses were performed. Missing cost and outcome data (16%) were 
imputed with multiple imputation techniques, using Fully Conditional Specification 
and Predictive Mean Matching procedures. The imputation model included age, sex, 
baseline health status, randomisation group, and available costs and outcomes at each 
measurement. Baseline characteristics were compared with an independent samples 
t test for normally distributed data, a Mann-Whitney test for non-normally distributed 
data, and a Pearson’s chi-squared test for categorical data.
Economic analyses
The incremental cost-effectiveness ratio (ICER) was calculated as the difference in 
costs divided by the difference in QALYs between the intervention and the control 
group using a bootstrap analysis with 1000 simulations. From the bootstrap analysis, 
a cost-effectiveness plane was plotted, where each quadrant indicates whether the 
intervention is more or less effective and more or less expensive than usual health care. 
Furthermore, cost-effectiveness acceptability curves (CEACs) were plotted to illustrate 
the uncertainty of cost-effectiveness estimates. The CEAC shows the probability that the 
SLIMMER intervention is cost-effective compared with usual health care, for a range of 
threshold values for willingness to pay (WTP) per additional QALY. In the Netherlands, 
threshold values of €20,000 to €80,000 per QALY are commonly used [20]. 
Sensitivity analyses
Sensitivity analyses were performed to assess cost-effectiveness using different input 
parameters. In the first sensitivity analysis, cost-effectiveness was calculated from a 
health care perspective, taking into account only intervention costs and direct health 
care costs. The second sensitivity analysis was restricted to participants with complete 
cost and effect data, that is, complete cases. In the third sensitivity analysis, intervention 
costs were reduced. If the SLIMMER intervention would be implemented regularly in 
health care, the project coordinator would be redundant, therefore these costs were 
excluded. 
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RESULTS
For the economic analysis, data for 288 (91%) SLIMMER study participants were available 
(Figure 7.1). Twenty-eight participants were excluded because they did not complete a 
single questionnaire nor were other measurements available. As shown in Table 7.1, 
baseline characteristics were similar between the intervention and the control group.
Costs
Table 7.2 shows costs of the intervention and the control subjects. Total costs of the 
intervention were €677 per participant. Costs for the intervention, participant out-of-
pocket costs, and costs for absenteeism were higher in the intervention group than in 
the control group, whereas costs for hospitalisation, medication, and presenteeism 
were lower. The incremental cost difference between groups was €547. 
QALYs
Participants’ health status at baseline was comparable between the intervention and 
the control group, whereas it was higher in the intervention group than in the control 
group after 12 and 18 months, albeit non-signifi cantly. Total QALY over the 18-month 
study period was 0.02 (-0.01; 0.05) higher in the intervention group than in the control 
group (Table 7.3).
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Intervention group at baseline 
n = 155 (49%)
Control group at baseline 
n = 161 (51%)
Initial identification from GPs’ patient 
registration database (subjects 40–70 years 
without diabetes)
n = 1009
Invitation by GP
n = 590 (58%)
Randomisation after baseline measurement
n = 316 (54%)
n = 419 (42%)
Reasons:
- Not fulfilling criteria
- Not responding to laboratory
glucose test or Diabetes Risk
Test
n = 274 (46%)
Reasons:
- Lack of time (25%)
- Lack of interest (22%)
- Reporting ‘I already exercise
enough’ (11%)
- Reporting ‘It is of no
importance to me’ (10%)
- Not being able due to illness
or handicap (9%)
- Other reasons (23%)
No single data point after 
baseline measurement 
n = 10 (6%)
No single data point after 
baseline measurement 
n = 18 (11%) 
Intervention participants 
included in the economic 
analysis 
n = 145 (94%)
Control participants included in 
the economic analysis 
n = 143 (89%)
Figure 7.1. Flow diagram of the SLIMMER randomised controlled trial, for cost-effectiveness analyses.
Economic analyses
The higher costs and effects in the intervention group compared with the control group 
resulted in an ICER of 28,094/QALY (Table 7.4). From the bootstrap analysis, it appeared 
that most simulations showed higher costs for the intervention as well as small positive 
QALY differences between the intervention and the control group (Additional fi le 
7.2). Figure 7.2 shows that, if society is willing to pay either €20,000 or €80,000 per 
additional QALY, the probability that the intervention will be cost-effective is 43% and 
70%, respectively. 
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Table 7.1. Baseline characteristics of the SLIMMER study participants included in the cost-effectiveness analyses a.
Intervention
(n = 145)
Control 
(n = 143)
Sex (n female, %) 67 (46%) 71 (50%)
Age (years) 60.9 ± 6.0 61.1 ± 6.5
Education level (n, %)
 Low
 Middle
 High
77 (53%)
40 (28%)
28 (19%)
76 (53%)
28 (20%)
39 (27%)
Ethnicity (n, %)
 Dutch
 Western non-Dutch
 Non-western non-Dutch
128 (88%)
13 (9%)
4 (3%)
129 (90%)
11 (8%)
3 (2%)
Family history of diabetes (n, %)
 No
 First degree
 Second degree
46 (32%)
70 (48%)
29 (20%)
61 (43%)
65 (45%)
17 (12%)
Paid job (n, %) 67 (46%) 68 (48%)
Smoking (n, %) 22 (15%) 27 (19%)
BMI (kg/m2)b 30.3 ± 4.6 29.9 ± 4.8
Waist circumference (cm) b
 Male
 Female
109.1 ± 12.2
101.3 ± 12.9
107.8 ± 10.1
99.9 ± 12.6
Fasting glucose (mmol/l) 6.6 ± 0.6 6.5 ± 0.6
2-h glucose (mmol/l) b 8.2 ± 2.8 8.0 ± 2.5
Fasting insulin (pmol/l) 89.6 ± 51.7 84.8 ± 52.2
SF-6D health state 0.79 ± 0.12 0.79 ± 0.10
a Data are mean ± SD, or n (%). b INT n = 144, CON n = 143
Sensitivity analyses
The sensitivity analyses for complete cases and reduced intervention costs revealed 
similar results as the base case analysis (Table 7.4). However, when cost-effectiveness 
was calculated from a health care perspective, the ICER decreased to 13,605/QALY 
(Table 7.4). The probability of the intervention being cost-effective was 56% at a WTP 
of €20,000/QALY and 81% at a WTP of €80,000/QALY (Figure 7.3).
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Table 7.2. Mean (standard error of the mean) costs for intervention and control subjects.
Intervention
(n = 145)
Control 
(n = 143)
Unit costs (€) Mean total costs € 
(SEM)
Mean total costs € 
(SEM)
Intervention costs
Selection and recruitment by practice nurse 37.08 per participant 37 (0) 0 (0)
Materials 15.65 per participant 16 (0) 0 (0)
Project coordinator 133.02 per 
participant
133 (0) 0 (0)
Individual consultations with dietician 28.64 per hour 101 (1) 0 (0)
Group session with dietician 6.20 per session 4 (0) 0 (0)
Group-based training sessions with 
physiotherapist
8.06 per session 319 (13) 0 (0)
Sports clinics at local sports club 24.69 per sports 
clinic
60 (4) 0 (0)
Return session with dietician and 
physiotherapist
8.92 per session 6 (0) 0 (0)
Subtotal 677 (16) 0 (0)
Direct health care costs 
Consultations general practice Additional file 7.1 118 (12) 190 (16)
Consultations dietician 28.64 per hour 2 (1) 9 (4)
Consultations physiotherapist 38.18 per hour 111 (26) 94 (21)
Consultations health care specialist 76.38 per visit 291 (41) 272 (35)
Hospital days 484.72 per day 426 (146) 637 (374)
Medication Individualised 369 (38) 526 (55)
Subtotal 1,317 (178) 1,728 (414)
Direct non-health care costs
Sports club membership Individualised 233 (35) 224 (31)
Sports equipment Individualised 151 (28) 112 (36)
Subtotal 384 (49) 336 (48)
Indirect non-health care costs
Absence from work Individualised 1,995 (714) 1,285 (574)
Less productivity while working Individualised 500 (180) 975 (367)
Subtotal 2,495 (763) 2,261 (730)
Total costs (€)
 Societal perspective
 Health care perspective
-
-
4,872 (854)
1,993 (178)
4,325 (887)
1,728 (414)
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Figure 7.2. Cost-effectiveness acceptability curve of the SLIMMER intervention compared to usual health care, 
from a societal perspective.
Figure 7.3. Cost-effectiveness acceptability curve of the SLIMMER intervention compared to usual health care, 
from a health care perspective.
DISCUSSION AND CONCLUSION
The current study showed that the SLIMMER intervention was both more costly and 
more effective than usual health care. As expected, the intervention group had a lower 
health care utilisation and reported less presenteeism than the usual care group. From a 
societal perspective, the ICER was 28,094/QALY, reflecting a relatively low probability of 
43-70% at usual Dutch threshold values of WTP per QALY. From a health care perspective, 
the ICER was 13,605/QALY, with a moderate probability of being cost-effective (56% at a 
WTP of €20,000/QALY and 81% at a WTP of €80,000/QALY). 
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Nowadays, more and more insight into the cost-effectiveness of diabetes prevention 
programmes is becoming available. Recently, a systematic review found a median ICER 
for diet and physical activity programmes of $13,761/QALY, from a health care perspective 
[2]; this is comparable to our ICER. Most of the studies included in that review were 
based on the US Diabetes Prevention Program or the Finnish Diabetes Prevention Study 
(DPS), like our DPS-based SLIMMER study. However, a Dutch study that investigated 
the cost-effectiveness of a primary care lifestyle intervention for prevention of type 
2 diabetes and cardiovascular disease showed that the intervention was cost-saving 
without being effective [21]. Another Dutch study, on the prevention of weight gain 
among employees, failed to reveal cost-effectiveness too [22]. 
The higher costs in the intervention group were due mainly to costs of the 
intervention programme. We should therefore consider possibilities to reduce 
these intervention costs, like appointing sports instructors instead of higher-
salaried physiotherapists. The Greaves et al.’s review [23] showed that a wide range 
of providers can deliver effective interventions. Furthermore, the provision of group-
based dietary consultations could be considered, as Li et al.’s review showed that 
group-based interventions were less costly and more cost-effective than individual-
based interventions [2]. In addition, an even more individually tailored intervention 
approach could be used by referring participants earlier to regular sports clubs when 
they are ready to do so, rather than adhering strictly to the programme’s schedule. 
These adaptations were not taken into account in the sensitivity analysis because 
the impact of changes in the intervention on its effectiveness is currently unknown. 
Further research on this issue is necessary.
Costs for health care utilisation, mainly hospitalisation and medication use, and 
presenteeism were lower in the intervention group than in the control group. This 
was also found in the DPP study [24] and the Dutch Hoorn Prevention study [21]. The 
reduced direct health care costs indicate that the benefi ts of this intervention may be 
attractive for health insurance companies. Out-of-pocket costs were €48 higher in the 
intervention group than in the control group. We separately asked participants about 
their willingness to pay for the intervention. On average, they reported that they would be 
willing to pay €97 (data not shown). The additional out-of-pocket costs of €48 therefore 
appear to be acceptable for participants. Unexpectedly, costs for absenteeism were 
higher in the intervention group than in the control group. More detailed inspection 
of the causes of absenteeism revealed that these productivity losses were in general 
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unrelated to physical fitness or diabetes, but for example to fever. Hence, the higher 
productivity costs in the intervention group could be a coincidental finding.
Limitations of the study should be considered. First, data were collected intermittently 
to reduce participant burden, but this may be associated with a slight inaccuracy in 
data reporting, and in cost estimates as a consequence [25]. Second, besides monetary 
investments, participants have to make a time investment, which was not taken 
into account in the current analysis. Third, we included costs and effects during the 
intervention period up to six months after the end of the intervention. Although the 
intervention was not cost-saving, beneficial effects on intermediate outcomes were 
found. Improvements in weight, fasting insulin, dietary intake, and physical activity 
were observed at 12 months, and most of these improvements were sustained at 18 
months [8]. In Li et al.’s review, it was shown that programmes were most cost-effective 
in the longer term, indicating that short-term studies are limited in their ability to 
capture the full range of an intervention’s health benefits and cost savings [2].Therefore, 
more insight into longer-term cost-effectiveness is needed, and the results of our study 
should be modelled to a lifetime horizon. We expect more favourable cost-effectiveness 
on the longer term because diabetes will be postponed or prevented, leading to cost 
savings in the future.
A strength of the current study is the use of a randomised design in a real-world setting. 
Furthermore, data were complete for 84% of the measurements. In the event of missing 
values, multiple imputation techniques were used, which is a status quo method 
for dealing with missing data [26]. Moreover, we performed the CEA from a societal 
perspective as recommended by the Dutch guideline for costing analysis in health 
care [15, 16]. In addition, we performed the evaluation from a health care perspective, 
the perspective most relevant to health insurance companies which may consider to 
reimburse the intervention programme. 
In summary, our results indicate that the SLIMMER intervention is more cost-effective 
from a health care perspective than from a societal perspective. Costs were higher in 
the intervention group, mostly due to costs of the intervention programme and higher 
productivity losses. Intervention costs could be decreased to a certain extent to further 
enhance the cost-effectiveness of the SLIMMER intervention. 
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Additional fi le 7.1. Detailed description of cost prices.
Cost prices of intervention implementers (practice nurse, dietician, and physiotherapist), 
the project coordinator, and sports clubs’ instructors (giving sports clinics) were retrieved 
from the Dutch guideline for costing analysis in health care [15, 16]. 
Cost prices of health care utilisation (general practice, dietician, physiotherapist, health 
care specialist, and hospital days) were retrieved from the Dutch guideline for costing 
analysis in health care [15, 16]. An overview of exact cost prices can be found in Table 7.2 
and Table 7.A1.
Cost prices of medication were based on summary cost prices for average daily dosages as 
used in the Netherlands, according to the Pharmacotherapeutic Compass [27], augmented 
by the 3-month delivery tariff charged by pharmacies. 
The participant out-of-pocket costs were valued as indicated by the participants 
themselves. 
Productivity losses were assessed with the friction cost approach [15, 16], using a friction 
period of 115 days. For all participants with a paid job, age- and sex-standardised 
productivity costs per hour were used, following the Dutch guideline for costing analysis 
in health care [15, 16]. 
Table 7.A1. Unit costs for cost categories not mentioned in Table 7.2
Unit costs (€)
Direct health care costs
General practice
 Visit to practice
Phone consultation
Home visit
Phone contact for medical prescription
29.70 per visit
14.85 per consultation
45.61 per visit
14.85 per contact
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Additional file 7.2. Cost-effectiveness plane from 1000 bootstrap simulation for the SLIMMER intervention 
compared to usual health care.
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General discussion
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MAIN FINDINGS
The overall objective of this project was to improve the lifestyle behaviour in high-risk 
subjects in order to reduce the risk of developing type 2 diabetes. The main findings of 
this research project as described in chapters 2 to 7 are summarised in Table 8.1.
The literature in chapter 2 showed that, all over the world, clinical diabetes prevention 
trials have been translated to daily practice. In Dutch practice, however, this was still 
lacking. Therefore, the SLIM intervention – conducted in an experimental setting and 
revealing a 47% diabetes risk reduction – was translated to practice, and the adapted 
intervention, called SLIMMER, was tested in a one-year pilot study. Collaboration 
between professionals from primary health care and public health was considered 
necessary to prevent diabetes.
A pilot study (n = 31) with process evaluation was conducted to test the feasibility 
and desired impact of the SLIMMER intervention (chapter 3). This study showed that 
inclusion and retention of high-risk subjects was successful and that both participants 
and health care professionals were satisfied with the SLIMMER intervention. Overall, the 
intervention was implemented as planned and appeared to be suitable for application 
in practice. Some improvements were identified and refinements were made prior to 
further implementation and evaluation. 
The evaluation design of the SLIMMER intervention was described in chapter 4. A 
logic model of change was composed to link intervention activities, their mechanisms 
of change, expected behaviours, and intervention outcomes in a logical order. 
The SLIMMER intervention consisted of a 10-month dietary and physical activity 
intervention, including case management and a maintenance programme. Effect, 
process, and economic evaluations were performed. 
The effectiveness of the SLIMMER intervention was tested in a randomised controlled 
trial (chapter 5). We found that, after 12 and 18 months, the intervention group 
significantly improved weight (β=-2.7 kg and β=-2.5 kg, respectively) and fasting insulin 
(β=-12.1 pmol/l and β=-8.0 pmol/l, respectively) compared with the control group. 
Furthermore, intake of total and saturated fat decreased and fibre intake increased 
more in the intervention group than in the control group, both at 12 and at 18 months 
(p < 0.05). Fruit intake increased at 12 but not at 18 months, whereas vegetable intake 
increased at 18 but not at 12 months. The DHD-index score, indicating adherence to 
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the Dutch dietary guidelines, was signifi cantly higher in the intervention group than 
in the control group, both at 12 and at 18 months (p < 0.05). Improvements in vigorous 
activities and physical fi tness were found, both at 12 and at 18 months. Finally, benefi cial 
changes in several domains of quality of life were found both at 12 and at 18 months, 
although not all domains reached statistical signifi cance.
As described in chapter 6, the process evaluation showed that 316 high-risk subjects 
were recruited and that the intervention was very well received by both participants 
and health care professionals. The intervention programme was to a large extent 
implemented according to the manual and fi tted well within the regular functioning 
and professional performance of health care professionals. Higher dose received 
and participant acceptability were related to improved health outcomes and dietary 
behaviour, but not to physical activity behaviour. Furthermore, targeting both diet 
and physical activity, using behaviour change techniques, focusing on behaviour 
maintenance, tailoring the intervention, and adopting a multidisciplinary approach 
may have facilitated intervention effectiveness.
The economic evaluation in chapter 7 showed that the SLIMMER intervention was both 
more costly and more effective than usual health care. From a societal perspective, the 
incremental cost-effectiveness ratio (ICER) was 28,094/QALY, reflecting a relatively low 
probability of 43–70% at usual Dutch threshold values of willingness to pay (WTP) 
per QALY. From a health care perspective, the ICER decreased to 13,605/QALY, with a 
moderate probability of being cost-effective (56% at a WTP of €20,000/QALY and 81% 
at a WTP of €80,000/QALY). Intervention costs could be decreased to a certain extent 
to further enhance cost-effectiveness. 
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Table 8.1. Summary of the main findings of this thesis.
Objective To give an overview of the translation of the SLIM intervention to a Dutch real-life setting and 
discuss the role of primary health care in implementing lifestyle intervention programmes.
Methods Literature overview
Findings •	 	A one-year pilot study was conducted, consisting of a dietary and physical activity part, and 
guided by process evaluation, to test the applicability of the adapted SLIM intervention in 
Dutch primary health care.
•	 	Collaboration between professionals from primary health care and public health is needed 
to prevent diabetes.
Objective To describe and investigate the feasibility and impact of the SLIMMER intervention in Dutch 
primary health care.
Methods Pilot study with a one group pre-test post-test design, guided by process evaluation
Findings •	 31 subjects participated in the intervention with mean weight loss of 3.5 kg.
•	 Both participants and health care professionals were satisfied with the intervention.
•	 	The intervention was implemented as planned and appeared to be suitable for application 
in practice.
•	 	Improvements were identified and refinements are made prior to further implementation 
and evaluation.
Objective To describe the evaluation design of the SLIMMER diabetes prevention intervention in a Dutch 
real-life setting.
Methods Study protocol
Findings •	 	A logic model of change was composed to link intervention activities with intervention 
outcomes in a logical order.
•	 	Subjects at high risk of diabetes were randomly allocated to the intervention (10-month 
combined dietary and physical activity intervention, including case management and 
maintenance programme) or to the control group (usual health care). 
•	 The intervention is guided by effect, process, and economic evaluation.
Objective To investigate the effectiveness of the SLIMMER intervention in Dutch primary health care on 
clinical and metabolic risk factors, dietary intake, physical activity, and quality of life after 12 and 
18 months.
Methods Randomised controlled trial
Findings •	 Improvements in clinical and metabolic characteristics after 12 and 18 months
 -  Significantly more weight loss in intervention group than in control group (β=-2.7 kg 
at 12 months, β=-2.5 kg at 18 months).
 -  Significantly greater decrease in fasting insulin in intervention group than in control 
group (β=-12.1 pmol/l at 12 months, β=-8.0 pmol/l at 18 months).
 -  Intervention subjects improved weight and glucose tolerance, independent of 
manner of recruitment.
•	 Improvements in dietary intake, physical activity, and quality of life.
Objective To investigate how the SLIMMER intervention was delivered and received in Dutch primary health 
care and how this could explain intervention effectiveness.
Methods Process evaluation
Findings •	 In total, 316 subjects at high risk of developing type 2 diabetes were recruited.
•	 Actual dose received was in line with the planned dose according to the manual.
•	 	The SLIMMER intervention was very well received by both participants and health care 
professionals.
•	 The intervention programme was to a large extent implemented according to the manual.
•	 	In general, the SLIMMER intervention was not very different from health care professionals’ 
regular functioning and professional performance.
•	 	Higher dose received and participant acceptability were related to improved health 
outcomes and dietary behaviour, but not to physical activity behaviour. 
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Objective To assess the cost-effectiveness of the SLIMMER intervention compared with usual health care in 
Dutch primary health care. 
Methods Economic evaluation alongside a randomised controlled trial
Findings •	 Incremental costs were €547 and the incremental effect was 0.02 QALY.
•	 	From a societal perspective, the incremental cost-effectiveness ratio (ICER) was 28,094/
QALY, with a low probability of being cost-effective (43% at a willingness to pay (WTP) of 
€20,000/QALY and 70% at a WTP of €80,000/QALY).
•	 	From a health care perspective, the ICER was 13,605/QALY, with a moderate probability of 
being cost-effective (56% at a WTP of €20,000/QALY and 81% at a WTP of €80,000/QALY).
METHODOLOGICAL CONSIDERATIONS
Research in practice
Effi cacy trials, such as the Finnish Diabetes Prevention Study (DPS) [1], the US Diabetes 
Prevention Program (DPP) [2], and the Dutch Study on Lifestyle intervention and 
Impaired glucose tolerance Maastricht (SLIM) [3], provided us with convincing evidence 
on type 2 diabetes prevention by lifestyle interventions in high-risk subjects. Such trials 
show us the performance of interventions under highly controlled and more or less 
ideal conditions and maximise the likelihood of observing an intervention effect, if 
there is one. Although this has several methodological advantages and increases 
internal validity, the circumstances are far from those of the real world [4]. The 
diabetes prevention interventions in these effi cacy trials were intensive, prohibitively 
expensive, and used highly standardised protocols, thereby not reflecting real-world 
circumstances. Therefore, these studies were translated to real-world settings and 
tested in effectiveness trials. Such trials account for external factors that may moderate 
the intervention’s effect, reflecting real-world conditions, and can therefore be more 
relevant to primary health care and policy [4]. Effectiveness trials have a higher external 
validity than effi cacy trials, resulting in better generalisability. 
Several steps are needed for an effi cacious intervention to become effective in the real 
world. A thorough adaptation of an effi cacious intervention and pilot-testing of this 
adapted intervention are important steps. When an intervention is being translated from 
research to practice, adaptations are inevitable because of the substantial differences 
between those settings. These adaptations, however, might have consequences for 
intervention effectiveness. Few studies, however, describe how and which adaptations 
have been made [5]. In the SLIMMER study, fi rstly, we adapted the effi cacious SLIM 
study [3] to Dutch primary health care. Core elements of the SLIM intervention 
Table 8.1. Continued
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were identified, and consensus on suggested adaptations was achieved between 
intervention developers and local health care professionals in a joint decision-making 
process [6]. Secondly, the adapted intervention was tested in a pilot study (chapter 3). 
Several studies have shown that pilot-testing before large-scale implementation is 
valuable, as challenges for refinement become clear, recruitment and retention may 
improve, there may be fewer deviations from the budget, and chances for success may 
increase [7-9]. The thorough preparation of the SLIMMER intervention, including the 
abovementioned steps, may have contributed to its effectiveness. 
The distinction between efficacy and effectiveness trials is a continuum rather than 
a dichotomy [4]. In this respect, the SLIMMER intervention can be positioned closer 
to an effectiveness trial. The intervention was implemented in a primary health 
care setting and delivered by representative usual providers (general practitioners 
(GPs), practice nurses, dieticians, and physiotherapists) who did not need much 
additional training as the intervention fitted well within their regular functioning 
and professional performance (chapter 6). GPs referred participants to the 
intervention programme and used their natural referral lines, as is normal practice in 
the Netherlands. Active case finding for high-risk patients, as was done in our study, 
does not conform to daily practice. However, most practice nurses perceived this 
active approach as useful (data not shown). Furthermore, a standardised protocol 
was used, but this was applied with flexibility in order to tailor the intervention 
to participants’ needs and wishes. No additional resources or equipment were 
needed to implement the intervention. In conformity with normal practice in the 
Netherlands, the control group received the usual health care provided by GPs and 
practice nurses (yearly monitoring of blood glucose, according to the guidelines of 
the Dutch College of General Practitioners) [10]. 
Conducting research in practice often has implications for the study design. Performing 
a randomised controlled trial, which is considered the gold standard for determining 
the effects of a treatment, is often difficult. However, we were able to use a randomised 
design and individuals rather than groups were randomised. We adapted the 
randomised design to make it suitable for application in primary health care practice 
by incorporating block randomisation at GP level (chapter 4). This was done in order to 
motivate GPs to participate in the study and ensured that each GP had both intervention 
and control participants. We attempted to reduce contamination within general 
practices by paying special attention to this during the SLIMMER kick-off training for 
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health care professionals. By means of the randomised design, we were able to attribute 
the observed improvements (chapter 5) to the SLIMMER intervention. 
It is often said that ‘it takes 17 years to turn original clinical research to the benefi t of 
patients’ [11]. This means that uptake of an intervention into clinical guidelines requires 
perseverance. When we look at the SLIMMER intervention, this is indeed the case. The 
SLIM study started in 1999 [3], and 17 years later, which is actually today, the SLIMMER 
intervention is not yet included in primary health care standards. However, the results 
of this study provide valuable insights that can contribute to this uptake.  
Theoretical basis
If we are to understand how interventions work, we must understand the causal 
mechanisms hypothesised to explain intervention effectiveness [12]. Therefore, theories 
are often used as a basis for lifestyle intervention development. However, evidence on 
the association between using theory and increased effectiveness is mixed [13, 14]. The 
original SLIM study used a combination of theories such as the Stages of Change model 
[15] and the Theory of Planned Behaviour [16]. 
In the SLIMMER study, insight into causal mechanisms was gained in two ways. Firstly, 
behaviour change techniques used in the SLIMMER intervention were identifi ed and 
linked to behavioural determinants by means of the Theoretical Domains Framework 
[17, 18]. These determinants were then linked to intermediate and long-term outcomes 
in a logic model (chapter 4) to describe how changing determinants could possibly 
lead to behaviour change and improved health outcomes. In addition, a maintenance 
programme for the SLIMMER intervention was designed using the Intervention 
Mapping protocol [19]. Specifi c behaviours and determinants for maintenance were 
identifi ed and then linked to behaviour change techniques and practical applications 
[20]. Greaves et al.’s review [13] showed that the use of behaviour change techniques 
(e.g. goal-setting and self-monitoring) was associated with increased intervention 
effectiveness. These techniques were also used in the SLIMMER intervention, thereby 
possibly contributing to intervention effectiveness. Greaves et al. [13] recommend a 
planned approach to intervention design, such as the Intervention Mapping protocol 
[19] used in our study. As discussed below, further research into the relation between 
behavioural determinants and health outcomes in the SLIMMER intervention is 
needed. Secondly, a process evaluation was performed to gain insight into the 
relationship between specifi c intervention activities and outcomes [21]. This provided 
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us with valuable information on intervention elements that were probably linked to 
intervention effectiveness, such as a highly intensive intervention programme, focusing 
on behaviour maintenance, and tailoring the intervention (chapter 6).
Evaluation design
A comprehensive evaluation approach, including effect, process, and economic 
evaluations, was used to investigate causal processes for behaviour change. An effect 
evaluation was used to gain insight into outcomes on several levels (behaviour, health, 
quality of life). A process evaluation was conducted to assess how the intervention was 
delivered and received and how this could explain intervention effectiveness. Finally, 
an economic evaluation was performed to provide valuable information on costs and 
benefits of the intervention. A logic model was composed to describe the hypothesised 
causal pathway. This facilitated the understanding of intervention effectiveness and 
provided insights for further improvements, as discussed below. 
Furthermore, triangulation of qualitative and quantitative data – gathered by a 
combination of multiple methods from both participants and health care professionals 
– increased the credibility and validity of our results. This gave us a profound 
understanding of the delivery of the intervention and possible aspects that could 
explain intervention effectiveness. 
Generalisability to other individuals and settings
The generalisability of intervention results to other individuals and settings can be 
very dependent on these factors [22]. Our study participants were not substantially 
different from non-responders and drop-outs (chapter 5), and, as they were recruited 
by GPs who reach nearly all segments of the population [23], they can be considered 
as a representative sample of patients in the Netherlands. Furthermore, our study 
focussed on high-risk subjects and our study participants indeed could be classified as 
such, as most of them were of an advancing age (mean of 61 years), were overweight 
or obese (48% and 42%, respectively), and had a family history of diabetes (63%). Also, 
subjects with a low socioeconomic status (SES) were successfully reached (53% of the 
participants had a low SES) (chapter 5). The prevalence of type 2 diabetes is especially 
high among low SES subjects [24], and this group is often hard to reach [25, 26]. The fact 
that this group was successfully reached might be due to the fact that participants were 
recruited by GPs, who reach nearly all segments of the population [23], including those 
with a low SES. However, the number of subjects with no education or only primary 
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school (lowest SES group) was rather low in our study (9%). Furthermore, only 11% of 
the study participants were of non-Dutch origin (chapter 5). Therefore, the results of 
our study might not apply to subjects with the lowest SES or to ethnic minorities, and 
the intervention programme might need to be tailored to the specifi c needs of these 
groups. This issue is currently being addressed in the Dutch MetSLIM study [27]. In this 
study, the original SLIM intervention has been adapted to the needs of these specifi c 
groups by providing activities for men and women separately, paying attention to price 
concerns, and providing the programme in the neighbourhood. 
The SLIMMER intervention was implemented in two primary health care settings that 
are considered representative of Dutch primary health care. This was verifi ed during 
the translational process by checking whether adaptations made to SLIM corresponded 
with national health care practices, and the result was positive [6]. However, intervention 
implementation in more rural and remote areas might require additional adaptations 
as facilities might not be available in the neighbourhood. Participants were recruited 
by GPs and practice nurses, and this fi ts in their role as gatekeepers of the Dutch health 
care system [28]. Implementation of this intervention could therefore be generalised to 
countries with similar health care systems, such as the UK and Scandinavian countries, 
whereas implementation in countries with different systems might need adaptations. 
RESULTS IN PERSPECTIVE
The feasibility and potential impact of the intervention were optimised by conducting a 
pilot study (chapter 3), as was also shown in the BRIDGES programme, in which several 
diabetes translational research studies were implemented in real-world settings [7]. 
From our pilot study, we learned that local support among stakeholders was created 
by initiating a local steering committee who took responsibility for the intervention’s 
implementation process. This was also recognised in the BRIDGES programme, where 
strong networks were seen as an enhancer for implementing and disseminating 
interventions [7].
An overview of clinical diabetes prevention trials that were translated into practice 
was given in chapter 2. Since then, increasing attempts have been made to translate 
interventions to real-world settings. However, the translation of effi cacious interventions 
into routine practice remains a challenge [29]. In chapter 5, we showed that the 
SLIMMER intervention improved body weight and several clinical and metabolic risk 
factors, both at 12 and at 18 months. In general, these improvements were stronger than 
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in most other real-world programmes [29-32]. On the basis of the weight loss results in 
our study, we estimated that diabetes risk could be reduced by 43% at 12 months and 
by 40% at 18 months. This is comparable to the 47% risk reduction in the original SLIM 
study [3] and higher than the 26% risk reduction that was revealed in a review of 36 
real-world studies [29]. Possibly, the high intensity of our intervention programme has 
contributed to its effectiveness, as was shown in chapter 6. 
In a recent review, it was stated that effects of dietary intake and physical activity on 
diabetes prevention in real-world settings are poorly reported in the literature [29]. 
In chapter 5, we reported in detail on effects on dietary intake and physical activity. 
We found beneficial changes in intakes of fat, saturated fat, and fibre, and vigorous 
activities. The literature has shown that fat intake, especially saturated fat, is probably 
associated with an increased risk of type 2 diabetes, although evidence is mixed [33-37], 
and that dietary fibre intake [34, 38-41] and increased physical activity [1-3, 42, 43] could 
reduce this risk. 
Our process evaluation revealed that higher intervention intensity (dose received) was 
associated with weight loss and change in dietary behaviour, but not with change in 
physical activity behaviour (chapter 6); this is in line with other studies [13, 29, 44, 45]. 
However, no clear evidence exists for a particular minimum threshold for intervention 
intensity [13]. Also, higher participant satisfaction was associated with increased weight 
loss in our study. Mean participants’ acceptability rating for the overall SLIMMER 
intervention was 82 out of 100. This is slightly higher than in the Dutch Beweegkuur 
lifestyle intervention, with an acceptability rating of 7.7 out of 10 [46]. In general, results 
on process outcomes are difficult to compare between studies, because a systematic 
approach to process evaluation has not been used, and consequently a wide range 
of process indicators and methods are reported in publications. Other intervention 
components that might be associated with increased intervention effectiveness were 
observed in our process evaluation, like targeting both diet and physical activity, 
using behaviour change techniques, focusing on behaviour maintenance, tailoring 
the intervention, and adopting a multidisciplinary approach. These intervention 
components were also found in Greaves et al.’s review [13].  
In chapter 7, we showed that the SLIMMER intervention was more cost-effective from a 
health care perspective than from a societal perspective (ICERs were 28,094/QALY and 
13,605/QALY, respectively). Costs were higher in the intervention group, mostly due to 
costs of the intervention programme and higher productivity losses. A recent systematic 
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review found a median ICER for diet and physical activity programmes of $13,761/QALY, 
from a health care perspective [47]; this is comparable to our ICER. One Dutch primary 
care lifestyle intervention proved to be cost-saving without being effective [48], and 
another Dutch study failed to show cost-effectiveness [49].
IMPLICATIONS FOR PRIMARY HEALTH CARE
Our study showed that the SLIMMER intervention was effective in improving diabetes 
risk factors in the short and the long term (chapter 5), feasible to implement in primary 
health care (chapter 6), and cost-effective from a health care perspective (chapter 7). 
However, several other prerequisites must be met before a sustainable intervention can 
be implemented in routine practice.
Firstly, an infrastructure is needed to scale up intervention implementation. Local 
prevention structures need to be built in which an alliance between public health 
and primary health care is achieved [50]. This alliance was also emphasised in WHO 
European Region’s health policy framework Health 2020: A European policy framework and 
strategy for the 21st century [51]. A Dutch study on promoting collaboration between public 
health and primary care showed that local stakeholders were open to collaboration and 
perceived collaboration as positive [52]. A study on global translational diabetes research 
showed that having a collaboration between several sectors enhanced intervention 
implementation [7]. In our study, a local steering committee was formed, in which 
local authorities, the public health service (community health service), the regional 
supporting organisation for primary care (ROS), and primary health care professionals 
worked together and took responsibility for the intervention’s implementation 
process. The initiation of this local steering committee created local support among 
stakeholders (chapter 3). Often, a third party, such as the community health service in 
our study, is of added value in bringing several parties together [53]. It has, however, 
been shown that sustaining an alliance is diffi cult [53]. Within the Dutch BeweegKuur 
lifestyle intervention, local networks in over 120 municipalities were formed in which 
primary health care, public health, and local sports clubs worked together [54]. Further 
implementation of the SLIMMER intervention might make use of these networks. 
Secondly, an intervention should fi t into the regular functioning and performance 
of health care professionals. Intervention effectiveness might not be achieved if 
intervention providers are unfamiliar with the intervention approach [55]. Furthermore, 
it is likely that deviating from regular functioning and performance will require more 
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training, threaten implementation integrity, and lower professional motivation. Health 
care professionals in our study indicated that the SLIMMER intervention was not very 
different from their regular functioning and professional performance and that a two-
hour kick-off training session was sufficient to make them well-informed and prepared 
for the implementation (chapter 6). 
Thirdly, multidisciplinary teams are needed to effectively implement diabetes prevention 
programmes [56]. In our study, GPs, practice nurses, dieticians, physiotherapists, and 
local sports clubs together implemented the SLIMMER intervention (chapter 4), and 
they appreciated its multidisciplinary nature (chapter 6). GPs are in a unique position 
to provide guidance for diabetes prevention because of their high referral score, high 
perceived expertise, and reach to nearly all segments of the population [23], and almost 
75% of the Dutch population has yearly contact with a GP [57]. However, GPs perceive 
barriers to giving their patients nutrition and physical activity guidance, such as time 
constraints and lack of self-efficacy [58-62]. Nowadays, practice nurses support GPs 
and provide an increasing proportion of preventive lifestyle advice [63]. Although they 
are knowledgeable and patients are satisfied with their care, they perceive the same 
barriers as GPs. Therefore, they need to cooperate with dieticians and physiotherapists 
who are specialists in the area of nutrition and physical activity [63], as was done in 
our study. As GPs act as gatekeepers of the health care system [28], they have natural 
referral lines with dieticians, and often also with physiotherapists (chapter 4). 
However, our health care professionals indicated that multidisciplinary collaboration, 
especially collaboration with physiotherapists, could be improved (chapter 6); this 
is in line with another Dutch study on diabetes care [64]. Health care professionals 
in our study indicated that collaboration between them was better and easier when 
physical distances were short, that is, when they all worked in the same building. This 
was also perceived as a facilitator among Dutch health care professionals in another 
study [64]. Furthermore, GPs’ referral of patients to local sports facilities is low because 
knowledge of these facilities is limited [65], and this might also be true for other health 
care professionals [66]. In our study, local sports clubs were organised in a municipal 
sports stimulation organisation (chapter 4). This organisation provided an overview of 
local sports facilities, which was used during the intervention. Such overviews can guide 
participants from primary health care towards local sports facilities. In addition to such 
overviews, the use of community liaison workers with knowledge of the local situation, 
such as the Dutch neighbourhood sports coaches, may facilitate contact with local 
sports facilities and thereby increase referral of participants to these facilities [65, 66]. 
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Adding a psychologist or psychological care to the intervention programme might 
have been benefi cial for several participants. Several of our health care professionals 
indicated that, for some participants, psychological care was needed before lifestyle 
changes could be made (data not shown). The literature shows that obese people with 
depression, anxiety, family problems, or problems at work are more likely to drop out 
of intervention programmes and are less likely to successfully complete a programme 
[67-69]. These barriers might fi rst have to be resolved before people are able and willing 
to change their lifestyle. A disadvantage, however, is that adding a psychologist or 
psychological care may increase intervention costs.
Fourthly, non-invasive, easy, and cheap screening for people at high risk of type 2 
diabetes is needed, as this is the fi rst step in the prevention of this disease. In our study, 
a two-stage screening approach was used, consisting of identifying high-risk subjects 
from GPs’ patient registration databases followed by fasting plasma glucose testing 
or the Dutch Diabetes Risk Test (chapter 4); this is in line with the guidelines of the 
Dutch College of General Practitioners [70]. We found improvements in weight and 
glucose tolerance, independent of manner of recruitment (chapter 5); this is in line 
with a review by Ashra et al. [29]. Our results therefore suggest that risk scores, such as 
the Dutch Diabetes Risk Test, might be feasible and effective for screening in primary 
health care to identify and recruit people at high risk of type 2 diabetes. In order to 
implement SLIMMER in routine practice, a coordinated screening action is needed. The 
guidelines of the Dutch College of General Practitioners [70] advise using opportunistic 
screening (case fi nding) for diabetes at most once every three years; this is supported by 
a cost-effectiveness study [71]. Therefore, it might be advisable to start a new SLIMMER 
intervention every three years. 
Fifthly, high-risk subjects should be selected properly. Our health care professionals 
suggested applying a stricter selection of those at risk in order to include those most able 
and willing to change. In our study, several participants already had a healthy lifestyle 
at the start of the intervention (chapter 6), and this left less room for improvement. 
Furthermore, some participants had a low motivation to change (chapter 6). Therefore, 
additional screening on intrinsic motivation could identify participants who are 
suffi ciently motivated to take part in the intervention [72], thereby potentially leading 
to increased effectiveness. 
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Sixthly, our pilot study recognised the need for a case manager, an independent health 
care professional who could take action towards professionals and participants in the 
event of difficulties, and thereby enhance participant compliance and the feasibility 
of intervention implementation (chapter 3). Practice nurses were appointed as case 
managers and participants were satisfied with their care (chapter 6); this is in line 
with another study [73]. However, practice nurses indicated that problems appeared 
incidentally, and it was almost never necessary to motivate participants (chapter 6). 
Possibly, the availability of such a person might be sufficient to ascertain and solve 
problems, if needed.
Seventhly, the economic evaluation showed that incremental costs arose mainly from 
costs of the intervention programme (chapter 7), and financial barriers were foreseen 
by health care professionals (chapter 6) as a possible limitation to intervention 
implementation. Therefore, possibilities for reducing intervention costs should be 
considered. In chapter 7, we suggested appointing sports instructors instead of higher-
salaried physiotherapists. Greaves et al.’s review [13] showed that a wide range of 
providers can deliver effective interventions. As stated above, we conclude that GPs 
and practice nurses should not be appointed as lifestyle counsellors, and this seems to 
be confirmed by two Dutch studies on lifestyle interventions to prevent type 2 diabetes 
that were not effective [32, 74]. Furthermore, we could consider providing group-based 
dietary consultations, as Li et al.’s review showed that group-based interventions were 
less costly and more cost-effective than individual-based interventions [47]. Moreover, 
an even more individually tailored intervention approach could be used to reduce costs. 
In this approach, participants are referred earlier to regular sports facilities when they 
are ready to do so, rather than adhering strictly to the programme’s schedule. Another 
possibility for reducing costs is to shorten the intervention period. However, our dose-
response analysis showed that effectiveness was associated with increased dose of the 
intervention received (chapter 6), but the optimum intervention intensity and duration 
are not yet known. Two Dutch studies with a lower intervention intensity than ours 
found no effect [32, 74]. All these suggestions for reducing intervention costs require a 
joint approach by intervention developers, health care professionals, and other parties 
concerned in order for such adaptations to be implemented successfully.
IMPLICATIONS FOR DUTCH HEALTH POLICY 
In the Netherlands, the Ministry of Health, Welfare, and Sport is responsible for the 
national prevention policy. In the government policy document Health nearby, diabetes 
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is indicated as one of the main priorities, and an alliance between primary health 
care and prevention is advocated [75]. A new health policy plan is expected from the 
Dutch government in autumn of 2015, in which diabetes is still indicated as a main 
priority [76]. Because an alliance between primary health care and prevention does not 
naturally exist in the Netherlands, the government supported the realisation of local 
network structures within the Beweegkuur lifestyle intervention [75]. These structures 
can be used by other initiatives, such as the SLIMMER intervention. Furthermore, 
local governments have an important role in formulating local health priorities and 
collaborating with health insurance companies in order to fi nance health care together 
[75]. Recently, the National Prevention Programme was launched, in which integration 
of prevention within primary health care has a prominent place [77].
In addition to policies, standards for prevention of type 2 diabetes in primary health 
care have been developed by the Dutch Diabetes Federation [78] and the Dutch College 
of General Practitioners [70, 79, 80]. In conformity with these standards, individuals 
at increased risk are identifi ed, given general lifestyle advices, and referred to local 
intervention initiatives. In the Netherlands, the Centre for Healthy Living – part of the 
National Institute for Public Health and the Environment – has a recognition system 
in which lifestyle interventions are rated for their quality, effectiveness, and feasibility 
[81]. This system can help primary health care and public health professionals to refer 
individuals to effective interventions. 
Despite these developments, to date there has been no structural embedding of diabetes 
prevention interventions in daily routines. Furthermore, structural funding is lacking. 
Our health care professionals perceived this as a barrier to implementation (chapter 
6); this result confi rmed fi ndings of the Beweegkuur study [46] and the Heartbeat 2 
study [82]. Traditionally, little money has been spent on prevention, and prevention is 
even considered as not ‘sexy’ [53]. The Dutch government does not support the inclusion 
of combined lifestyle interventions in the basic insurance scheme but suggests 
collaboration between local governments, health insurance companies, and other 
local parties to co-fi nance prevention initiatives [75]. Currently, regional collaborations 
between municipalities and health insurance companies are being explored, and these 
offer prospects for the future of SLIMMER. The results of our study (chapters 5, 6, and 
7) therefore provide valuable insights that can contribute to the structural embedding 
and funding of effective diabetes prevention programmes in Dutch primary health care. 
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IMPLICATIONS FOR FUTURE RESEARCH
Although our results contribute to the knowledge on effective implementation of a 
diabetes prevention intervention in primary health care, we can conclude that further 
research is needed.
Firstly, more insight is needed into the effects of our intervention over extended follow-
up in order to determine whether effects are maintained. As discussed in chapter 5, 
most of the outcomes in our study improved and were sustained after 18 months. It is 
well known, however, that maintaining these results over a longer period is difficult [83]. 
Weight reduction during our study was modest, but it is likely to be relevant, as several 
studies have shown than even modest weight reduction can reduce the risk of diabetes 
[84, 85]. On the basis of this weight reduction, we estimated subsequent diabetes risk 
reduction. However, following our participants over a longer time period to investigate 
whether diabetes is actually prevented would provide us with more precise and actual 
information on the reduction in risk. 
Secondly, further investigation of effective intervention components is needed 
in order to identify the most effective intervention programme at lowest cost. In 
chapters 5 and 6, several factors were identified that were associated with increased 
effectiveness. The optimal combination of intervention components, however, 
remains unclear. Combining data on effective intervention components from several 
other Dutch studies (e.g. Aphrodite [32], Hoorn study [74], Beweegkuur [86], GOAL 
[87], IJSCO [88], NDF Road Map [89], DH!AAN [90], and MetSLIM [27]) could provide 
valuable insights.  
Furthermore, investigating behavioural determinants and their relation to health 
is important in order to gain more insight into mechanisms of change. Behavioural 
determinants were linked to behaviour change techniques used in the SLIMMER 
intervention, and several of these techniques (e.g. social support, goal-setting, relapse 
prevention) have been associated with increased intervention effectiveness [13]. 
Knowing which behaviour change techniques contribute to improved health helps to 
identify effective intervention components.
Moreover, insight into dietary intake and physical activity is needed to identify the aspects 
of the intervention that are most strongly associated with decreasing diabetes risk [13]. 
Furthermore, changes in dietary intake and physical activity need to be perceived as 
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feasible by participants. Our study investigated changes in dietary intake and physical 
activity and provided us with more insight into determinants contributing to diabetes 
prevention, such as intake of fat, saturated fat, and fi bre, and vigorous activities (chapter 
5). These changes were moderate but feasible to achieve and may have contributed to 
benefi cial changes in weight and glucose tolerance, thereby contributing to diabetes 
prevention. As noted by Ashra et al., however, overall effects of dietary intake and 
physical activity on diabetes prevention in real-world settings are poorly reported in 
the literature [29].
Thirdly, it is important to evaluate the consequences of the above-suggested adaptations 
of the intervention programme on intervention effectiveness. This could provide useful 
information on an optimal intervention strategy for diabetes prevention.
Fourthly, more insight into longer-term cost-effectiveness is needed, and therefore 
the results of our study should be modelled to a lifetime horizon. We expect more 
favourable cost-effectiveness on the longer term because our study found benefi cial 
effects on intermediate outcomes (chapter 5), indicating that diabetes will be 
postponed or prevented, leading to cost savings in the future. This is supported by Li 
et al.’s review which showed that interventions were most cost-effective in the longer 
term, indicating that short-term studies have are limited in their ability to capture 
the full range of intervention’s health benefi ts and cost savings [47]. Furthermore, it 
is shown that lifestyle interventions are much more cost-effective than many diabetes 
treatment interventions, such as intensive glycaemic control [91]. 
OVERALL CONCLUSION
In conclusion, this study showed that a thorough preparation of translation and 
implementation has led to a cost-effective intervention to prevent type 2 diabetes 
which is feasible to implement in Dutch primary health care. In fact, our clinical effects 
were larger than those in most other real-world intervention programmes, and we 
provided additional insight into dietary intake and physical activity. Further research is 
needed on effects and costs over longer follow-up, effective intervention components, 
and consequences of suggested adaptations of the programme on intervention 
effectiveness. The results of this study provide valuable insights that can contribute to 
the structural embedding and funding of effective diabetes prevention programmes in 
Dutch primary health care.
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Diabetes is a worldwide epidemic, causing a high disease and economic burden. Type 2 
diabetes, the most common form of diabetes, is associated with an unfavourable lifestyle, 
including overweight and obesity, unhealthy diet, and physical inactivity. Over the last 
two decades many large-scale experimental trials have shown that type 2 diabetes can 
be delayed or prevented by lifestyle modification in high-risk subjects. This evidence has 
been translated and implemented in interventions in real-world settings, however, this 
remains a challenge. At the time this project started, translation and implementation 
of a (cost-)effective diabetes prevention programme in Dutch primary health care 
was lacking. Therefore the SLIMMER study (SLIM iMplementation Experience Region 
Noord- en Oost-Gelderland) was started in which the SLIM intervention, revealing a 
47% diabetes risk reduction, was translated to Dutch primary health care. The overall 
objective of this study was to improve the lifestyle behaviour in high-risk subjects in 
order to reduce the risk of developing type 2 diabetes. The main findings of this research 
project as described in chapters 2 to 7 are summarised below.
The literature in chapter 2 showed that, all over the world, clinical diabetes prevention 
trials have been translated to daily practice. In Dutch practice, however, this was still 
lacking. Therefore, the SLIMMER project was started in which the SLIM intervention was 
translated to practice. The adapted SLIM intervention, called SLIMMER, consisted of a 
10-month combined dietary and physical activity programme. A one-year pilot study 
was conducted to test its applicability in Dutch primary health care, guided by a process 
evaluation. Collaboration between professionals from primary health care and public 
health was considered necessary to prevent diabetes.
When diabetes prevention programmes are translated to real-world settings, 
adaptations are inevitable and this may have unknown consequences for effectiveness 
of the intervention. Therefore, a pilot study with process evaluation was conducted 
to test the feasibility and desired impact of the SLIMMER intervention (chapter 3). 
The pilot study (n = 31) showed that inclusion and retention of high-risk subjects was 
successful and that both participants and health care professionals were satisfied with 
the SLIMMER intervention. Overall, the intervention was implemented as planned 
and appeared to be suitable for application in practice. Some improvements regarding 
measurements, planning aspects of intervention elements, and organisational matters 
were identified. Refinements (e.g. including monitoring, a case manager, and a 
maintenance programme) were made prior to further implementation and evaluation. 
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A comprehensive evaluation approach is required, as interventions in real-world settings 
are often complex and not delivered in tightly controlled environments. The evaluation 
design of the SLIMMER intervention was described in chapter 4. A logic model of 
change was composed to link intervention activities, their mechanisms of change 
(i.e. behavioural determinants), expected behaviours, and intervention outcomes in a 
logical order. The SLIMMER intervention consisted of a 10-month dietary and physical 
activity intervention, including case management and a maintenance programme. The 
effectiveness of the intervention was tested in a randomised controlled trial, including 
outcomes at several levels: quality of life, health outcomes, dietary and physical 
activity behaviours, and behavioural determinants. In addition, a process evaluation 
was conducted to assess how the SLIMMER intervention was delivered and received in 
Dutch primary health care. Furthermore, an economic evaluation was performed, both 
from a societal and health care perspective. 
The effect of the SLIMMER diabetes prevention intervention in Dutch primary health care 
on clinical and metabolic risk factors (primary outcome fasting insulin), dietary intake, 
physical activity, and quality of life after 12 and 18 months, was tested in a randomised 
controlled trial (chapter 5). We found that after 12 and 18 months, the intervention 
group signifi cantly improved weight (β=-2.7 kg and β=-2.5 kg, respectively) and fasting 
insulin (β=-12.1 pmol/l and β=-8.0 pmol/l, respectively) compared with the control 
group. Intervention subjects improved weight and glucose tolerance, independent of 
manner of recruitment (laboratory glucose test or Diabetes Risk Test). Furthermore, 
intake of total and saturated fat decreased and fi bre intake increased in the intervention 
group compared with the control group, both at 12 and at 18 months (p < 0.05). Fruit 
intake increased at 12 but not at 18 months, whereas vegetable intake increased at 18 
but not at 12 months. The DHD-index score – indicating adherence to the Dutch dietary 
guidelines – was signifi cantly higher in the intervention group than in the control group, 
both at 12 and at 18 months (p < 0.05). Vigorous activities and physical fi tness improved 
both at 12 and at 18 months. Finally, benefi cial changes in several domains of quality of 
life were found both at 12 and at 18 months, although not all domains reached statistical 
signifi cance.
As described in chapter 6, a process evaluation was conducted to gain insight into how 
the SLIMMER intervention was delivered and received and to identify intervention 
components that contribute to intervention effectiveness. The process evaluation 
showed that 316 high-risk subjects were recruited. The actual dose that intervention 
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subjects received was in line with the planned dose according to the manual. Overall, 
participants and health care professionals were highly satisfied with the SLIMMER 
intervention, with mean acceptability ratings of 82 and 80 (out of 100), respectively. The 
intervention programme was to a large extent implemented according to the manual 
and fitted well within the regular functioning and professional performance of health 
care professionals. Higher dose received and participant acceptability were related to 
improved health outcomes and dietary behaviour, but not, however, to physical activity 
behaviour. Furthermore, targeting both diet and physical activity, using behaviour 
change techniques, focusing on behaviour maintenance, tailoring the intervention, and 
adopting a multidisciplinary approach may have facilitated intervention effectiveness. 
The economic evaluation in chapter 7 showed that the SLIMMER intervention was both 
more costly and more effective than usual health care. As expected, the intervention 
group had a lower health care utilisation and reported less presenteeism than the usual 
health care group. The cost-effectiveness analysis showed that the incremental costs 
of the SLIMMER lifestyle intervention were €547 and the incremental effect was 0.02 
QALY, resulting in an incremental cost-effectiveness ratio (ICER) of 28,094/QALY. From a 
health care perspective, the ICER decreased to 13,605/QALY, with a moderate probability 
of being cost-effective (56% at a willingness to pay (WTP) of €20,000/QALY and 81% at 
a WTP of €80,000/QALY). Intervention costs could be decreased to a certain extent to 
further enhance cost-effectiveness.
In conclusion, this study showed that a thorough preparation of translation and 
implementation has led to a cost-effective intervention to prevent type 2 diabetes 
which is feasible to implement in Dutch primary health care. In fact, our clinical effects 
were larger than those in most other real-world intervention programmes, and we 
provided additional insight into changes in dietary intake and physical activity. Further 
research is needed on effects and costs over longer follow-up, effective intervention 
components, and consequences of suggested adaptations of the programme on 
intervention effectiveness. The results of this study provide valuable insights that can 
contribute to the structural embedding and funding of effective diabetes prevention 
programmes in Dutch primary health care.
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Diabetes is een wereldwijde epidemie die gepaard gaat met een grote ziektelast en 
hoge kosten. Type 2 diabetes, de meest voorkomende vorm van diabetes, is geassocieerd 
met een ongunstige leefstijl, waaronder overgewicht en obesitas, ongezonde voeding 
en lichamelijke inactiviteit. In de afgelopen twee decennia hebben vele grote studies 
aangetoond dat type 2 diabetes in hoog-risico personen uitgesteld of voorkomen kan 
worden door leefstijlverandering. Dit bewijs is verkregen in een onderzoeks-setting 
en dit is vervolgens vertaald naar interventies in de dagelijkse (zorg)praktijk. De 
implementatie van dergelijke interventies blijft echter een uitdaging. Op het moment 
dat het huidige project startte, bestond er nog geen vertaling en implementatie van 
een (kosten)effectief diabetes preventie programma in de Nederlandse eerstelijnszorg. 
Daarom is de SLIMMER studie (SLIM iMplementation Experience Region Noord- en 
Oost-Gelderland) gestart. In deze studie is de SLIM-interventie, die het risico op diabetes 
met 47% verlaagde, vertaald is naar de Nederlandse eerstelijnszorg. Het doel van de 
SLIMMER studie was het verbeteren van het leefstijlgedrag in hoog-risico personen 
om zo het risico op type 2 diabetes te verminderen. De belangrijkste bevindingen van 
dit onderzoeksproject, zoals beschreven in de hoofdstukken 2 tot en met 7, worden 
hieronder samengevat. 
De literatuur in hoofdstuk 2 laat zien dat klinische diabetespreventie studies 
wereldwijd zijn vertaald naar de dagelijkse praktijk. Echter, in de Nederlandse praktijk 
ontbrak dit nog. Daarom werd het SLIMMER project gestart, waarin de SLIM-interventie 
werd vertaald naar de praktijk. Het SLIMMER-project bestond uit een gecombineerd 
voedings- en beweegprogramma van 10 maanden. Samenwerking tussen zorgverleners 
uit de eerstelijnszorg en de publieke gezondheidszorg werd noodzakelijk geacht om 
diabetes te voorkomen. Ook het aanstellen van een casemanager die samenwerkt met 
alle betrokken zorgverleners werd noodzakelijk geacht.
Aanpassingen zijn onvermijdelijk wanneer diabetespreventie programma’s naar de 
dagelijkse (zorg)praktijk worden vertaald. Dit kan mogelijk gevolgen hebben voor de 
effectiviteit van de interventie. Daarom werd een pilotstudie met een procesevaluatie 
uitgevoerd om de haalbaarheid en de gewenste impact van de SLIMMER-interventie te 
testen (hoofdstuk 3). De pilotstudie (n = 31) toonde aan dat de werving en het behoud 
van hoog-risico personen in de interventie succesvol was en dat zowel deelnemers als 
zorgverleners (praktijkondersteuners, diëtisten en fysiotherapeuten) tevreden waren 
met de SLIMMER-interventie. Over het algemeen werd de interventie uitgevoerd 
zoals gepland en bleek deze ook geschikt te zijn voor toepassing in de praktijk. 
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Enkele verbeteringen ten aanzien van metingen, planning van interventie-elementen 
en organisatorische zaken werden gesignaleerd. Aanpassingen aan het SLIMMER 
programma (bijvoorbeeld het toevoegen van monitoring, een casemanager en een 
uitstroomprogramma) werden gedaan voorafgaand aan verdere implementatie en 
evaluatie. 
Een uitgebreide evaluatie is nodig, omdat interventies in de dagelijkse (zorg)
praktijk vaak complex zijn en niet worden uitgevoerd in een volledig gecontroleerde 
omgeving. Het evaluatiedesign van de SLIMMER-interventie wordt in hoofdstuk 4 
beschreven. Een logisch model werd samengesteld om interventie-activiteiten, hun 
mechanismen voor verandering (gedragsdeterminanten), verwachte gedragingen en 
interventie-uitkomsten op een logische manier met elkaar te verbinden. De SLIMMER-
interventie bestond uit een voedings- en beweegprogramma van 10 maanden, inclusief 
casemanagement en een uitstroomprogramma. Deelnemers kregen persoonlijke 
adviezen van een diëtist en sportten tenminste een keer per week in een speciaal 
SLIMMER groepje onder leiding van een fysiotherapeut. Ook maakten ze kennis 
met lokale sportverenigingen. De controlegroep kreeg de gebruikelijke zorg van 
de huisarts. De effectiviteit van de interventie werd getest in een gerandomiseerde 
gecontroleerde studie, met uitkomsten op verschillende niveaus: kwaliteit van leven, 
gezondheidsuitkomsten, voedings- en beweeggedrag en gedragsdeterminanten. 
Daarnaast werd een procesevaluatie uitgevoerd om te onderzoeken hoe de SLIMMER-
interventie werd uitgevoerd en ontvangen in de Nederlandse eerstelijnszorg. 
Aanvullend werd een economische evaluatie uitgevoerd, zowel vanuit een 
maatschappelijk perspectief als een gezondheidszorg perspectief. 
Door middel van de gerandomiseerde gecontroleerde studie werd onderzocht wat 
het effect van de SLIMMER-interventie was op klinische en metabole risicofactoren 
(primaire uitkomstmaat nuchter serum insulinegehalte), voedingsinname, 
lichamelijke activiteit en kwaliteit van leven na 12 maanden en zes maanden na 
afloop van de interventie (hoofdstuk 5). We vonden na 12 en 18 maanden signifi cante 
verbeteringen in de interventiegroep ten opzichte van de controlegroep in gewicht 
(β=-2.7 kg en β=-2.5 kg, respectievelijk) en nuchter insuline (β=-12.1 pmol/l en β=-8.0 
pmol/l, respectievelijk). Personen in de interventiegroep verbeterden hun gewicht en 
glucosetolerantie onafhankelijk van de manier van werving (via een glucosetest of via 
de Diabetes Risico Test). Verder verminderde de inname van totaal en verzadigd vet en 
steeg de inname van vezels in de interventiegroep in vergelijking met de controlegroep, 
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zowel op 12 als 18 maanden (p < 0.05). Fruitconsumptie nam toe na 12 maanden, maar 
niet na 18 maanden, terwijl groenteconsumptie toenam na 18 maanden, maar niet na 
12 maanden. De DHD-index score, die aangeeft in welke mate men voldoet aan de 
Nederlandse voedingsrichtlijnen, was significant hoger in de interventiegroep dan in 
de controlegroep, zowel op 12 als 18 maanden (p < 0.05). Zware fysieke activiteiten en 
fysieke fitheid verbeterden zowel na 12 maanden als na 18 maanden. Tot slot werden 
gunstige veranderingen in verschillende domeinen van kwaliteit van leven gevonden, 
zowel na 12 als na 18 maanden, maar niet in alle domeinen was het effect statistisch 
significant. 
Zoals beschreven in hoofdstuk 6, werd een procesevaluatie uitgevoerd om inzicht 
te krijgen in hoe de SLIMMER-interventie was uitgevoerd en ontvangen, en om 
interventie-componenten te identificeren die bijdragen aan effectiviteit van de 
interventie. De procesevaluatie liet zien dat 316 hoog-risico personen zijn geworven. 
Het daadwerkelijke aantal voedingsconsulten en sportlessen (dosis) dat interventie-
personen hebben ontvangen, was in lijn met de geplande dosis zoals beschreven in 
het draaiboek. Over het geheel waren deelnemers en zorgverleners zeer tevreden met 
de SLIMMER-interventie, met gemiddelde tevredenheidsscores van respectievelijk 82 
en 80 (op een schaal van 1 tot 100). Het interventie-programma werd in grote lijnen 
uitgevoerd volgens het draaiboek en paste goed binnen het reguliere functioneren en 
professionele handelen van zorgverleners. Een hogere ontvangen dosis en een hogere 
tevredenheid bij deelnemers waren gerelateerd aan betere gezondheidsuitkomsten en 
voedingsgedrag, maar niet aan beweeggedrag. Andere factoren die mogelijk hebben 
bijgedragen aan de effectiviteit van de interventie waren: een programma dat zowel op 
voeding als bewegen was gericht, het gebruik van gedragsveranderingstechnieken, de 
focus op gedragsbehoud, het op maat aanbieden van de interventie (‘tailoring’) en de 
multidisciplinaire aanpak. 
De economische evaluatie in hoofdstuk 7 liet zien dat de SLIMMER-interventie zowel 
duurder als effectiever was dan reguliere zorg. Zoals verwacht had de interventiegroep 
een lager zorggebruik en rapporteerde deze groep minder arbeidsproductiviteitsverlies 
dan de controlegroep. De kosteneffectiviteitsanalyse liet zien dat de netto kosten van 
de SLIMMER-interventie €547 bedroegen en dat het netto effect 0.02 QALY was. Dit 
resulteerde in een netto kosteneffectiviteitsratio (ICER) van €28,094/QALY. Vanuit een 
gezondheidszorg perspectief daalde de ICER tot 13,605/QALY, met een matige kans dat 
de interventie kosteneffectief zou zijn (56% bij een betalingsbereidheid van €20,000/
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QALY en 81% bij een betalingsbereidheid van €80,000/QALY). Interventiekosten 
zouden tot een bepaalde hoogte kunnen worden beperkt om de kosteneffectiviteit 
verder te vergroten, zoals het aanstellen van een goedkopere sportinstructeur in plaats 
van een fysiotherapeut, het aanbieden van groepsconsulten bij de diëtist en het nog 
meer op maat maken van het programma.
Samenvattend heeft deze studie laten zien dat een gedegen voorbereiding van de 
vertaling en implementatie heeft geleid tot een kosteneffectieve interventie ter preventie 
van type 2 diabetes, die uitvoerbaar is in de Nederlandse eerstelijnszorg. Daarbij waren 
onze klinische effecten groter dan in de meeste andere interventieprogramma’s in de 
dagelijkse (zorg)praktijk. We hebben daarnaast de veranderingen in voedingsinname 
en beweging inzichtelijk gemaakt. Verder onderzoek is nodig naar de effecten en kosten 
op de langere termijn, de effectieve interventie-componenten en de gevolgen van de 
voorgestelde aanpassingen van het programma op de effectiviteit van de interventie. De 
resultaten van deze studie bieden waardevolle inzichten die kunnen bijdragen aan de 
structurele verankering en fi nanciering van effectieve diabetespreventie programma’s 
in de Nederlandse eerstelijnszorg.
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OVERVIEW OF COMPLETED TRAINING ACTIVITIES
    
Discipline specific activities Institute and location Year
Courses and workshops
Introduction to public health economy NSPOH, Amsterdam 2010
Masterclass ‘Public health interventions in real-life settings: the 
AGORA experience’
VLAG/AGORA, 
Wageningen 
2010
Masterclass ‘Multilevel analysis’ VLAG, Wageningen 2011
Introduction to structural equation modeling using Mplus Utrecht University, 
Utrecht 
2012
Introduction to multilevel analysis Utrecht University, 
Utrecht 
2012
Masterclass ‘How to develop effective interventions in public health 
practice’
VLAG/AGORA, 
Wageningen
2012
Methodology in health economic evaluation UMC Utrecht/Julius 
Centre, Utrecht 
2013
Masterclass ‘Confounding’ VLAG, Wageningen 2014
Conferences and meetings
PREVENT-2010: National congress structured prevention of chronic 
diseases
NDDO Education 
Foundation, Oegstgeest 
2010
European public health conferencea EUPHA, Amsterdam 2010
Heelsum VI: Practice-based evidence for weight managementa Heelsum Collaboration, 
Heelsum 
2010
Dutch public health congress (NCVGZ) Amsterdam 2011
Behaviour change symposium Maastricht University, 
Maastricht 
2011
Multidisciplinary symposium dieticians cooperation Netherlandsa DCN, Utrecht 2011
Annual meeting NWO nutrition NWO, Deurne 2011
World congress on prevention of diabetes and its complicationsa Madrid (Spain) 2012
NVDO young investigators meetinga NVDO, Zaltbommel 2013
Dutch public health Congress (NCVGZ)a Ede 2013
National diabetes day NDF, Den Haag 2014
Dutch public health Congress (NCVGZ) Rotterdam 2014
Public lecture ‘Nutrition, diabetes and my doctora VLAG, Wageningen 2014
Expert meeting on implementation of diabetes prevention 
interventions in real-life settingsa
CNAMTS, Paris (France) 2014
Annual Dutch diabetes research meetinga NVDO, Oosterbeek 2014
FENS European nutrition conferencea FENS, Berlin (Germany) 2015
World diabetes congressb IDF, Vancouver (Canada) 2015
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General courses and workshops Institute and location Year
Teaching and supervising thesis students DO, Wageningen 2009
24th Edition of the PhD introduction week VLAG, Baarlo 2010
PhD Competence assessment WGS, Wageningen 2011
Information literacy including EndNote introduction WUR library, 
Wageningen
2011
Mini-symposium ‘How to write a world class paper’ WUR library, 
Wageningen
2011
Interviewing techniques YRM/WUR, 
Wageningen
2011
Workshop ‘Successful presenting’ Mennen Training 
& Consultancy, 
Wageningen
2011
Techniques for writing and presenting a scientifi c paper WGS, Wageningen 2012
Career assessment WGS/Meijer & 
Meijaard, Wageningen
2014
Career perspectives WGS, Wageningen 2015
Optional courses and activities Institute and location Year
Preparing PhD research proposal VLAG, Wageningen 2010
Literature and discussion groups: ‘Epi-research club’, ‘Methodology 
club’, ‘Rothman lunch’, ‘Paperclip club’
HNE, Wageningen 2010-2015
PhD tour organising committee HNE/VLAG, 
Wageningen
2010-2011
PhD study tour Mexico & USAa,b HNE/VLAG, 
Wageningen
2011
PhD study tour Australiaa HNE/VLAG, 
Wageningen
2013
a oral presentation given; b poster presentation given
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De cirkel is rond! Na ruim 5 jaar werken aan het SLIMMER project, ligt het proefschrift 
er nu toch echt! En dat was niet gelukt zonder de hulp van velen, waarvoor dank!
Edith, Gert Jan en Annemien, wat heb ik het getroffen met jullie als begeleiders! 
Edith, jouw kennis, enthousiasme en interesse hielpen mij steeds weer op weg. Dank 
daarvoor! Gert Jan, jouw ervaring, peptalks en immer optimistische kijk heb ik zeer 
gewaardeerd. Annemien, dankzij jou kwam ik in een warm nest terecht en daar ben ik 
je zeer dankbaar voor. Fijn dat jouw deur altijd open stond voor advies en een luisterend 
oor, ook buiten het werk om!
Sofieke en Josien, waar zouden het SLIMMER project en ik zijn geweest zonder jullie 
tomeloze inzet en enthousiasme! Sofieke, ik heb veel van je geleerd en bewonder jouw 
manier van doen enorm. Het was fijn om altijd mijn ei bij je kwijt te kunnen! Josien, 
de manier waarop jij de praktijk betrekt, heb ik enorm gewaardeerd en de positieve 
energie die jij uitstraalt, werkt aanstekelijk! Ardine, bedankt voor jouw kennis en hulp 
bij de economische evaluatie. Wat heb ik in korte tijd veel van je geleerd! Dank voor de 
prettige samenwerking.
Graag wil ik Prof. Pieter van ’t Veer, Prof. Guy Rutten en Prof. Caroline Baan bedanken 
voor het plaatsnemen in mijn promotiecommissie. I would like to show my gratitude to 
Prof. Jaana Lindström for coming to the Netherlands to be part of the thesis committee.
Het SLIMMER project was nooit mogelijk geweest zonder de enthousiaste inzet van 
alle deelnemers en betrokken zorgverleners in Apeldoorn en Doetinchem, ontzettend 
veel dank daarvoor! De positieve verhalen van deelnemers en de fijne samenwerking 
met huisartsen, POH’ers, diëtisten en fysiotherapeuten maakten het voor mij dubbel 
zo leuk!
En er waren zo ontzettend veel meer mensen en organisaties die hun steentje op wat 
voor manier, maar hoe dan ook belangrijk, hebben bijgedragen. Gemeenten Apeldoorn 
en Doetinchem, Caransscoop, Huisartsenzorg regio Apeldoorn, Menzis, Bureau BS&F, 
Accres, sportverenigingen in Apeldoorn en Doetinchem, Vérian, SaFyrA en vrijgevestigd 
diëtisten en fysiotherapeuten, dank voor jullie inzet. Medisch Centrum de Veluwe, De 
Rozengaarde en Astrid Wenneker, dank voor het openstellen van jullie locaties voor 
ons onderzoekscentrum. Topshare, wat hadden we een mooie website! SHO en alle 
verpleegkundigen, dank voor alle bloedafnames en analyses.
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Mijn collega’s bij Humane Voeding, zonder jullie was het lang zo leuk niet geweest! 
Rianne, Marieke en Ellen, wat was het fi jn om lief en leed met jullie te delen. Betere 
kamergenootjes kon ik me niet wensen. Rianne, ik mis je nog regelmatig als stabiele 
en gezellige factor! Marieke, ook jouw boekje is klaar, fi jn dat we deze laatste loodjes 
samen konden doen! Ellen, dankzij jouw terreur zijn we ver gekomen, ik had me geen 
betere partner in crime kunnen wensen, je bent een topper . Sandra, uren hebben we 
gekletst over onze onderzoeken en alles daarbuiten, top! Elise, uit het oog maar zeker 
niet uit het hart, wat heb ik genoten van onze wandelingen en gesprekken! Joanne, 
we hebben een bijzonder jaar achter de rug , fi jn om werk en privé te kunnen delen! 
Alle dames van het secretariaat, dank voor jullie hulp en het inplannen van zovele 
overleggen. Corine, dank voor alle hulp bij de FFQ! Alle AIO-genootjes en collega’s: het 
was gezellig en fi jn om met jullie samen te werken!
Mijn collega’s bij de GGD, ook jullie bedankt voor de samenwerking! Het was waardevol 
en leuk om ook in jullie wereld mee te draaien. Judith, bedankt voor je hulp bij de KEA, 
het was fi jn om met je te sparren en op pad te gaan! Carolien en Cobi, dank voor jullie 
enthousiaste inzet en samenwerking. Carolien, jouw rust, hulp en ervaring waren 
ontzettend fi jn! Cobi, jij was de frisse wind die ons project nodig had, dank voor je 
enthousiasme! Ingrid, dank voor je interesse en inzet voor SLIMMER! Dames van het 
secretariaat: dank voor al jullie hulp!
Vele handen maken licht werk! Alle onderzoeksmedewerkers en studenten die mij 
hebben geholpen tijdens de metingen in het onderzoekscentrum, zonder jullie hulp 
was het nooit gelukt! Jolien, Paulien, Mirjam, Lisette en Ellen, dank voor jullie inzet! 
Alle studenten hartelijk dank voor jullie bijdragen aan mijn onderzoek, het was leuk en 
leerzaam om met jullie samen te werken: Jorien, Carlijn, Ellen Elsman, Lianne, Moniek, 
Dorien, Janet, Fallon, Celine, Sanne, Aafke, en Maartje. Ellen Elsman en Marleen, bedankt 
voor het uitwerken van alle interviews!
Wat zou het leven zijn zonder vrienden... Mijn liefste miepjes, ruim 10 jaar later is de 
club nog steeds compleet! Siets, wat hebben we het goed en leuk samen! Annemarie, 
naast vriendinnetje ook collega, was dat even boffen! Anke, Eline, Frederike, Madeleen, 
Marijke en Nynke, dank voor de gezelligheid en luisterend oor, hopelijk blijven we nog 
jarenlang compleet! Doorlianne, soms lijkt groep 3 nog maar zo kort geleden... Fijn 
om al zolang alles met jou te kunnen delen! Corine, dank voor je altijd wijze woorden 
en gezelligheid, fi jn om zo’n bijzondere vriendin te hebben! Carola, Mariëtte, Mariska, 
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Antje en Marjolein, kletsen, thee drinken en lekker eten, blijven we hopelijk nog heel 
lang doen! 
Alles is familie... Wat is het fijn om een lieve familie te hebben! Papa en mama, dank 
voor alle kansen die jullie me hebben gegeven! Het is fijn om nog altijd een echt thuis 
te hebben! Berdike, jij bent bijzonderder dan ik je ooit kan zeggen, dank voor alles. Een 
betere zus kan ik me niet wensen! Kleine broertjes worden groot, lieve Gijs, ook voor 
jou is het studeren (bijna) klaar. Ik hoop dat je een mooie weg tegemoet gaat (en wat 
betreft voeding: ik heb gelijk!)! Lieve oma, wat kom ik graag bij u langs, dank voor de 
gezelligheid en het heerlijke eten! Herman en Baukje, fijn om ook bij jullie familie te 
mogen horen, dank voor alles! Esther, Wouter, Jesse, Cisca en Frans, fijn dat jullie met 
me hebben meegeleefd!
Tot slot mijn twee grote mannen, waar zou ik zijn zonder jullie! Lieve André, jij hield 
me met beide benen op de grond en draaide rondjes met me als dat nodig was. Zonder 
jouw hulp was ik niet zover gekomen. Dikke tút voor jou . Lieve Jitse, jij bent het 
mooiste wat me in deze vijf jaren is overkomen. Wat is het fijn dat jij er bent, jij laat me 
zien waar het in het leven om draait. De cirkel is rond!
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